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Nodes of Ranvier (NORs) are characteristics of the myelinated axon. By now, 
the molecular mechanisms underlying glial regulation of NORs largely remain 
poorly-established. In the central nervous system (CNS), 
myelin/oligodendrocyte-derived proteins such as tenascin-R (TN-R), 
myelin-associated glycoprotein (MAG), Nogo-A and oligodendrocyte-myelin 
glycoprotein (OMgp) are long-believed playing adverse roles in neuronal/axonal 
regrowth. But yet, some of them have been implicated in axon-glial interactions 
occurring at the NORs.  
The current study was focused to identify roles of these inhibitory proteins in 
the axon-glial communication and myelin development. By immunofluoresent (IF) 
staining, OMgp and Nogo-A were newly identified as clusters in the nodal and 
paranodal domains respectively; whereas their common receptor NgR evenly 
distributed along the axons. Immunoprecipitation (IP) and several cell biology 
approaches further enunciated that Nogo-A, via Nogo-66, interacted with the 
junction-associated protein Caspr/paranodin, by which means it could contribute to 
integrity of the paranodal axon-glial junction. In demyelinating conditions such as in 
the experimental autoimmune encephalomyelitis (EAE) rats, the ceramide 
galactosyltransferase (CGT) and myelin basic protein (MBP) deficient mice, 
disruption of Nogo-A-Caspr interaction, although to different severity, concurred with 
a common misplacement of the shaker family potassium (Kv1) channels. These 







OMgp may exist as a secreted molecule from oligodendrocytes in the CNS 
and likely from Schwann cells in the peripheral nervous system (PNS). In the spinal 
cord, nodal accumulation of this Gal (beta 1-3) GalNAc antigen bearing glycan was 
proportionately associated with axon diameters. At the nodes, OMgp co-localized and 
complexed with abundant extracellular matrix (ECM) and axonal molecules including 
TN-R and Nav channel subunits. The developmental studies further demonstrated that 
the expression and clustering of OMgp correlated with myelin maturation and nodal 
formation at late phase. To examine role of OMgp in clustering Nav channels, purified 
retinal ganglion cells (RGCs) were exposed to OMgp protein in culture. However, 
Nav1.2 was uniformly labeled along the neurites, suggesting that OMgp may not be 
essential for accumulation of Nav channels at the NORs. Moreover, to address 
whether OMgp involves myelination and nodal formation/maintenance, an antisense 
OMgp transgenic (tg) mouse was generated to selectively down-regulate OMgp’s 
expression in myelin-producing glial cells. Unexpectedly, analyses showed that in 
these mice, myelination was inversely affected in the CNS and PNS: 
hypo-myelination in the spinal cord but hyper-myelination in the sciatic nerve. 
Nevertheless, transverse bands were normally matured. 
Remarkably, nodal architecture in the OMgp tg mice was impaired. A 
substantial portion of the lateral glial loops remained unlanded and the nodal span was 
strikingly shortened. As a control, TN-R knock-out mice exhibited none of these 
phenotypes. Hence, these observations indicated that OMgp could regulate the 






mechanical signal to counteract the internodal extension. Moreover, Nav channel α 
subunit was considerably down-expressed in the OMgp tg mice. Given that it readily 
interacts with Nav β subunits, OMgp is implicated as a regulator of channel 
expression. In the OMgp tg mice, recording of action potentials along the ventral 
funiculus of spinal cords revealed a slowed conduction which could be a consequence 
of these abnormalities. In contrast to TN-R, however, OMgp protein did not show a 
direct modulation of Na+ currents as recorded from the Chinese hamster lung (CHL) 
cells or hippocampal neurons.   
Collectively, the results obtained in the current study provide deeper insight 
into the mechanisms of how oligodendrocytes regulate organization of the axonal 
domains, and probably, the expression and functions of Nav and Kv1 channels. The 
present findings also corroborated the hypothesis that myelin inhibitory proteins may 
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CHAPTER 1 INTRODUCTION 
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1. Neuronal polarity and axonal initial segment 
The mammalin nervous system is made up of neurons and a rich variety of glial cells, 
including oligodendrocytes, astrocytes, and microglia in the central nervous system 
(CNS) and Schwann cells in the peripheral nervous system (PNS).  
Neurons, similar to epithelial cells, are extremely polarized cells (Horton and 
Ehlers, 2003; Salzer, 2003). Even after dissociation, neurons in culture develop 
physically and functionally specialized membrane domains, which include two 
distinct types of processes called the dendrite and the axon (Craig and Banker, 1994). 
Each neuron is recognized with multiple dendrites and a single axon that is the longest 
process and roughly uniform in diameter. Generally speaking, dendrites receive 
electrical inputs via synapses from a broad field whereas axons transmit efferent 
signals to the terminus, which are generated in cell body by integrating all the 
dendritic inputs. Axons and dendrites themselves can be further polarized (e.g., apical 
versus basolateral dendrites; myelinated versus unmyelinated axons). In particular, 
myelinated axons are even further polarized at both radial and longitudinal directions 
according, in large amount, to the principles adopted by epithelial cells (Salzer, 2003).  
The specialized morphology of neurons is determined predominantly by the 
cytoskeleton network which is composed of three main filamentous structures: 
microtubules, neurofilaments, and actin microfilaments (Kandel et al., 2000). How is 
the neuronal polarity established and maintained? Studies done in yeast, fibroblasts, 
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clearance of proteins and lipids, the stable anchoring to underlying cytoskeleton, and 
the junctional barriers against free diffusion, all of which are conserved to neurons 
(Winckler and Mellman, 1999; Horton and Ehlers, 2003). Establishment and 
maintenance of cell polarity require the combination of these machineries, each of 
which is believed to involve several signaling cascades and a large number of proteins. 
In addition to intrinsic machineries, extracellular cues, such as neurotrophins, bone 
morphogenetic proteins (BMPs) and semaphorins, also play a role in regulating 
neuronal polarity in vivo (for review see Horton and Ehlers, 2003).    
The initial event in establishing neuronal polarity is the determination of the 
single axon (Fukata et al., 2002). Axons contain a repertoire of molecules that is 
absolutely distinct from what appear in the somatodendritic compartment. Proteins 
that are exclusively transported to axons include NgCAM/L1, Kv1.2, Nav1.2/1.6 and 
so on (Garrido et al., 2001; Gu et al., 2003; Sampo et al., 2003). Just beyond the 
axonal hillock the axonal initial segment (AIS) serves this polarity as a diffusion 
barrier between the axon and somatodendritic compartments (Boiko and Winckler, 
2003; Dotti and Poo, 2003). The AIS is thought to be intrinsically specified owing to 
the observations that cultured neurons form it even in the absence of glial cells 
(Catterall, 1981; Winckler et al., 1999). Undoubtedly, axonal targeting of Na+ and K+ 
channels constitutes the molecular basis for generation and traveling of action 
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2. Myelination and axonal polarity 
In vertebrate nervous systems, nerve impulses generated in excited neurons propagate 
much more rapidly along the shaft of myelinated axons than in unmyelinated axons. 
The term myelination describes myelin wrapping around axons. Oligodendrocytes in 
the CNS and Schwann cells in the PNS are myelin producing glia. Myelin lamillae 
function as an insulator to confer high resistance and low capacitance to the axon 
membrane. Along the entire length of myelinated axons, the regularly interrupted 
regions that remain uncovered by myelin sheathes, are named the node of Ranviers 
(NORs). From node to node, rapid “saltatory” conduction is accomplished. Next to 
NORs, a myelinated axon is further organized into several other continuous domains 
which are easily differentiated by using electron microscopy (EM). They are the 
internode, the juxtaparanode and the paranode (Fig. 1). Of particular note is that the 
diameter of a myelinated axon is not uniform. Instead, nodes and paranodes are 
slightly reduced in the diameter compared to those of juxtaparanodes and internodes 
along the same fiber (Salzer, 2003). In evolutionary light, all these features are of 
great advantages. Firstly, the myelin layers, the large internodal distance, and the 
constricted diameters in the node and paranode maximize the conduction velocity in 
myelinated fibers (Rushton, 1951; Waxman, 1980; Halter and Clark, 1993). Secondly, 
the saltatory conduction via nodes saves energy and space by several thousand folds 
compared with diffusing conduction along the unmyelinated axons.   
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several other parameters. Associated with nodal and paranodal constriction are slowed 
axonal transport, decreased neurofilament phosphorylation, and accumulation of 
membranous organelles in both two domains (Salzer, 2003; Edgar et al., 2004). Ion 
channels, adhesion molecules and associated cytoskeletal elements are expressed 
uniformly on the surface of unmyelinated and demyelinated axons but asymmetrical 
on myelinated axons. In summary, regulation of nerve conduction velocity in 
myelinated axons may involve at least four parameters: axon diameter, internodal 
distance, alteration in node size and architecture, and potentially, ion channel 
expression (Salzer, 2003). 
 
Figure 1. A schematic drawing depicts the myelinated axon and related 
axon-glial interactions.  
The node of Ranvier (N) is the region uncovered by myelin sheaths (Ms). In the CNS, 
processes emanated from so-called perinodal glia (PNG) form contacts with nodal 
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the interposed Schwann cells microvilli (SCM) which is further tightly covered by the 
basal lamina (BL). The paranode transverse band (TB) is characteristic of the 
axon-glial junction at paranodes. PN: paranode; JPN: juxtaparanode; IN: internode. 
 
Myelin sheath itself is also radially polarized. One reflection is that myelin 
components are differentially expressed with myelin-associated glycoprotein (MAG) 
in adaxonal (adjacent to axon) membrane, myelin basic protein (MBP) in compact 
myelin and myelin-oligodendrocyte glycoprotein (MOG) in abaxonal (external 
surface of the sheath) membrane, for example (Salzer, 1995; Buss and Schwab, 2003). 
Most likely, the development of longitudinal axonal domain organization and 
circumferential myelin polarity are mutually dependent. 
Myelination occurring in the CNS differs from that in the PNS in several ways. 
A single oligodendrocyte ensheathes multiple axons simultaneously while in the PNS 
each Schwann cell myelinates only one axon so that they have an approximately 1:1 
relationship. Secondly, the outside of Schwann cells, but not of oligodendrocytes, 
deposits a well-defined basal lamina (Bunge et al., 1986). The deposition of basal 
lamina containing type IV collagen, laminin and heparan sulphate proteoglycan 
(Bunge, 1987) plays a critical role in ensheathing axons by Schwann cells. An 
additional distinction between the CNS and PNS nodes is that finger-like Schwann 
cell microvilli are interlinked and project closely to nodal axolemma. Rather than 
microvilli, processes emanated from perinodal glia (PNG; Fig. 1) form contacts with 
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et al., 1994; Butt et al., 1999). 
How is it then that axons signal oligodendrocytes and Schwann cells to enable 
them myelinating-competent? And how do glial cells inversely recognize axons to 
ensheath them? During the period of development, interactions between the myelin 
producing glia and neighboring axons (Bhat, 2003) take place readily. Axons regulate 
oligodendrocyte survival, gene expression and myelin sheath thickness (Smith et al., 
1982; Friedrich and Mugnaini 1983; Chakraborty et al., 1999; Lopresti et al., 2001; 
Michailov et al., 2004). Inversely, oligodendrocytes and Schwann cells regulate axon 
caliber (Sanchez et al., 1996; Yin et al., 1998), establish axonal domains and 
consequently the clustering of ion channels and cell adhesion molecules at and near 
NORs (Arroyo and Scherer 2000; Peles and Salzer, 2000; Rasband and Trimmer, 
2001; Girault and Peles, 2002). In brief, communications between neurons and 
myelinating glia direct differentiation of the oligodendrocytes and the Schwann cells 
(Barres and Raff, 1999), which in turn remodels axonal domains (Arroyo et al., 1999). 
In this view, not only do myelin sheaths function to insulate and nourish the axon, but 
also differentiate the axonal membrane into distinct cytoplasmic domains in terms of 
structural compartmentation and protein expression. 
Establishment of subcellular domains in myelinated axons, herein referred to 
as axonal polarization, depends heavily upon at least two distinct types of axon-glia 
interactions. One occurs at the node, between the perionodal glial processes or 
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exists in the paranodal region between axon membrane and overlying 
oligodendrocyte/Schwann cell processes (Rosenbluth, 1988) (Fig. 1).  
 
2.1 Myelinating glia initially recognize internodes 
The internode refers to the segment extending from node to node, which is covered by 
compact myelin sheath. Therefore, the internode constitutes the longest portion of the 
axon which is roughly 100 times the axon diameter (Hess and Young, 1952). One 
structural feature of internodes, much apparent in the PNS, is that at certain sites, the 
myelin laminae is not so consolidated but remains as funnel-like enlargements filled 
with cytoplasm, called Schmidt-Lanterman incisures (Cajal, 1928). It appears most 
likely that these cytoplasmic channels provide conduits communicating the inner and 
outer cytoplasmic compartments.  
At the very beginning of myelinogenesis, the internode is recognized as the 
initiating site for oligodendrocytes or Schwann cells to lay down their myelin 
membrane. They subsequently spread longitudinally away from the beginning sites 
towards the apposed counterpart until it cannot move any further (Peters et al., 1991). 
In the PNS, this initial adhesion and Schwann cell spreading is thought to involve the 
cell adhesion molecule L1 (Wood et al., 1990). However, L1 does not appear to 
continue myelin wrapping based on the finding that L1 expression is down-regulated 
as MAG is abruptly upregulated, at the point when the myelin processes achieve 1.5 
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The terminal processes of the myelinating glia act as a molecular sieve or 
plough to ensure the proper distribution of many axonal proteins, such as nodal 
clustering of voltage-gated sodium channels (VGSCs) and consolidation of Caspr 
spirals (Pedraza et al., 2001). These developmental events starting from the internode 
have been vividly recapitulated by in vitro co-cultures (Ching et al., 1999; Atanasoski 
et al., 2004). As myelination proceeds, the internodal distance in the PNS keeps 
increasing but is precisely matched to both Schwann cells growth and axonal 
elongation, thereby modulating the conduction velocity (Court et al., 2004).  
By comparison, the internodal distance accounts for 99% of gross segmental 
length and the cleft between inner glial membrane and axolemma at internodes 
remains uniformly around 15 nm, which allows extensive axon-glia interactions to 
occur (Salzer, 2003). For instance, MAG, a protein belonging to the immunoglobulin 
cell adhesion molecules (Ig-CAMs) family, is thought to interact with axonal ligands 
(Trapp et al., 1989; Sadoul et al., 1990; Kelm et al., 1994) at internodes. Even if the 
internode is relatively free of specialized structures, the sub-cellular topology and 
signaling therein is still a studying focus.   
 
2.2 Potassium channels aggregate within juxtaparanodes 
The juxtaparanode is a short zone separated from the internode and beyond the 
innermost paranodal junction. Although lacking any landmark for recognition, this 
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signaling molecules such as Caspr2, transient axonal glycoprotein-1 (TAG-1) (Traka 
et al., 2002), and protein 4.1B (Denisenko-Nehrbass et al., 2003b). There is also a 
molecular sieve which is sealed by MBP accounting for the sharp boundary between 
juxtaparanodal and paranodal domains (Pedraza et al., 2001).  
Members of the delayed rectifier K+ channels of the Shaker family, such as 
Kv1.1, Kv1.2 and their associated axoplasmic subunit Kvβ2, are co-enriched in the 
juxtaparanode. During myelin development and also during remyelination, it is noted 
that Kv1.1 and Kv1.2 are transiently expressed at nodes, possibly modulating 
conduction properties (Rasband et al., 1998; Vabnick et al., 1999).  
It is generally believed that accumulation of Kv1 channels at juxtaparanodes is 
critical for maintaining the internodal resting potential. Shaker K+ channels are in 
association with the co-localized Caspr2, another member of Neurexin IV superfamily 
(Poliak et al., 1999, 2003). At the carboxyl-terminus of Caspr2 is the binding 
sequence for PDZ-domain. PSD-95, a PDZ-domain containing protein which is 
previously known to cluster Kv1 channels in mammalian neurons (Sheng and Sala, 
2001), colocalizes with Kv1 potassium channels and Caspr2 at juxtaparanodes. 
However, it is not essential for clustering because Caspr2 and Kv1 channels seem to 
be normally distributed in PSD-95 knock-out mice (Rasband et al., 2002). Therefore, 
it remains interesting to identify other PDZ-domain comprising proteins playing this 
role. Besides Nav channels, Shaker-type Kv1 channels are excluded from dendrites. 
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N-terminal T1 tetramerization domain of Kv1.2 (Gu et al., 2003). 
Caspr2 interacts with TAG-1 expressed by both the axon and overlying 
myelinating glia (Poliak et al., 2003; Traka et al., 2003) to form a ternary complex. 
TAG-1, a glycosylphosphatidylinositol (GPI)-linked CAM with ~50% identity to 
contactin/F3, is the core component of the juxtaparanode (Traka et al., 2002), actively 
engaging in homophilic and heterophilic interactions. Particularly at juxtaparanodes, 
axonal TAG-1 trans-interacts with the glial expressed TAG-1 (Traka et al., 2003). By 
far, this homophilic binding is considered the only tethering force across the 
axon-glial cleft at juxtaparanodes. On the axonal side, the heterophilic interaction 
between TAG-1 and Caspr2 provides a scaffold retaining Shaker Kv1 channels at the 
juxtaparanodal region (Poliak et al., 1999; Traka et al., 2003). This hypothesis is 
partially supported by the observations in which Kv1 channels as well as the 
reciprocal binding partner are reduced and often disappear from juxtaparanodes in 
both TAG-1 and Caspr2 deficient mice (Poliak et al., 2003; Traka et al., 2003). The 
protein 4.1B, a member of the 4.1 family of cytoskeletal proteins (Ohara et al., 2000; 
Parra et al., 2000), is enriched at juxtaparanodes but also at paranodes, via binding to 
Caspr2 and Caspr, respectively. In both sites, protein 4.1B has the same role by 
anchoring these axonal proteins to the actin-based cytoskeleton (Denisenko-Nehrbass 
et al., 2003b).  
An intact paranode is a prerequisite for the proper location of Kv1 channels at 
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al., 2002; Ishibashi et al., 2002). In terms of binding properties, the complex at 
juxataparanodes is composed of Caspr2-TAG-1-TAG-1 and resembles the paranodal 
Caspr-contactin-Nf155, to be discussed below. 
 
2.3 The paranode plays a central role in domain organization  
Between the juxtaparanode and NORs is the paranode where the non-compact myelin 
loops come into close contact with the axolemma, leaving a space of merely 3-5 nm. 
The paranodal loops are continuous with the layers of compact myelin, with as many 
as 40 or more and the outer most loops being closest to the node (Salzer, 2003). As 
shown by EM and freeze-fracture analyses (Ichimura and Ellisman, 1991; Peters et al., 
1991), intercellular ladder-like electron dense particles named the transverse bands are 
periodically distributed inside the cleft. The transverse band is regarded as a hallmark 
indicating ultimate maturation of the paranodal axon-glial junctions. An alternate 
name for the paranodal axon-glial junction is the septate-like junction because of their 
similarities to septate junctions identified in fruit fly drosophila (Baumgartner et al., 
1996; Bellen et al., 1998; Faivre-Sarrailh et al., 2004).  
At the protein level, a tripartite complex that consists of axonal contactin/F3, 
Caspr/paranodin, and putatively, the glial receptor neurofascin 155 (Nf155) 
constitutes the paranodal junction. In the course of myelination, these molecules 
co-distribute at the tips of the terminal loops of the myelinating glia and lastly 
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may suggest that the triple adhesive complex forms a paranodal sieve separating Kv1 
channels from Nav channels (Pedraza et al., 2001).  
 
2.3.1 Cis-complex of Caspr/paranodin and contactin/F3 
In the vertebrate CNS, contactin/F3 is predominantly expressed by neurons and has 
been identified in heterophilical interactions with an increasing number of partners. 
These interactions are implicated in diverse functions such as control of axonal 
growth via interactions with L1, NrCAM and Nf, influencing fasciculation via 
association with TN-C, TN-R and Rptpβ/phosphacan, and directing myelinogenesis 
(Falk et al., 2002) through the Notch pathway (Hu et al., 2003). In myelinated axons, 
a particular role of contactin/F3 is to demarcate different subcellular domains. 
Association with contactin/F3 potentiates Caspr (contactin-associated protein) 
delivery to the paranodes (Faivre-Sarrailh et al., 2000). Interestingly, the portion of 
Contactin/F3 that is not associated with Caspr is expressed at the NORs rather than at 
paranodes (Rios et al., 2000; Bhat et al., 2001). At paranodes, contactin/F3 functions 
like a “glue” not only recruiting axonal counterparts but also adhering to opposing 
glial loops to stabilize axon-glial contacts in this region. Given that contactin/F3 is 
also expressed by oligodendrocytes independent of Caspr (Einheber et al., 1997; Koch 
et al., 1997), it has been speculated that contactin/F3 detected in the paranodes may be 
also expressed by oligodendrocytes where it binds to axons homophilically.  
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a molecular component of Drosophila septate junctions (Einheber et al., 1997; Peles 
et al., 1997, Bellen et al., 1998). More recently, CONT was identified as the 
Drosophila homolog of contactin/F3 working with Neurexin IV inter-dependently in 
these junctions (Favivre-Sarrailh et al., 2004). In general, recruitment of 
Caspr/paranodin would make the complex suitable for signal transduction considering 
that contactin/F3 is embedded in cell membrane via just a GPI tail. Indeed, the 
cytoplasmic moiety of Caspr/paranodin, although quite short, provides a scaffold 
binding site for the cytoskeleton-associated protein 4.1B, so as to make itself of great 
relevance to the insertion and retention of this complex in the paranodes (Ohara et al., 
2000; Gollan et al., 2002). In transgenic mice expressing a mutant Caspr, deleted of 
the cytoplasmic domain, Caspr is still targeted properly to the paranodes, but 
aberrantly internalized (Gollan et al., 2002). This excludes a role of the cytoplasmic 
moiety for Caspr localization in the paranodes.  
In either Caspr (Bhat et al., 2001) or contactin/F3 (Boyle et al., 2001) 
deficient mice, junctional structures are severely compromised, leading to a dramatic 
decrease in nerve conduction velocity and disappearance of the transverse bands. The 
similar phenotypes strengthen the impression that both molecules by forming a 
complex are equally required for maintaining the axon-glial interactions at paranodes. 
Notably, the shift of Kv1 channel distribution in these deficient mice suggests an 
essential role of this complex in maintaining axonal polarity (Bhat, 2003).  
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and contactin/F3 deficient mice, are also observed in galactocerebroside, sulfatide, 
myelin protein zero (P0)-deficient mice or myelin-deficient (md) rats (Dupree et al., 
1999; Arroyo et al., 2002; Ishibashi et al., 2002; Ulzheimer et al., 2004). This 
emphasizes the indispensability of myelin components in stablizing the paranodal 
compartment. Stablization of axonal domains relies largely upon the lateral diffusion 
barriers and paranodal axon-glial junctions. Autotypical junctions which are formed 
between adjacent myelin layers, including tight junctions, adheres junctions and gap 
junctions, also contribute. Hence, dysfunctions of these barriers and/or junctions may 
cause the similar morbidity. An alternate explanation for this phenotype, however, 
could be the loss of counter-receptors of Caspr and/or contactin/F3 due to a 
malformation of myelin in these mice.  
 
2.3.2 Neurofascin 155 (Nf155)   
Neurofascin belongs to the L1 family of neural CAMs. It contains 6 extracellular Ig- 
and 3 fibronectin III (FNIII) domains, as well as the cytoplasmic ankyrin binding 
sequence (Ratcliffe et al., 2001). Two splice variants of Nf (Davis et al., 1996) are 
155- and 186- kD in size. While Nf186 is the axonal isoform cis-associating with 
NrCAM, the glial expressed Nf155 is shown to form a complex with Caspr/paranodin 
and contactin/F3, putatively representing a typical axon-glia interaction at the 
paranodes (Tait et al., 2000; Charles et al., 2002). To further address whether this 
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mouse deficient for Nf155 expression should be done in near future.  
Also noteworthy is that paranodal septate-like junctions are partially 
preserved in either Caspr or contactin/F3 deficient mice, indicating the existence of 
additional yet unidentified participants in stablizing and/or determining paranodal 
domain. In support of this notion, it has been reported that direct interaction between 
contactin/F3 and Nf155 is inhibited by Caspr recruitment (Gollan et al., 2003). The 
candidate paranodal components may include the protein tyrosine phosphatase alpha 
(PTPalpha), which is also expressed by glial cells (den Hertog, 1999; Ledig et al., 
1999) and interacts with contactin/F3 (Zeng et al., 1999), Schwannomin/merlin and 
β1 integrin detected in complex with Caspr in vivo (Denisenko-Nehrbass et al., 
2003a).  
 
2.4 The formation of node of Ranvier (NOR) 
The establishment of NORs accompanies myelin maturation. NORs, the bare regions 
of axolemma in myelinated fibers, are regularly spaced owing to the intermittent 
attachment of myelin sheaths along an axon. During myelinogenesis, the myelinating 
glia lay down their stretching plasma membranes firstly on the presumptive 
internodes. This initial axon-glial recognition is likely mediated by adhesive 
molecules that are not fully identified, including some from axons and the others from 
apposing glia. At least, there exist paranodal and juxtaparanodal sieves to demarcate 
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complex (contactin/F3, Caspr and Nf 155) has been suggested to form the sieve 
separating Kv1 channels from Nav channels. With continued internodal growth, Nav 
channels are pushed forward to be increasingly concentrated at mature nodes. In part, 
this model has been substantiated by the observation in which Caspr consolidates 
gradually as myelin matures (Pedraza et al., 2001). However, a question remains as to 
why impairment of a paranodal molecular sieve, for example, in Caspr and 
contactin/F3 deficient mice, always causes misplacement of Kv1 channels, but rarely 
of Nav channels (Bhat et al, 2001; Boyle et al., 2001). One possibile explanation is 
that Nav channels are additionally stablized by interactions with extra-axonal 
molecules and/or the underlying ankyrin G at NORs.   
It has been broadly accepted that the establishment of NORs and assembly of 
adjacent domains are differently fulfilled in the CNS and PNS. Position of nodes in 
the PNS appears to be determined by Schwann cells and the subsequent nodal clusters 
of Nav channels and ankyrin G require direct axon-glial contact (Ching et al., 1999). 
Soluble factors released by Schwann cells do not cluster Nav channels (Deerinck et al., 
1997). By contrast, Nav channel clustering along the optic nerve is ascribed to a 
soluble factor released from oligodendrocytes (Kaplan et al., 1997; 2001). Similarities 
between them have proposed the current model that glial signals drive clusters into 
the nodes. Secondly, Nf and NrCAM, not ankyrin G and Nav channels, are the first 
clusters to appear at NORs in the PNS (Lambert et al., 1997), suggesting that glial 
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channels into these sites. Thus, identification of glial partners for Nf and NrCAM will 
provide an opportunity to decipher mechanisms governing the clustering of axonal 
molecules. More recently, gliomedin is just demonstrated as a mediator of Schwann 
cell-axon interaction. And as expected, this protein regulates the molecular assembly 
by serving as a glial ligand for both Nf and NrCAM (Eshed et al., 2005). In contrast to 
the PNS, ankyrin G, not Nf, identifies the earlist nodal specification in the CNS 
(Jenkins and Bennett, 2000). The third distinction regarding nodal organization 
between the CNS and PNS lies in the different nodal surroundings. NORs are 
contacted by microvilli in the PNS but not so in the CNS. Instead, processes emanated 
from the perinodal glia associate with CNS nodes, particularly of large rather than 
small axons (Bjartmar et al., 1994; Butt et al., 1999) (Fig. 1). However, whether these 
processes serve a similar role as Schwann cell microvilli is not known.   
By comparison, the mechanisms responsible for the maintenance of nodal 
architecture are little known. How is the nodal span determined and maintained? 
Axonal elongation and internodal growth may place an increasing lateral pressure on 
existing nodes. Symmetric lateral compression from both sides may act as a factor in 
the formation and maintenance of the normal architecture of NORs (Pedraza et al., 
2001). In the sciatic nerve, the growth rate of Schwann cells determines the length of 
the internodes and conduction velocity (Court et al., 2004). But, whether and how the 
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2.5 Sodium channels (Nav) at NORs and the action potential 
During myelination, the axonal targeted Nav channels, which are initially scattered, 
are moved laterally by the stretching oligodendrocyte/Schwann cell processes and 
concentrated eventually at the nodal region. In myelinated fibers, a significant 
consequence of Nav channel clusters is that action potentials, generated in the initial 
segment (a region immediately near the axonal hillock), propagate rapidly from node 
to node (Hodgkin and Huxley, 1952). This jumping (saltatory) is in comparision with 
the slower continuous traveling of APs along unmyelinated nerves. The latter is based 
on the diffuse distribution of Nav channels (Waxman, 1983; Hille, 2001). How the 
NORs are specified on both structural and biochemical criteria has invited some 
efforts of addressing but is still far from clear.  
 
2.5.1 Clustering of Nav channels 
Upon myelination, Nav channels are extremely enriched at NORs with a density up to 
1,500 molecules /μm2 but remain just less than 100 molecules /μm2 in the non-nodal 
areas (Rosenbluth, 1976). The Nav channels present in the CNS NORs are composed 
of the pore-forming α subunit and at least two ancillary β subunits of which β1-4 have 
been identified (Isom et al., 1995; Morgan et al., 2000; Qu et al., 2001; Yu et al., 
2003). The β1 subunit is noncovalently associated with α subunit in vivo, whereas the 
β2 subunit is covalently linked by disulfide bonds (Messner and Catterall, 1985). Both 
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al., 2002; 2004). So far as documented, the possible roles of β subunits include 
shifting channel’s gating kinetics and facilitating the membrane insertion of α subunits, 
as observed when they are co-expressed in an exogenous system like Xenopus occyte 
(Schmidt et al., 1985; Schmidt and Catterall, 1986; Isom et al., 1992; 1995; McEwen 
and Isom, 2004; Vijayaragavan et al., 2004). In mice, knock-outs of β1 and β2 
indicate that both are required for the functional expression of the full channel but not 
for localization of Nav1.6 at nodes (Chen et al., 2002; 2004).  
The high density of Nav channels at nodes is fundamental for the saltatory 
conduction of nerve impulses. But, what are the key determinants of Nav channel 
aggregation? It has been reported recently that an intrinsic sequence within the 
Nav1.2 α subunit, dubbed axonal initial segment (AIS) motif, is sufficent to drive the 
clustering at the AIS (Garrido et al., 2003; Fache et al., 2004). However, whether the 
same machinery operates at all NORs awaits further characterization. An alternate 
idea is that glial messages are transduced to induce Nav channel clustering. 
Experiments done by Barres’ group showed that a heat and trypsin senstitive protein, 
which is specifically secreted by matured oligodendrocytes, considerably induced Nav 
channels aggregation along the neurites of retinal ganglion cells (RGCs) even without 
glial surrounding (Kaplan et al., 1997). Unfortunately, the biochemical identity of this 
protein remains unknown. Concerning this, another doubt comes with the finding that 
Nav channel clusters along the naked neurites as shown by them are uniformly spaced; 
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farther away from the retina (Baker and Stryker, 1990; Hildebrand et al, 1993).   
Nav channel clustering also occurs at the neuromuscular junction (NMJ). 
Using a co-culture system, Sharp and Caldwell (1996) found that Agrin8 could induce 
accumulation of Nav channels, in addition to acetylcholine receptors (AChRs), on 
innervated muscle fibers. Because agrin is an extracellular matrix (ECM) protein, the 
mechanism has been extrapolated such that Nav channel accumulation might be 
driven similarly by ECM molecules. Nevertheless, it is still presumed that both 
intrinsic and extrinsic machineries probably co-direct the sorting, trafficking and 
clustering of Nav channels at NORs. Future studies should elucidate how these two 
types of machineries communicate and work together.  
 
2.5.2 Developmental transition of Nav channel isoforms at NOR 
Regarding the clustered Nav channels, an interesting observation is that Nav1.2 (α 
subunit 1.2) is gradually replaced by Nav1.6 as nodes mature during myelination 
(Boiko et al., 2001; Kaplan et al., 2001; Salzer, 2002). It appears likely that this 
replacement of Nav channel isoforms depends upon the intactness of compact myelin 
because in shiverer mice, Nav1.2 is sustained at the nodes whereas Nav1.6 is scant 
(Boiko, et al., 2001; Rios et al., 2003). Based on this observation, it can be suggested 
that myelinating glia not only are accountable for Nav channel distribution, but also 
regulate the temporal expression of different subtypes of Nav channels. At present, the 
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One reason for this switch could be that Nav1.6 is potentiated at high frequencies of 
activation (W. Zhou and A.L Goldin, 2002, Soc. Neurosci., abstract) and rapidly 
recovers from inactivation (Herzog et al., 2003), both ensuring high rates of activity at 
NORs. This suggestion has been partially strengthened by the phenotypes in medj 
mouse that does not express Nav1.6 due to a splice donor site mutation (Buchner et al., 
2003). They display slowed nerve conduction and severe neurologic deficits (Meisler 
et al., 2001; Kearney et al., 2002).  
What are the signals accountable for the transition from Nav1.2 to Nav1.6? As 
discussed above, the axon is constricted in diameter at nodes and paranodes, which 
may work as a “bottleneck” for axonal transport (Berthold et al., 1993). As a result, 
transport vesicles slow and accumulate in the nodal cytoplasm, providing a possible 
mechanism whereby proteins in these vesicles are focally inserted and replenished at 
the nodal membrane. Is Nav1.6 contained in these vesicles, then? Indeed, a 
considerable portion of Nav1.6 is seen in vesicles associated with microtubules 
(Caldwell, 2000). Decreased phosphorylation of neurofilaments is also identified 
within NORs and paranodes, which subsequently diminishes their separation and then 
the diameter of axon (Price et al., 1988; Zhu et al., 1997). It is reported that 
myelinating glia provide signals to regulate axonal caliber via a kinase-phosphatase 
cycle affecting phosphorylation of neurofilaments (de Waegh et al., 1992). The 
hypothesis is thus raised that the same regulation may further involve membrane 
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technically feasible to track this process and monitor the influences of glia using live 
imaging to visualize pre-labelled nodal molecules. 
 
2.5.3 Cis-interactions with axonal cell adhesion molecules (CAMs) 
Nav channels at NORs are engaged in a vast network of biochemical interactions, 
including the cis- (referred to as the “side-by-side” formation of parallel dimmers on 
the same cell) and trans-interactions (the “face-to-face” contacts among molecules 
from two opposing cells). Firstly, they associate with the cytoskeleton via direct 
binding to the scaffolding protein ankyrin G, one of three ankyrin proteins (Bennett 
and Lambert, 1999). It is proposed that the sequential binding of the Nav channel to 
ankyrin G and then to cytoskeleton-associated spectrin IV contribute to the clustering 
mechanism for Nav1.2 in the initial segment (Garrido et al., 2003; Fache et al., 2004). 
Ankyrin proteins are commonly implicated in skeleton organization, membrane 
targeting, and cell polarity (Mohler et al, 2002). NrCAM and Nf186, both enriched at 
the NORs, are also ankyrin-binding proteins. Strikingly, clustering of these two 
molecules precedes that of Nav channels at the PNS NORs (Lambert et al., 1997; 
Lustig et al., 2001), which may imply sequential interactions among all the clusters at 
NORs within the PNS.  
The β subunits of Nav channel account for the majority of interactions with 
adjacent axonal molecules. β1 and β2 each contain a single extracellular Ig-like 
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contactin/F3 (Isom et al., 1995; Isom and Catterall, 1996). Due to this property, they 
act like cell adhesion molecules (CAMs) (Isom et al., 2002) mediating homophilic 
and heterophilic interactions.  
Contactin/F3 is mostly enriched in the paranode but also detectable at CNS 
nodes (Rios et al., 2000; Kazarinova-Noyes et al., 2001). It interacts with β1 and α 
subunits to enhance channel expression at NORs and also the amplitude of Na+ 
currents passing through Nav1.2, Nav1.3 and Nav1.9 (Kazarinova-Noyes et al., 2001; 
Liu et al., 2001; Shah et al., 2004). β1 subunit serves as a critical communication link 
between the Nav channels and nodal CAMs, scaffolding and cytoskeleton proteins, 
simply through cis-interactions with β2, contactin/F3, NrCAM, Nf186, ankyrin G and 
so on (McEwen and Isom, 2004). Like contactin/F3, Nf186 interacts with the 
extracellular Ig fold of β1, thereby increasing the surface density of Nav1.2 (Ratcliffe 
et al., 2001; McEwen and Isom, 2004) 
 
2.5.4 Trans-interactions with extra-axonal molecules 
The nodal axolemma is free of myelin covering, therefore accessible and susceptible 
to the outside matrix. Logically, molecules derived from perinodal glial processes in 
the CNS or Schwann cells microvilli in the PNS or the secreted messages from other 
glia are potential vehicles for axon-glia signalling at the NORs. This seems true in the 
CNS, because tenascins (TNs) from astrocytes and/or oligodendrocytes trans-interact 
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subunits interact with TN-R and TN-C and by doing so the channel function is 
modulated (Srinivasan et al., 1998; Xiao et al., 1999). As well, phosphocan/Rptpβ 
interacts with Nav channel β1 and α, by which the Na+ current could be elevated after 
the channel being dephosphorylated (Ratcliffe et al., 2000). In the PNS, it is of 
particular interest to note that dystroglycan/syntrophin mediates trans-interactions 
between Schwann cell microvilli and the nodal axolemma through binding to Nav 
channels (Gee et al., 1998; Saito et al., 2003). As a result, selective deletion of 
dystroglycan in Schwann cells caused a slowed axonal conduction and nodal 
abnormalities, including reduced Nav channel density and disorganized microvilli 
(Saito et al., 2003). Additional trans-interactions involving Nav channels, as alluded 
to above, may include coupling with external cues responsible for Nav channel 
clustering such as agrin (Sharp et al., 1996) and an oligodendrocyte-specific protein 
(Kaplan et al., 1997, 2001).  
All these findings support the notion that Nav channel distribution and 
function are intricately modulated by a plethora of signaling pathways. It seems likely 
that Nav channel expression, accumulation, and functions are subjected to interactions 
coupling both ECM proteins and intracellular cytoskeletal proteins. 
 
3. Signaling pathways underlying myelination and axonal domain formation 
The onset of myelination may be triggered by extracelluar interactions via axonal 
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cell adhesion molecules and growth factors (Einheber et al., 1995; Stankoff et al., 
2002; Chun et al., 2003; Hu et al., 2003; Chan et al., 2004; Michailov et al., 2004) 
stimulate Schwann cells or oligodendrocytes to exit from the proliferation/cell cycle 
and differentiate over several different stages: premyelinating, promyelinating and 
myelinating stages in sequence. In addition to signals from the axon that is being 
myelinated, it is much likely that cues from neighboring astrocytes and microglia, as 
well as autocrine signals from Schwann cell and oligodendrocyte themselves, 
modulate the process of myelination. For example, collagen matrix within the basal 
lamina, neurotrophins, and interleukin-6 (IL-6) are involved in myelination (Xu et al., 
1998; Chan et al., 2001; Haggiag et al., 2001). 
The dynamic capacities of the cytoskeleton underly cell motility, including 
migration and cytoplasmic spreading, both of which are involved in the process of 
myelination. Kinases and phosphatases, serving as the regulators of the assembly of 
the cytoskeleton, are core elements of the relevant signaling pathways (Bhat, 1995). 
For example, there is a critical role for Rho kinase (ROCK) in coordinating the 
movement of the glial membrane around the axon at the onset of myelination via 
regulation of myosin phosphorylation and actomyosin assembly (Melendez-Vasquez 
et al., 2004). Furthermore, laminin 2 (LN-2) signals oligodendrocytes spreading via 
integrin by activating phosphoinositide 3-kinase (PI3-K) and integrin-linked kinase 
(ILK) (Chun et al., 2003). During myelination, an alternate pathway downstream of 
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kinase (MAPK) (Fragoso et al., 2003). Fyn tyrosine kinase, one of the 
non-receptor-type tyrosine kinases of the Src family, participates in the initial events 
of myelination as a signaling molecule downstream of MAG (Umemori et al., 1994). 
Indeed, severe hypomyelination was identified in MAG and Fyn double knock-out 
mutants (Biffiger et al., 2000). PTPα is also implicated in myelin maturation probably 
by intervening with Fyn signaling (Bhandari et al., 1998).    
Terminal differentiation of Schwann cells and oligodendrocytes is 
characterized by the up-regulated expression of myelin-associated genes. Recent 
studies have witnessed the identification of an increasing number of transcription 
molecules when dissecting signals for myelination. Four categories are basic 
helix-loop-helix (bHLH) proteins, homeodomain proteins, zinc finger proteins, and 
HMG-domain proteins (Wegner, 2000a, b).  
Olig1 and Olig2 are closely related bHLH transcription factors that are 
expressed in myelinating oligodendrocytes and their progenitor cells in the developing 
CNS. While Olig2 is necessary for the specification of oligodendrocytes and 
motoneurons (Zhou et al., 2001; Lu et al., 2002; Zhou and Anderson, 2002), Olig1 is 
recently suspected of a role in remyelination that occurs in patients with multiple 
sclerosis (Arnett et al., 2004). 
The homeodomain transcription factors contain several subgroups such as 
paired-type, Nk-type and POU domain proteins (Wegner, 2000a). Pax-3, belonging to 
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to neural crest cells (Read and Newton, 1997). There is a dramatic reduction or loss of 
embryonic Schwann cells in homozygous embryos of Pax-3 mouse mutants. A 
suggested role for Pax-3 is determining the choice between the myelinating and 
nonmyelinating phenotype of a Schwann cell (Kioussi et al., 1995). Nkx2.2 and 
Nkx6.2 of the Nk-subtype are implicated in oligodendrocyte differentiation and 
myelination but absent in Schwann cells (Komuro et al., 1993; Awatramani et al., 
1997). In Nkx6.2 null mice, abnormal expression of paranodal junctional proteins 
including Nf155 and contactin/F3 causes widespread disorganization of myelinated 
axons, as well as neurological deficits (Southwood et al., 2004). In Nkx2.2 knock-out 
mice, the numbers of MBP-positive and proteolipid protein (PLP-DM20)-positive 
oligodendrocytes are dramatically decreased and myelination is delayed throughout 
the CNS. However, the number of Olig1/Olig2-positive oligodendrocytes is slightly 
increased. These findings have thus provided evidence pointing to a direct role for 
Nkx2.2 in oligodendrocyte differentiation and suggesting Nkx as a repressor of Olig 
expression (Qi et al., 2001; Vallstedt et al., 2001).  
Studies have suggested that the myelination program or terminal 
differentiation of myelinating glia is crucially dependent on the expression of at least 
two transcription factors, Oct-6/Scip/Tst-1 (Monuki et al., 1989) and Krox20/Egr2 
(Zorick et al., 1996). Myelination is delayed in Oct6-deficient mice (Bermingham et 
al., 1996; Jaegle et al., 1996; Ghazvini et al., 2002), while in Krox20-deficient animals, 
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domain proteins that is expressed in both Schwann cell and oligodendrocyte lineages 
and can be induced in Schwann cells by axonal contact or simply by the elevation of 
cAMP (Monuki et al., 1989; Arroyo et al., 1998). Oct-6 bears dual properties in 
regulating the target genes: repression and activation. Which effect it produces is 
critically dependent on the protein-protein interactions it engages (Renner et al., 1994; 
Kuhlbrodt et al., 1998a). Krox-20 is a zinc finger protein that acts as a regulator for a 
wide range of myelin-specific genes. During development, Oct-6 expression is 
decreased while Krox-20 upregulated. Krox-20 does not appear to be expressed in 
oligodendrocytic lineages where Krox-24/Egr1 is identified to be an alternate for 
Krox-20 (Sock et al., 1997). 
Sox proteins are a subgroup of proteins that contain a high-mobility-group 
(HMG) domain as their DNA-binding sequence. Sox-10 is the one detected in both 
oligodendrocyte and Schwann cell lineages (Kuhlbrodt et al., 1998b). Homozygotes 
for Sox-10 deletion are embryonic lethal, whereas the heterozygotes exhibit defects in 
the neural crest. The importance of Sox-10 in regulating gene expression lies in its 
efficient cooperation with coexpressed transcription factors. For example, it was 
observed in transient transfection that Sox-10 strongly potentiated the activity of 
Pax-3 and Oct-6 (Kuhlbrodt et al., 1998a).  
Upstream of Oct-6, nuclear factor kappa B (NF-kB) could serve as the signal 
across the nuclear membrane upon activation (Nickols et al., 2003). NF-kB belongs to 
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neurons (Mattson and Camandola, 2001). In the cytoplasm, NF-kB is repressed by the 
endogenous inhibotor IkB that is degraded after undergoing phosphorylation and 
ubiquitination, suggesting that NF-kB activation is under regulation of the activities of 
certain kinases and phosphatases. According to the evidence presented by Nickols et 
al. (2003), a full pathway involving NF-kB has been summarized. Signals from axons 
stimulate kinase cascade in Schwann cells or oligodendrocytes, resulting in 
phosphorylation of IkB and the subsequent activation of NF-kB p65/p50 transcription 
factor dimer. Activated NF-kB then translocates into the nucleus, where it binds to 
cis-acting elements of the responsible genes including Oct-6 and Krox-20, and those 
encoding proteins that stimulate the differentiation of Schwann cells or 
oligodendrocytes and the myelin process, for exmaple, the MBP gene (Mattson, 
2003).  
Results obtained by my colleagues also formulated a specific signaling 
pathway which accelerates oligodendrocyte maturation and potentially the 
myelination process (Hu et al., 2003; Cui et al., 2004). In either neuronal stem cells or 
oligodendrocyte precursor cells (OPCs), exposure to contactin/F3 leads to activation 
of Notch 1 receptor followed by the release of the Notch intracellular domain (NICD) 
that relays the signal into nucleus to eventually upregulate CNPase or MAG 
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4. The inhibitory hypothesis and regeneration failure in the central nervous 
system (CNS)  
Neurite outgrowth describes the extension of neuronal processes (including the axon 
and all dendrites) from the cell body and is easily seen in culture or in vivo. Inhibition 
or stimulation of neurite outgrowth has been observed in a broad range of CNS 
disorders and injuries including stroke, Parkinson’s disease, Alzheimer’s disease, and 
spinal cord injuries. Axonal elongation, either in development or during repair, 
involves the cytoskeletal re-organization and re-orientation particularly in growth 
cones. The growth cone is both a sensory and motor structure which responses rapidly 
to what it encounters. Environmental signals detected by the actin-rich, finger-like 
philopodia can transactivate certain signal cascades that modulate cytoskeletal 
dynamics to eventually extend, retract, collapse or turn the growth cone. Guidance 
cues, whether inhibitory or attractive, commonly trigger phosphotases, kinases and 
Rho family GTPases pathways in growth cones (Dent and Gertler, 2003; Gallo and 
Letourneau, 2004).   
Cultured or implanted neurons are able to regrow selectively into peripheral 
nerve grafts but fail when confronted with the CNS white matter in many conditions 
(Richardson et al., 1980; Schwab and Thoenen, 1985, Schwab and Caroni, 1988; 
Schnell and Schwab, 1990). This observation has led to the speculation that 
oligodendrocytes, in contrast to Schwann cells, do not support neuronal regeneration 
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inhibitory and thus limit axonal growth and regeneration in adult mammalian CNS 
(Schwab et al., 1993).  
To identify biochemichal identities of the inhibitory myelin components, 
neurite outgrowth assay has been developed in the culture model. In agreement, 
neurite outgrowth inhibitors (NOIs) are referred to as those proteins that inhibit 
neurite elongation in this assay (Schwab and Thoenen, 1985). Up to now, the 
identified NOIs fall into at least three categories: myelin-related inhibitors, tenascins 
(TNs), and chondroitin sulphate proteoglycans (CSPGs). Among the myelin-related 
inhibitors are Nogo, MAG, and oligodendrocyte-myelin glycoprotein (OMgp). 
 
4.1 Myelin components regulate axonal sprouting 
Two membrane-bound proteins from CNS myelin fraction, of 35- and 250-kD as 
visualized by SDS-PAGE, were shown to yield potent non-permissive substrate 
properties, irrespective of lipid, but sensitive to proteases (Caroni and Schwab, 1988a; 
Schwab and Caroni, 1988). Antibodies raised against both proteins, one of which is 
the monoclonal antibody IN-1, were sufficient to improve CNS regeneration and 
facilitate axonal sprouting (Caroni and Schwab, 1988b, 1989; Crutcher, 1989; Schnell 
and Schwab, 1990).  
The complementary DNA encoding the antigens recognized by IN-1 was 
cloned in the year 2000 and named Nogo (Chen et al., 2000; GrandPre et al., 2000). 
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the Nogo family, namely Nogo-A, B and C (GrandPre et al., 2000). Nogo belongs to 
the Rtn-4/Nogo subgroup of Reticulon gene family. In Nogo-A, two domains 
demonstrate potent inhibitory activity on neurite growth and cell spreading: the 
N-terminal Nogo-A specific region (Nogo-N), and the segment at the C-terminus, 
which comprises 66-amino acids (Nogo-66) between its two transmembrane domains 
(Woolf and Bloechlinger, 2002). While the receptor, which signals Nogo-66’s 
inhibition, was found to be a GPI-linked molecule termed NgR (Fournier et al., 2001), 
no binding partner for Nogo-N has been identified (Fig. 2 and 3). Many strategies 
targeted at intervening with Nogo function have shown some promises for treating 
CNS disorders such as spinal cord injuries and stroke (Cadelli et al., 1992; Hauben et 
al., 2001; David and Lacroix, 2003). 
MAG was firstly characterized as a member of Ig-CAM family, which 
comprises five Ig-like domains within the extracellular N-terminus and shares the 
L2/HNK-1 epitope with L1, N-CAM, TN-R, TN-C, and OMgp (Favilla et al., 1984; 
Kruse et al., 1985; Martini and Schachner, 1986; Vourc’h and Andres, 2004). The 
structural features and its predominant location at the axon-glial cell junction suggest 
a role for MAG in axon-glia communication (Kruse et al., 1985; Popko, 2000; 
Vourc’h and Andres, 2004). Other studies indicated MAG being an inhibitor of neurite 
outgrowth (McKerracher et al., 1994; Mukhopadhyay et al., 1994), via an in vitro 
assay using purified myelin soluble fractions and the recombinant MAG protein as 
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al., 1994; Montag et al., 1994) and showed minimal enhancement in axonal 
regeneration (Bartsch et al., 1995), thus suggesting additional sources of axonal 
inhibition.  
The newly identified inhibitory portion (Kottis et al., 2002) of CNS myelin is 
the OMgp, which remarkably arrests axonal extension and was first named arretin. 
OMgp bears a series of tandem leucine-rich repeats (LRs), a short cysteine-rich motif 
(CR) homologous to the epidermal growth factor (EGF) motif, and the HNK-1 
epitope (Mikol et al., 1990), by which it is well-equipped as a CAM (Fig. 2B). OMgp 
is expressed not just by oligodendrocytes in vivo and in vitro, but also in some CNS 
neurons (Habib et al., 1998). OMgp is anchored on the plasma membrane via the GPI 
moiety which renders this molecule highly mobile in the membrane and being readily 
cleaved by phospholipases in vivo. Some observations noted that OMgp might exist 
either in the membrane-bound or soluble form as a ligand involving the transmission 
of a growth suppressive signal (Vourc’h et al., 2003; Vourc’h and Andres, 2004). 
However, the well-established temporo-spatial expression pattern underscores the 
undetermined actions of this myelin-associated protein.  
CNS myelin fraction or differentiated oligodendrocytes possess the ability to 
impede neurites extension (Schwab and Caroni, 1988; Crutcher, 1989). Neutralization 
of myelin-derived inhibitors succeeds in promoting axonal regeneration, sprouting 
and functional recovery, particularly after spinal cord injuries (Dyer et al., 1998; 









Figure 2. Structures of Nogo-A, OMgp and the common receptor NgR.  
(A) The cytoplasmic amino-Nogo and extracellular loop named Nogo-66 are two 
inhibitory domains of Nogo-A. (B) OMgp is made up of a signal sequence, the 
cysteine-rich region, 5 leucine-rich repeats (LRR) and the glycosylphosphatidylinositol 
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of the NgR protein. Signal, signal peptide; LRRCT, LRR C-terminal domain; TM/GPI, 
transmembrane/glycosylphosphatidylinositol linkage.  
 
However, the strategies so far targeted at axonal regeneration usually hold on 
to sequester the inhibitory actions of these proteins but leave behind their additional 
functions. Recently, an opinion is emerging that myelin and associated inhibitory 
proteins are merely regulators of axonal sprouting which prevails during development 
as well as after lesions (Schwegler et al., 1995; Hiebert et al., 2000; Blochlinger et al., 
2001; Raisman, 2004). According to this viewpoint, long-distance axonal elongation 
proceeds to destinations only through the facilitory astrocytic processes in which 
adhesive molecules provide the guidance. Myelin inhibitory components are aligned 
beside the astrocytic processes by which the side branching of axons is completely 
abrogated and growth is then confined to a straight trajectory (Raisman, 2004). 
Branching is associated with the cessation of elongation, which occurs normally only 
after the growth cone reachs the target so as to make synaptic contacts. Following 
injuries, however, the spatial pattern is altered so that the regenerating axon can not 
advance forward but rather sprout around. These sprouts could then bridge 
short-range connections locally and even form multi-synaptic travel toward the 
destinations so as to restore functions partially. This kind of neural re-connection, 
although abnormal, may offer an interpretation for some functional recovery reported 
by some studies as of now. In this sense, myelin inhibitory molecules are viewed 





CHAPTER 1 INTRODUCTION 
37 
4.2 Tenascins (TNs) produce repulsive substrates 
Extracellular matrix (ECM) is largely composed of collagens, glycoproteins and 
proteoglycans. In multicellular organisms, the ECM provides a framework for tissue 
morphogenesis, supporting and information processing. The TNs is a family of large 
ECM glycoproteins that to date comprise five known members (TN-C, TN-R, TN-W, 
TN-X and TN-Y). Amongst them, TN-C, -R and -Y are expressed in the nervous 
system with well-defined patterns during development and are commonly 
down-regulated after maturation. However, following lesions or in other pathologic 
conditions, they can be re-expressed.  
TN-R, referred to diversely as restrictin, janusin or J1-160/180 (Pesheva et al., 
1989; Bartsch et al., 1993; Fuss et al., 1993), is the smallest member of the TN family. 
It is expressed by Schwann cells in the PNS (Probstmeier et al., 2001), whilst in the 
CNS by oligodendrocytes, reactive astrocytes and a subpopulation of neurons as well 
(Pesheva et al., 1989; Bartsch et al., 1993; Fuss et al., 1993). As a typical ECM 
protein, TN-R may be involved in a broad spectrum of activities including the control 
of neuronal growth, axonal defasciculation, and modulation of perineuronal network 
(Schachner et al., 1994; Xiao et al., 1998; Bruckner et al., 2000). TN-R imparts 
contrary effects to cells, depending on the mode of presentation (i.e., soluble or 
substrate-bound) and the cell type. When presented as a sharp substrate boundary, for 
example, TN-R considerably restricts axonal extension from dorsal root ganglion cells 
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its elevated expression in response to lesions, is likely attributable to TN-R’s 
inhibitory nature. 
During the development of the CNS, TN-C (formerly named cytotactin) is 
expressed by immature astrocytes and a tiny population of neurons, for example, 
RGCs. TN-C consists of a serial arrangement of EGF repeats plus a varying number 
of FN-III domains. Hence, TN-C has played a variety of roles in many cellular 
processes, such as neuronal migration, neurite outgrowth, cell adhesion and cell 
proliferation (Joester and Faissner, 1999). Similar to TN-R, TN-C also displays 
adhesive or repulsive actions on the exposed cells. Which role is observed depends 
upon the way to present the protein, the cell lineages and also the distinct domains 
(Gotz et al., 1996). Regardless of these dual properties, TN-C is generally implicated 
in neuron-glia interactions (Gotz et al., 1996).    
By comparison, little is known about the contribution of TNs to failure of 
regeneration in the CNS. Surprisingly, studies conducted in mice lacking TN-C have 
not provided much insight into TN-C’s in vivo functions (Saga et al., 1992; Forsberg 
et al., 1996). This “negative” result obtained from TN-C deficient mice can be largely 
explained by functional redundancy of TN members or the other compensatory 
mechanisms. In general, glial TNs might be regulatory rather than inhibitory elements 
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4.3 Chondroitin sulphate proteoglycans (CSPGs) arrest the advance of growth 
cones 
CSPGs, comprising NG2, brevican, neurocan, versican, and phosphacan, mostly 
reside in the ECM. CSPGs are up-regulated in response to the injuries to the CNS and 
even the PNS (Levine, 1994; Haas et al., 1999; McKeon et al., 1999; Thon et al., 2000; 
Plant et al., 2001; Asher et al., 2000, 2002; Jones et al., 2002, 2003; Moon et al., 2002; 
Tang et al., 2003; Rezajooi et al., 2004). Their depositions in glial scar formed by 
reactive astrocytes or oligodendroglia constitute barriers against axonal elongation 
(Jones et al., 2003; Silver and Miller, 2004). At lesion sites, axonal growth cone 
respond to CSPGs with a rearrangement of actin cytoskeleton, leading to withdrawal 
and collapse (Snow et al., 2001). Treatment with chondroitinase ABC or matrix 
metalloproteinases, two types of enzyme that degrade CSPGs, substantially promoted 
axonal regrowth after brain and spinal cord injuries (Ferguson and Muir, 2000; Moon 
et al., 2001; Bradbury et al., 2002). 
The name of NG2 stands for “Nerve/glia antigen 2”. NG2 is well-known as a 
marker for identification of oligodendrocyte precursor cells (OPCs) and 
oligodendrocyte-type 2 astrocyte (O-2A) progenitor cells in the CNS. The interactions 
with both extracellular ligands, such as collagen VI, and intracellular partners, 
including cytoskeleton, are responsible for NG2 mediated cell spreading and motility 
(Stallcup, 2002). In this respect it is most likely that NG2 deposition after CNS 
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A common elevation of neurocan, brevican, phosphacan, and versican was 
noted after spinal cord injury (Jones et al., 2003). Apparently they limit axonal 
regeneration in a way distinct from NG2 and the myelin inhibitors. For example, 
versican V2 was shown to thwart neurite outgrowth even in the absence of p75 
expression, meaning that CSPGs act through other independent receptor(s). Even so, 
exposure to these CSPGs makes neurons undergo the Rho/ROCK signaling cascade 
same as to other types of inhibitory molecules (Monnier et al., 2003; Jain et al., 2004; 
Schweigreiter et al., 2004). 
 
4.4 NgR/p75 signaling complex 
MAG, Nogo-A and OMgp all bind to NgR as the ligands (Fournier et al., 2001; 
Domeniconi et al., 2002; Liu et al., 2002; Wang et al., 2002b). Lack of cytoplasmic 
domain in NgR structure requires the recruitment of some other molecules working as 
the “co-receptors” to transduce the glial stimuli successfully into cell interior. P75NTR 
and the LINGO-1 are such “co- receptors” (Wang et al., 2002a; Yamashita et al., 2002; 
Mi et al., 2004). In targeted neurons, the downstream pathway of NgR involves RhoA 
activation and cytoskeletal re-arrangement (McGee and Strittmatter, 2003) (Fig. 3). 
Given the promiscuous ligands converging at NgR, an attractive strategy is seeking 
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Figure 3. The NgR/p75 signaling pathway leading to regeneration failure in the 
CNS. 
Oligodendrocytes exert inhibitory effects on neighboring neurons, via the surface 
expressed molecules such as OMgp, MAG, Nogo-A binding to neuronal NgR. OMgp, 
MAG and Nogo-66 converge at NgR/p75 receptor complex, subsequently activating 
RhoA GTPase and Rho kinases and re-organizing skeleton networks, leading to 
growth cone collapses. By now, specific receptor(s) of Nogo-A N-terminal segment 
remain unidentified, although RhoA and Rho kinases might be similarly involved. 
Meanwhile, little is known about roles of neuronal OMgp and Nogo-A. 
 
However, more recent observations noticed that in vivo expression and 
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ability of individual tract to regenerate (Hunt et al., 2002a; 2002b; 2003), challenging 
against the predominant role of NgR system in the CNS degeneration. In whole 
lengths of Nogo-A and -B, a proline-rich region spanning from 67-176 amino acids 
would be a good candidate interacting with other proteins (Kay et al., 2000). 
Moreover, potential SH3-domain and WW-ligands binding sites were identified 
within Nogo-A specific sequence, which facilitates this molecule to engage in more 
interactions (Einbond and Sudol, 1996; Oertle et al., 2003). A mitochondrial protein 
so called NIMP (Hu et al., 2002), which is expressed in neurons and astrocytes, was 
shown to be a possible interacting partner for the Nogo-66 sequence. Moreover, 
Nogo-A associates with α-tubulin and MBP, as revealed by co-immunoprecipitation 
(Taketomi et al., 2002).  
Mice genetically deficient for expression of inhibitors, such as MAG and 
Nogo-A, should allow their roles in axonal regeneration to be directly evaluated. 
Unexpectedly, MAG knock-out mice exhibited little or no enhancement of axonal 
regeneration (Bartsch et al., 1995). More recently, three groups carried out studies in 
different strains of Nogo-deficient mice (Woolf, 2003). Results reported by these 
three laboratories appear contradictory. Zheng et al. (2003) observed a lack of 
enhancement of axonal regeneration in their mice, as opposed to the improved 
regenerative responses described by Strittmatter’s group (Kim et al., 2003) and 
Simonen et al. (2003). Although the different genetic backgrounds of these knockouts 
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Nogo in axonal degeneration.   
The better models for directly assessing the adverse roles of NgR/p75 
signaling pathway in regeneration are mice single or double deleted of these two 
genes. Unfortunately, neither NgR nor p75 deficient mice have shown improved 
neuronal regeneration compared to wild-type littermates (Song et al., 2004; Zheng et 
al., 2005). Similarly local administration of a dominant-negative form of p75 to the 
injury site had no beneficial effects on spinal cord regeneration (Song et al., 2004). 
NgR deficient neurons in culture still respond to myelin or Nogo-66 substrates to the 
same extent as wild-type neurons do (Zheng et al., 2005). These data together imply 
the complex nature concerning axonal regeneration in the CNS.  
 
5. Roles of neurite outgrowth inhibitors (NOIs) at the NOR 
All the inhibitory proteins possess programmed expression profiles independent of 
lesions and thus suggested their physiological roles. Given the fact that most of them 
have a dististribution at and near the NORs, it is conceivable that they may play a role 
in myelination and domain organization along the myelinated axons. Indeed, a 
handful of studies have shed new lights on this notion.   
 
5.1 TN-R and TN-C modulate Nav channels’ functions 
Expression of TN-R by oligodendrocytes coincides with the process of myelination 
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oligodendrocyte-neuron interaction during development (Schachner et al., 1994). As 
yet, the direct evidence comes from the specific location of TN-R at NORs (Bartsch et 
al., 1993; Rieger et al., 1986; Weber et al., 1999). Subsequent studies have suggested 
that TN-R is implicated in axon-glia interactions that presumably contribute to the 
assembly and/or stabilization of NORs. 
Members of the TNs family contain a variant number of EGF-like repeats and 
several FNIII-like modules, both accountable for a set of interactions with other 
proteins. In addition to integrins (Yokosaki et al., 1998; Yokoyama et al., 2000), one 
other set of neuronal receptors for TNs are the members of the Ig-CAMs, such as 
contactin/F3/F11 (Norenberg et al., 1996; Xiao et al., 1998), MAG (Yang et al., 1999) 
and β subunits of Nav channels (Srinivasan et al., 1998; Xiao et al., 1998). In vitro, 
both TN-C and TN-R alter the electrophysiological properties of Nav channels 
(Srinivasan et al., 1998; Xiao et al., 1999). Moreover, mice deficient for TN-R 
expression are afflicted by a decreased conduction velocity along the optic nerve 
(ON), although no abnormality of Nav channels expression and distribution has been 
detected (Weber et al., 1999). These findings, considered together, lead to a 
conclusion that TNs accumulated at the NORs may be functional regulators of Nav 
channels.  
 
5.2 Most of CSPGs are enriched at NORs 
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cell proliferation and migration (Stallcup et al., 1990; Peles et al., 1995; Perissinotto 
et al., 2000). In intact CNS, NG2 (Martin et al., 2001), versican (Oohashi et al., 2002) 
and phosphacan (the secreted form of Rptpβ) (Weber et al., 1999) have a high density 
at NORs and are thus believed to have roles in axon-glial recognition. Interestingly, 
the NG2-expressing perinodal cells, with a putative astrocytic phenotype, come into 
intimate contact with the nodal axolemma (Butt et al., 1999). Also, these perinodal 
cells resemble the O-2A progenitor cells identified elsewhere by NG2 presence (Raff, 
1989). It is not yet known if or how these cells and the NG2 protein signal axons at 
NORs. The phosphacan (Rptpβ) acts on Nav channel α and β1 subunits modulating 
the channel function by the mechanism of dephosphorylation (Ratcliffe et al., 2000).    
 
5.3 Myelin associated glycoprotein (MAG) is prone to clustering in myelinated 
axons 
MAG appears bifunctional with regard to the effects on neurons, at least in culture. It 
inhibits neurite outgrowth from adult neurons while promoting that of young neurons 
(Johnson et al., 1989; Mukhopadhyay et al., 1994; Turnley et al., 1998; De Bellard 
and Filbin, 1999). The different age and type of neurons may well explain this 
distinction in MAG function. MAG expression in oligodendrocytes, especially on the 
surface of oligodendrocytic processes, starts from the initialization of myelination 
(Trapp et al., 1989). Of particular interest is the observation that MAG is strinkingly 
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cessation of L1 expression (Martini and Schachner, 1986). After the compaction of 
myelin sheaths, MAG is restricted to the periaxonal membrane, where it intimately 
contacts the axon of the internode region, thereby providing ample opportunity for its 
interaction with axonal partners like GD1a and GT1b (Martini et al., 1986; Bartsch et 
al., 1989; Filbin, 2003). From a longitudinal view, MAG has a predominant 
enrichment at the paranodal region (Bartsch et al., 1989). Interestingly, in the PNS, 
MAG is clustered at Schmidt-Lanterman incisures; while in the CNS, congregation at 
incisures is not observed (Arroyo and Scherer, 2000). To date, the physiological 
significance of MAG in the internodal region remains unknown. Probably, the 
specific clustering in non-compact myelin compartments including incisures and 
paranodes as well as the adhesive properties (Martini and Schachner, 1986) confer on 
MAG a recognizing rather than inhibiting role at these sites (Johnson et al., 1989).  
 
6. Research aims and objectives 
In conditions of demyelination or dysmyelination caused either by diseases or 
genetical manipulation, axonal domains are commonly disorganized, Nav and Kv1 
channels are localized in tandem and become more dispersed (Bhat et al., 2001; Boyle 
et al., 2001; Poliak et al., 2001; Arroyo et al., 2002; Ishibashi et al., 2002). A growing 
body of evidence has suggested that molecules of both axonal and glial origin could 
mediate axon-glia interactions, and are thus responsible for the mature form of CNS 
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which the cell adhesion and recognition molecules have captured extensive attention. 
Here, the hypothesis is that myelin components including the neurite-outgrowth 
inhibitory molecules, for example, TN-R, MAG, Nogo, OMgp which are originally 
thought to be the regulators of axonal regeneration, are also participants in the 
dialogue between axons and glia. 
MAG, Nogo-A and OMgp have widespread expressions throughout the intact 
mammalian CNS commencing early at birth and are committed to 
myelin/oligodendrocytes. In the CNS regeneration field, there are still many 
unresolved issues; for example, what physiological roles do these molecules have? 
MAG is positioned in the axon-glial cell junction (Popko, 2003). However, deletion 
of MAG causes axonal pathology but no detectable irregularity in myelination (Li et 
al., 1994; Montag et al., 1994), perhaps implicating a role in axonal development. 
Immunohistochemical studies using antibodies against Gal (beta 1-3) GalNAc antigen 
or OMgp have suggested the location of OMgp in nodal or paranodal regions (Mikol 
and Stefansson 1988; Apostolski et al., 1994; Vourc’h and Andres, 2004). In an 
attempt to understand how Nogo-A and NgR are apposed together to regulate axonal 
growth, Nogo-A was recently identified in the setting of axon-myelin contact (Wang 
et al., 2002c). 
During the past decade, profiles of expression and distribution among NgR 
and its ligands, and their different responses to injury were underestimated or ignored. 
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unrelated to NgR binding. To explore functions of neurite outgrowth inhibitors (NOIs) 
during myelination and axon-glial communications, the following objectives have 
been considered for the present study: 
 1) To study the temporo-spatial expression of Nogo-A, OMgp, TN-R and 
MAG in axon-glial interface. Immunohistochemistry, immuno-electron microscopy 
(IEM) and Western blotting were used to detail their expression and distribution 
patterns.  
2) To study the interactions of Nogo-A, OMgp and TN-R with axonal 
molecules at NOR and the potential functions downstream of these interactions. 
Immunoprecipitation (IP) studies were the main approach to screen out the binding 
partners. Direct protein-protein interactions were then be verified by pull-down assays 
using the recombinant proteins comprising different domains of Nogo-A, OMgp and 
TN-R. This was further confirmed by using cell repulsion and adhesion assays with 
the recombinant proteins and cells transfected with ligands/receptors identified by the 
above methods. By plating cells expressing a certain protein in the presence of the 
other proteins or other protein expressing cells, it is also able to observe any cell 
behaviours following the trans-interactions.  
3) To study the contribution of the myelin-related NOIs including Nogo-A, 
OMgp and TN-R on the process of myelination and domain organization in 
myelinated axons. Developmental studies were conducted to check the correlation of 
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animal models such as shiverer mice, CGT-/- mice and EAE animals provided 
powerful tools to answer whether their distribution pattern are myelin dependent.    
4) To study the possible roles played by these myelin-associated components 
in axonal polarity, in particular on the ion channels’ clustering. Transgenic and 
genetic knock-out mice were used to enunciate whether distribution and expression of 
Nav and Kv1 channels are altered in the absence or over-presence of these molecules. 
To test whether these proteins have direct effects on channel clustering, primary 
culture of highy purified neurons was also used.  
5) To investigate signal transducing pathways towards the identified roles of 
Nogo-A, OMgp and TN-R. To elucidate the intracellular signaling cascades triggered 
by axon-glial recognition, primary culture of neurons alone or together with 
oligodendrocyte/Schwann cells will be exploited, using gene transducing approaches 
including RNA interference with short interfering RNA (siRNA).  
Advancements in this area are believed to benefit the patients with 
demyelinating as well as axonal degenerating pathologies such as multiple sclerosis 
(MS) and spinal cord injuries (SCI).  
























CHAPTER 2 MATERIAS & METHODS 
51 
1. Animals 
The numbers of animals used in this study are listed below (Table 1) as a 
summary. 
Table 1.  
Species Age Number Experiments  
Wistar Rat Adult 30 IF, WB, IP, IEM 
Wistar Rat E17, P0, 1, 5, 7, 14, 21, 30 60 WB, IF, IP 
Wistar Rat P6, 10, 15, 21, 30 15 IF 
Lewis Rat 2 months 30 inducing EAE  
S.D. Rat P8 120 Cell culture 
OMgp tg mice P15 and 2 months 10 + 50 IF, EM, WB, APR
TN-R -/- mice 2 and 6 months 20 IF, EM 
CGT -/- mice P16 and P21 10 IF, EM 
Shiverer mice 2 months 3 IF 
E: embryonic; P: postnatal; WB: Western blot; IF: immunofluorescence; IP: 
immunoprecipitation; IEM: immuno-electron microscopy; APR: action potential 
recording. 
All experiments involving animal application were approved by the 
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OMgp Dr. Habib AA 
(UTSMC) (Habib et 
al., 1998) 
Rabbit polyclonal 1:1000 1:200 3μl 
OMgp R&D Systems Goat polyclonal 1:10k NA NA 
Nogo-A Dr. Strittmatter SM 
(YUSM) (Wang et 
al., 2002) 
Rabbit polyclonal 1:5000 1:500 2μl 
Nogo-A Dr. Tang BL (NUS) 
(Liu et al., 2002) 
Rabbit polyclonal 1:1000 1:200 3μl 
NgR Dr. Strittmatter SM 
(YUSM) (Wang et 
al., 2002) 
Rabbit  polyclonal 1:1000 1:200 3μl 
NgR Dr. Tang BL(NUS); 
unpublished 
Rabbit polyclonal 1:1000 1:200 4μl 
Contactin/F3 Dr. Watanabe K 
(NTU) (Shimazaki et 
al., 1998) 
Rabbit polyclonal 1:1000 NA 3μl 
contactin R&D System Goat polyclonal NA NA 10μl 
Caspr raised in the lab Rabbit polyclonal 1:1000 1:200 3μl 
Caspr Dr. Rasband MN 
(UCHC) (Yang et al., 
2004) 
Mouse K65/35 NA 1:200 NA 
NB-3 Dr. Watanabe K 
(NTU) (Lee et al., 
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2000) 
Kv1.1 Chemicon Rabbit polyclonal 1:500 NA 6μl 
Kv1.2 Chemicon Rabbit polyclonal 1:500 NA 6μl 
Kv2.1 Chemicon Rabbit polyclonal NA NA 6μl 
Kvβ2 Upstate Biotech Mouse K17/70 NA 1:200 NA 
Kv1.1 Upstate Biotech Mouse K20/78 NA 1:200 NA 
Kv1.2 Upstate Biotech Mouse K14/16 NA 1:200 NA 
Neurofilament 
200 
Sigma Mouse NE14 NA 1:200 NA 
MAP-2 Sigma Mouse AP20 NA 1:200 NA 
Pan-Nav Sigma Mouse K58/35 1:500 1:100 3μl 
Nav1.6 Alomone Labs, Israel Rabbit polyclonal 1:200 1:50 10μl 
Nav1.2 Alomone Labs  Rabbit polyclonal 1:200 1:50 10μl 
Navβ2 Alomone Labs  Rabbit polyclonal 1:200 1:50 10μl 
Navβ1 Raised in the lab Rabbit polyclonal 1:500 1:100 3μl 
Pan-Nav Alomone Labs Rabbit polyclonal 1:200 1:50 3μl 
N-CAM Prof. Schachner M 
(UH) (Faissner et al., 
1984) 
Rabbit polyclonal NA NA 4μl 
TN-R/EGFL (Xiao et al., 1989) Rabbit polyclonal 1:1000 1:200 3μl 
CSPG (Xiao et al., 1997) Mouse 473 NA NA 3μl 
TN-R (Xiao et al., 1989) Mouse 596 NA 1:200 5μl 
TN-R (Xiao et al., 1989) Mouse 619 NA 1:200 5μl 
MAG Prof. Schachner M 
(UH) (Yang et al., 
1999) 
Mouse 513 NA 1:200 NA 
HNK Prof. Schachner M 
(UH) (Kruse et al., 
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1985) 
NG2 Chemicon Rabbit polyclonal NA NA 10μl 
NG2 Zymed Lab, USA Mouse D4.11 NA 1:100 10μl 
GAPDH Abcam, UK Mouse mAbcam 
9484 
1:5000 NA NA 
γ-Tubulin  Sigma Mouse GTU88 1:1000 NA NA 
βIII-tubulin Sigma Mouse TUB2.1 NA 1:200 NA 
O1 Chemicon Mouse  NA 1:200 NA 
NrCAM DSHB, Iowa, USA Mouse 23A7 NA NA 10μl 
WB: western blot; IF: immunofluorescence; IP: immunoprecipitation; NA: not 
applicable. 
Institutions: UH, University of Hamburg, Germany; NUS, National University of 
Singapore, Singapore; NUT, Nagaoka University of Technology, Japan; UCHC, 
Universtiy of Connecticut Health Center; UTSMC, University of Texas Southwestern 
Medical Center, USA; YUSM, Yale University School of Medicine, USA.  
  
In addition, rabbit anti-macrophage (Cedarlane Lab); monoclonal antibodies 
against Thy1.1 (clone OX-7, Chemicon) were used for retinal ganglion cell (RGCs) 
purification; secondary antibodies goat anti-mouse IgG (Chemicon), biotinilated goat 
anti-rabbit (Vector Lab), cy2-conjugated anti-rabbit, cy5-conjugated anti-rabbit and 
cy3-conjugated anti-mouse (Amersham Biosci.) were purchased from the respective 
commercial sources.  
To raise polyclonal antibodies against Caspr, a 230bp fragment encoding the 
cytoplasmic region (amino acids 1308-1377) of human Caspr (Einheber et al., 1997) 
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5’-AGTCGGATCCACAAAATCATCGACTATCACAGGG-3’ (forward) and 
5’-ACTCGAATTCAGACCTGGACTCCTCCTCCAAGGATCTGG-3’ (reverse) with 
an added BamH1 or EcoR1 site, respectively. The amplified fragment was digested 
with BamH1 and EcoR1 and subcloned in-frame into pGEX-3C, and the sequence of 
the final construct was verified by DNA sequencing. The plasmid was transformed 
into E. coli BL21, and upon induction a Caspr-GST fusion protein of the expected 
size was recovered from bacterial lysates using glutathione-agarose beads. Caspr-GST 
was eluted from the beads using reduced glutathione, concentrated by lyophilization, 
and used to immunize rabbits. The immune serum obtained from the rabbits was 
confirmed for its ability to recognize chick and mouse Caspr through immunoblotting 
and immunoprecipitation experiments. 
Polyclonal NgR was obtained similarly by immunization of rabbit with a GST 
fusion protein containing amino acids 277-430 of human NgR. Polyclonal anti-Navβ1, 
-Navβ2 were raised respectively by injection of rabbit with GST-Navβ1, GST-Navβ2 
comprising the extracellular portions of Nav channel β1 and β2 subunits, followed by 
affinity-purification using protein-A agarose column. The specificities were verified 
by comparative western blotting analyses with antibodies native or pre-absorbed with 
respective antigens. 
 
3. Peptides and recombinant proteins 
To generate recombinant proteins of GST-Nogo-66 and GST-Nogo-N-terminal 
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amplified from human brain cDNA clone HK07722 (Nogo-A) using the primer sets 
below:  
5’-CTGAATTCTTAGGATATACAAGGGTGT-3’ (forward)  
5’-GCTAAGCTTTCACTTCAGAGAATCAACTA-3’ (reverse) for 
Nogo-66-GST;   
5’-AGGAATTCTAGATGAGACCCTTTTTGC-3’ (forward)  
5’-CCCAAGCTTTCAATTAAAACTGTCTTTTGCTTT-3’ (reverse) for 
Nogo-N-GST. The PCR products were digested with EcoRI and HindIII and ligated 
into EcoRI/Hind III-digested pGEX-KG (Guan and Dixon, 1991). Full-length OMgp, 
Nav channel β1 and β2 extracellular portions, and TN-R/EGFL were respectively 
cloned into pGEX-KG vector and verified by DNA sequencing. 
All these constructs were amplified and expressed in E.Coli and purified as 
GST fusion proteins, following standard procedures as earlier described (Xiao et al., 
1996). Briefly, the competent bacterial cells (Strains: Top 10 or ECOSTM 101 provided 
by Yeastern Biotech Co., Ltd.) were transformed with the recombinant plasmids by 
heat shocking at 42 oC for 45 sec -1 min. Afterward, the bacteria were seeded onto the 
Luria-bertani (LB)/agar/Amp+ selection Petri dishes. Bacterial clonies were then 
picked up and grown in LB/Amp+ medium overnight. After the mini-prepared plasmid 
being confirmed, the rest of bacteria were further grown in 500 ml LB/Amp+ medium 
till the O.D.580 reaches ~0.8. The bacteria were induced with 
isopropyl-b-d-thiogalactopyranoside (IPTG) at the final concentration of 0.5 mM for 
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To purify soluble proteins, the suppernant after centrifugation (15,000 rpm at 
4oC, 45 min) was collected and immediately incubated with glutathione agarose 
(Sigma) overnight at 4oC. For some proteins (e.g., Nogo and MAG) which are 
preferably expressed in the inclusion bodies, pellets collected after the above 
mentioned preparation were subjected to another circle of sonication in the 
denaturation buffer (Appendix 1) for 10 min and then transferred to dialysis tubes 
(Sigma) put sequentially in the renaturation buffer (Appendix 1) and phosphate 
buffered saline (PBS; pH 7.4). After centrifugation, the supernatants were collected 
and incubated with glutathione agarose beads.  
After being thoroughly washed, proteins were eluted twice with the elution 
buffer (Appendix 1). Glutathione agarose beads were regenerated in 10 ml of the 
regeneration buffer (Appendix 1) by rotating at 4ºC. Lastly, resulting proteins were 
washed in PBS and further concentrated in the centricon (Millipore) with 10-kD 
cut-off.  
Recovered proteins as well as the control protein GST were subjected to 
Commassie brilliant blue staining after separation by electrophoresis (Fig. 4) and 
concentrations were determined by a Bradford protein assay kit (BioRad). 
Nogo-66 peptide (KLSDVLDDVLFLRRLEKITCNVHGLASNSYKQVLEES 
IAVESELYARFPHGEDSKQIAQIVGKYIR) was purchased from oke Diagnostics 











Figure 4. Purification of recombinant proteins comprising OMgp, TN-R/EGFL 
domains and two inhibitory fragments of Nogo-A.  
Recombinant proteins fused to Glutathione S-transferase (GST) were expressed and 
purified from E.Coli, subjected to SDS-PAGE and Coomassie brilliant blue (CBB) 
staining. These include full-length OMgp (fl; ~70 kD), TN-R/EGF like domains (~49 
kD), the extracellular segment (Nogo-66; ~33 kD) and the amino-terminal sequence of 
Nogo-A (Nogo-N; ~47 kD) as well as GST (~25 kD). Mr: molecular weight marker.  
 
4. Experimental autoimmune encephalomyelitis (EAE) Model 
The experimental autoimmune encephalomyelitis (EAE) in Lewis rats was induced as 
described (Ahn et al., 2001). In brief, each rat (2-month old, female) received an 
injection of 0.5 ml of cognate spinal cord homogenate freshly prepared in complete 
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in the hind footpads bilaterally. The progression of EAE was marked by seven clinical 
stages delineated as: Grade (G) 0, no signs; G1, floppy tail; G2, mild paraparesis; G3, 
severe paraparesis; G4, tetraparesis; G5, moribund condition or death; R0, recovery 
stage (Ahn et al., 2001). At 13 ~ 14 days post-injection (dpi), animals at the peak 
stage of EAE (G3-G4) were sacrificed for further experiments.  
 
5. Oligodendrocyte myelin glycoprotein (OMgp) antisense transgenic (tg) mice 
To generate the antisense transgenic construct, a 1kb-truncated OMgp fragment was 
amplified from mouse brain cDNA and cloned into the pIRES vector in an antisense 
direction to produce pIRES-αOMgp. A 1.8 kb fragment containing the truncated 
OMgp and SV40 poly-A tail was then released by KpnI-XbaI digestion. This fragment 
was further subcloned into the pSP72 vector to generate pSP72-αOMgp. Furthermore, 
the 1.4 kb MBP promoter was amplified from mouse genomic DNA and subcloned 
into pSP72-αOMgp to ultimately generate the pMBP-αOMgp construct (Fig. 5A). 
 The transgenic construct was verified by DNA sequencing. A 3.2 kb 
transgene fragment was released from pMBP-αOMgp by SphI-KpnI digestion for 
microinjection of fertilized mouse oocytes. Routine genotyping of tail genomic DNA 
was performed with the following PCR primer sequences: 
Forward (MBPPrF2): 5’-acagctagttcaagacccca-3’ 
Reverse (OMgpgeno): 5’-aagcccatgtgatagggact-3’ 
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genomic DNA    1.5 μl     
25 mM MgCl2    1.5 μl 
10x PCR buffer    2.5 μl 
10 mM dNTP    0.5 μl 
10 pmol/μl MBPPrF2  1 μl 
10 pmol/μl Omgpgeno  1 μl 
5 u/μl Taq     0.2 μl 
ddH2O (autoclaved)   16.8 μl 
Total volume:    25 μl 
As the positive control, the template consisted of 0.5 μl control genomic DNA and 1μl 




Figure 5. Verification of the OMgp anti-sense transgenic (tg) mice.  
(A) A truncated murine cDNA encoding OMgp was cloned in an antisense direction 




CHAPTER 2 MATERIAS & METHODS 
61 
pMBP-αOMgp. (B) A representative result of genotyping PCR. M: molecular weight 
marker; P: positive control; N: negative control.  
 
The program used for PCR was below: Initial Denaturation: 5 min, 94oC. 
3-step cycling, Denaturation: 1 min, 94oC; Annealing: 1 min, 58oC; Extension: 1 min, 
72oC. Number of Cycles: 30. Final Extension: 10 min, 72oC. The amplification 
product was ~ 600 bp in size (Fig. 5B). 
 
6. Other genetically modified mouse models 
The TN-R knock-out mice (Weber et al., 1999) and wild type littermates (aged 2 
months and 10 months) were generously provided by Prof. Schachner M (University 
of Hamburg, Germany). The CGT deficient mice (Coetzee et al., 1996) and their wild 
type littermates (aged P16 and P21) were gifts from Prof. Popko B (University of 
Chicago, USA). The Shiverer mice and wild types (2-month old) were obtained from 
the Jackson Laboratories (Bar Harbor, Maine).  
All these mice were used in immunofluorescent histochemistry and electron 
microscopy studies. 
 
7. Cell culture and transfection 
Caspr/F3 co-expressing Chinese Hamster Ovary (CHO) cells (Faivre-Sarraih et al., 
2000), and F3-expressing CHO cells (Gennarini et al., 1991) were gifts from Dr. 
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the wt CHO and OLN-93 (a cell line of the pre-mature oligodendrocytes) cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco BRL) supplemented 
with 10% fetal bovine serum (Gibco BRL) and 1% penicillin/streptomycin, at 37°C, 
5% CO2 in a humidified atmosphere. To maintain Caspr/F3-expressing CHO cells, the 
medium included 400 µg/ml of G418 as described (Faivre-Sarraih et al., 2000). 
Expressions of Caspr and F3 in these cells were confirmed by western blotting 
analyses.  
For biochemical experiments, Caspr/F3- or F3 expressing CHO cells were 
further transiently transfected with mammalian expression vector (pCI-neo and 
pRBG4, respectively) containing cDNA encoding Nogo-A or Kv1.1 (Nakahira et al., 
1996), respectively.  
The OMgp-expressing CHO cell gifted from Dr. He Z.G (Harvard Medical 
School, USA; unpublished) was grown in DMEM supplemented with 400 µg/ml of 
G418. In separate experiments, Nav channel β1 and β2L in pcDNA3.1+ (from Dr. 
Isom L.L Lab, Michigan University, USA) as well as the empty pcDNA3.1+ were 
transfected into CHO cells, followed by the selection using 600 µg/ml zeocine 
(Invitrogen). After 2-month of selective culture, growing clones were then picked up 
and cultured in the presence of zeocine at a maintaining concentration. All 
transfections were performed using LipofectamineTM 2000 (Invitrogen) according to 
the manufacturer’s instructions.  
Cell lysates were collected in the cell lysis buffer (Appendix 1). Western 
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8. Retinal ganglion cells (RGCs) purification and Nav channel clustering study 
RGCs were purified by two-step immunopanning as previously described (Barres and 
Chun, 1993) with some modifications.  
The day before cell purification, the panning dishes were prepared. One 
60-mm Petri dish (FALCON) was incubated with 8 ml of 50 mM Tris buffer solution 
(pH 9.5) containing 40 μg of goat anti-mouse IgG (Chemicon) for 12 hrs at 4oC. 
Another two 100-mm dishes (CORNING) were incubated in 15 ml of diluted goat 
anti-rabbit IgG (Vector Lab) for 12 hrs at 4oC in the same buffer. The 60-mm dish was 
further incubated in 10 ml of diluted Thy1.1 monoclonal antibody for at least 1 hr at 
room temperature (RT). After washing, Eagle’s MEM (Invitrogen) with 0.2% bovine 
serum albumin (BSA) was placed in these three dishes (10 ml/each) for later use. 
On the day of culture, retinae were collected from 20-30 S.D. (Sprague 
Dawley) rats at P8. Upon tissue collection, a papain solution was freshly prepared as 
below: 200 units of papain (ICN Biomedical Inc.), 400 μg of DNase I (ICN 
Biomedical Inc.) and 2.4 mg of L-cysteine (Calbiochem) in 10 ml of MEM, added 
before use. Washed retinae were immediately digested in the papain solution for about 
45 min at 37oC. Digestion was terminated by addition of 3 ml of ovomucoid (Biomed 
Diagnostics) inhibitor solution. The retinal suspension was then incubated in anti-rat 
macrophage antiserum (Cedarlane Lab) for 20 min, after which the cells were 
resuspended in MEM and moved to one of the pre-treated 100-mm dishes for 30 min 
and then the nonadherent cells were further incubated in the second 100-mm dish for 
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for 1 hr. After that, the panning dish was washed at least 8 times with 6 ml PBS (pH 
7.4) each time and swirled moderately to dislodge non-adherent cells. RGCs remained 
adherent and were removed by gentle pipetting or trypsin digestion.  
Purified RGCs (> 98%) were seeded onto 13-mm plastic coverslips pre-treated 
with poly-D-lysine (Sigma; 10 μg/ml) and natural mouse laminin (Invitrogen; 2 μg/ml) 
and further cultured in the growth medium prepared as below:  
 
Neurobasal-A (with P/S and 0.5 mM L-glutamine) (Invitrogen)  5 ml 
50x B27 (Invitrogen)       100 μl 
BSA (100 mg/ml) (Sigma)      50 μl  [F.C.] 0.1% 
Insulin (4 mg/ml) (Invitrogen)     6.25 μl  [F.C.] 5 μg/ml 
Forskolin (25 mM) (ICN biomedical Inc.)  1 μl   [F.C.] 5 μM 
BDNF (5 μg/ml) (Invitrogen)     20 μl  [F.C.] 20 ng/ml 
CNTF (2 μg/ml) (ICN biomedical Inc.)   25 μl  [F.C.] 10 ng/ml 
Ketamycin (optional) (Invitrogen)    25 μl 
 
To induce Nav channels clustering, RGCs were cultured in the growth medium 
for 7 days and another 3 days in the presence of concentrated oligodendrocyte 
conditioned medium (OCM), GST-OMgp and GST, respectively. Nav channel 
clustering was visualized by immunocytochemistry using monoclonal antibody to 
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9. Western blot analysis 
To prepare whole extracts, frozen tissues (spinal cords and brains) were homogenized 
in the tissue lysis buffer-1 (Appendix 1). After ultracentrifugation (150,000x g at 4oC, 
45 min), the supernatants were collected and stored at -80oC for further use.  
Alternatively, membrane fractions were prepared as previously described (Lei 
et al., 2002). Briefly, minced tissues were homogenized in the ice-cold tissue 
homogenizing buffer (Appendix 1) supplemented with 1% protease inhibitor cocktail 
(Sigma), and debris was removed by centrifugation at 5,000x g (4oC, 15 min). The 
supernatant was collected and further spun at 60,000x g (Beckman ultracentrifuge) for 
60 min at 4oC. Pellets were then dissolved in the tissue lysis buffer-2 (Appendix 1). 
All samples were subjected to Bradford protein assay.  
Equal amounts of protein were separated on SDS-PAGE gels and transferred 
onto nitrocellulose membranes. Membranes were routinely blocked with 5% skim 
milk for 1 hr. Western blotting was performed under standard conditions, applying 
rabbit polyclonal antibodies against Nogo-A (1:1,000), NgR (1:1,000), Caspr 
(1:1,000), F3 (1:1,000), OMgp (1:1,000), Nav1.6 (1:200), Navβ1 (1:500), Navβ2 
(1:200; alomone); goat polyclonal antibodies against mouse OMgp (1:10,000), MBP 
(1:200), and mouse monoclonal antibodies against pan-Navα (1:1,000), GAPDH 
(1:5,000) and γ-Tubulin (1:1,000) (The latter two proteins were used for loading 
normalization). After washing the membranes 3 times with TBS and once with TBST 
(Appendix 1) sequentially, either anti-mouse IgG, anti-rabbit IgG or anti-goat IgG 
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the blots were finally visualized with an ECLTM detection kit (Amersham).  
 
10. Fluorescent immunohistochemistry (IF) studies 
Animals were perfused transcardically with 0.1 M Ringer’s solution (Appendix 1) and 
4% paraformaldehyde in 0.1 M PB (phosphate buffer, pH7.4). The spinal cords, brain 
stems and sciatic nerves were removed immediately for different subsequent 
preparation. For cryosection, tissues were immersed firstly in 15% sucrose and then in 
30% sucrose in 0.1 M PB (pH7.4). Ten μm-thick sections were mounted onto gelatin 
or poly-l-lysine coated glass slides. After being air-dried, the slides were kept at -20oC 
for later use. To prepare teased sciatic nerves, the removed nerves were desheathed, 
immersed in 3.6 mg/ml of collagenase (Gibco BRL) for 1 hr. On the gelatinized slides, 
the digested nerves were gently separated with fine needles to single fibers.  
To perform immunofluorescent (IF) staining, tissue sections were first 
immersed in absolute acetone at -20oC for 20 min. Slices were further washed in 0.1 
M PBS (pH7.6) containing 0.3% Triton X-100. After being blocked with 10% normal 
goat serum (NGS) diluted in 0.1 M PB for 1 hr, tissue slices were incubated with 
primary antibodies at their optimal dilutions (Table 2) for 2 hrs or overnight at RT. 
After thorough washing in the same buffer, Cy2-, Cy3- or Cy5-conjugated secondary 
antibodies (Amersham) corresponding to the preceding primary antibodies were used 
for further incubation of 1 hr at room temperature (RT). For double stainings, one 
more cycle of labeling was similarly conducted for second primary antibodies. All the 
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fluorescent microscope or LSM5 Carl Zeiss confocal microscopic system.  
   
11. Conventional and immuno-electron microscopy 
Animals were perfusion-fixed transcardiacally with 2% paraformaldehyde plus 3% 
glutaraldehyde in 0.1 M calcodylate buffer (pH7.4) for conventional electron 
microscopy (EM). The spinal cords were removed, post-fixed in the same fixative 
solution for 2 hrs. After being finely trimmed, the samples were immersion-washed 
overnight. Tissue blocks were further post-fixed in 1% of osmium tetroxide (OsO4) 
containing 1.5% potassium ferrocyanide for 2 hrs, thereafter subjected to dehydration 
in an ascending ethanol serials and absolute acetone at RT. After undergoing the 
gradual infiltration in Araldite 502 (EMS), tissue blocks were ultimately embedded 
and polymerized overnight in 60oC oven. Ultrathin sections (~90 nm in thickness) 
were placed on 200-mesh copper grids, counterstained with saturated uranyl acetate 
and 1% lead citrate.  
For immuno-electron microscopy (IEM), animals were perfusion-fixed in 4% 
paraformaldehyde plus 0.1% glutaraldehyde. For pre-embedding labeling, tissue 
blocks were post-fixed and sectioned as 100-µm slices using a vibratome. These thick 
slices were stained with Nogo-A and OMgp primary antibodies in respective 
experiments, according to ABC (Avidin-Biotin Complex) method. Briefly, the 
sections of the spinal cord or brainstem were blocked with 10% NGS, followed by 
incubation with Nogo-A or OMgp antibody or non-immune rabbit IgG (1:1,000 
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(IgG, Vector Lab.) was applied for 1 hr. Tissue samples were further incubated in ABC 
for 1 hr, followed by reaction with diaminobenzidine (DAB) solution (Sigma). Areas 
of interest were selected under microscope for standard dehydration and infiltration.  
For post-embedding protocol, tissues fixed under the aforementioned 
condition were processed conventionally. Ultra-thin sections were picked up onto 
nikel grids, blocked in the buffer (1% BSA, 1% NGS, 0.1% Tween-20 and 0.05% 
NaN3 in 0.1 M PBS, pH 8.3) and incubated with Nogo-A (1:1,000 and 1:2,000), 
OMgp antibody (1:1,000 and 1:500) and pre-immune IgG (1:1,000) overnight at 4oC. 
After washing in the same buffer, grids were further incubated with 10-nm gold 
conjugated goat anti-rabbit IgG (Aurion; 1:20, 1 hr at RT). Thereafter, samples were 
fixed in 2.5% glutaraldehyde for another 15 mins and counterstained with saturated 
uranyl acetate and 1% lead citrate.  
All samples were examined and photographed under a Jeol 1220 electron 
microscope. 
 
12. Immunoprecipitation (IP) assay 
Brain or cell membrane fractions were prepared as mentioned in the second paragraph 
of Western blot analysis (Page 64). In immunoprecipitation (IP) experiments, 
samples were initially pre-cleared by incubation with an excess of protein A+G 
agarose. Then, 0.5 to 1.0 mg of brain or cell samples were incubated with antibodies 
at 4oC and tumbled overnight. Antibodies used were: anti-Nogo-A (3 μl); anti-NB-3 
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anti-TNR/EGFL (3 μg), anti-NG2 (4 μg), anti-NrCAM (10 μl), anti-N-CAM (3 μl), 
anti-human contactin-1 (2 μl), anti-NG2 (10 μl), mouse anti-TN-R (596, 5 μl; 619, 5 
μl), anti-pan Nav (5 μg), anti-Nav1.2 (3 μg), anti-Nav1.6 (3 μg), anti-Navβ2 (3 μg), 
anti-Navβ1 (3 μl) and the non-immune rabbit IgG (3 μg) (Table 2). Protein-A or G 
agarose (Roche) was added according to hosts in which antibodies were generated, to 
continue shaking for 2 hrs (4oC). After thorough washing, immunoprecipitates were 
eluted in 60 µl of 2x Laemmli sample buffer and subjected to immunoblotting 
analyses. 
 
13. Glutathione S-transferase (GST) pull-down assays 
After being pre-cleard by glutathione agarose (Sigma), 0.5 ~ 1.0 mg of tissue or cell 
samples (whole homogenates or membrane fractions) diluted in the binding buffer 
(Appendix 1) were mixed with 5 - 20 μg GST or GST-fused recombinant proteins 
(GST-Nogo-66, GST-Nogo-N, GST-TN-R/EGFL and GST-OMgp) (Fig. 4) bound to 
glutathione agarose beads. After thorough washing, the bound proteins were eluted 
with 2x Laemmli sample buffer followed by separation in SDS-PAGE and detection 
by western blotting.  
  
14. Cell adhesion/repulsion assay 
The cell adhesion assay was carried out with 4-well or 24-well culture dishes. They 
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commonly for both adhesion and repulsion assay.  
For the adhesion assay (Fig. 6), 2.5-µl spots of different recombinant proteins 
(GST-Nogo-66, GST-Nogo-N) or GST (each at a concentration of 25 mM) or 100 mM 
Nogo-66 were applied onto the nitrocellulose-coated surfaces of the petri dishes 
(Becton Dickinson) and incubated for 2 hrs at 37 °C in a humidified atmosphere. The 
dried spots were washed with PBS and then flooded with Hank’s balanced salt 
solution free of calcium and magnesium (CMF-HBSS) containing 2% 
heat-inactivated BSA (Sigma) and incubated for 2 hrs to block residual nonspecific 
protein binding sites. The dishes were then washed with PBS. Mock-transfected CHO, 
F3/contactin-transfected or Caspr/F3 co-transfected CHO cells were then plated in 2 
ml of chemically defined medium at a density of 2.5 × 105 cells/ml and incubated at 
37°C in a humidified atmosphere. Cultures were checked every 15 mins in 12 hrs and 
then fixed by flooding with PBS containing 2.5% glutaraldehyde. After fixation, 
cultures were stained with 0.5% toluidine blue. Cells adhering to the various spots 
were photographed and counted.  
To perform the repulsion assay (Fig. 6), poly-L-lysine was used to coat the 
wells for 1 hr at 37oC, and then washed out. After air-dried, proteins (GST, 
GST-OMgp, GST-Navβ1, GST-Navβ2, GST-TN-R/EGFL) were dot-coated at separate 
locations which were pre-marked on the undersurface of dishes. After 2 hrs incubation 
at 37oC, the wells were washed and plated with cells at 50-100 k/well (Navβ1-CHO, 
Navβ2-CHO, OMgp-CHO and wild-type CHO cells). After about 20 hrs of growth 








Figure 6. Schematic showing of cell adhesion and repulsion assays. NC: 
nitrocellulose; PLL: poly-L-lysine; BSA: bovine serum album. 
 
15. Phosphatidylinositol-specific phospholipase C (PI-PLC) treatment of cells 
Where indicated, Caspr/F3-transfected CHO, F3-CHO, or OMgp-CHO as well as 
wild-type CHO cells were pre-treated with PI-PLC (0.02, 0.04 or 0.06 U/m) (Sigma), 
incubated for 2 hrs at 37oC and then plated into the dishes for cell adhesion/repulsion 
assays or subjected to western blot analysis or immunocytochemistry studies for the 
detection of contactin/F3 or OMgp, in respective experiments. 
 
16. In vivo conduction velocity recording 
Compound action potential (CAP) was recorded in the ventral funiculus of the spinal 
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2003). Briefly, thoracic spinal cords were removed quickly from the animals and 
semi-sectioned. The ventral funiculus was carefully dissected out in Kreb’s solution 
(in mM: 126 NaCl, 26 NaHCO3, 3 KCl, 1.3 NaH2PO4, 2 MgCl2, 10 Dextrose and 2 
CaCl2; pH ~7.4). The funiculus was kept straight in a custom-made recording 
chamber with a thread tied to one end and a mild suction of the recording electrode at 
the other end, and perfused at 3-5 ml/min in the oxygenated (95% O2, 5% CO2) 
medium at 25oC. As a stimulus, a 10/100- µsec square-wave current pulse was applied 
at one end of the funiculus via a bipolar Pt/Ir electrode (FHC, Bowdoinham, ME). 
Voltage signal from the other end was recorded with a suction electrode, high-pass 
filtered at 50 Hz, and digitized at 20 kHz, using Clampex software and GeneClamp 
500B amplifier (Axon Instruments, Foster City, CA). Conduction velocity was 
defined as l/t, where l is the length of the funiculus and t is the time from stimulus 
onset to the response peak.  
 
17. Morphometric quantitation and statistical analyses 
Fluorescent confocal images were acquired in Carl Zeiss LSM5 system and quantified 
by the accompanying software Zeiss LSM Image Browser. Immunofluoresent images 
of cultured cells or light images were captured with the digital camera mounted to 
Leica RXA2 microscope (Leica, Germany) and measured using the software Leica 
Qfluoro.  
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density of protein bands obtained in western blotting was measured using a Molecular 
Analyzer/Densitometer (Bio-Rad).  
Raw data were collected from at least 3 independent experiments or animals 
and presented as mean ± SEM. IF staining and protein expressions of Nogo-A and 
Caspr in EAE and normal rats were subjected to paired-samples T-test. Myelin layer 
thickness, axon diameter, conduction velocity in OMgp tg and wild type animals were 
compared according to independent-samples T-test. Nodal distance, nodal index, 
paranodal length, myelin layer thickness, number of abnormal paranodal loops in 
axons with different dimaters were compared in OMgp tg versus wild type mice and 
TN-R -/- versus wild type mice, in accordance with one-way ANOVA. And, the cell 
numbers counted in cell adhesion and repulsion assays were subjected to student 
T-test. Statistical analyses were performed with the softwares SPSS11.5 for windows 
and Origin 7.0. p < 0.05 and p < 0.01 were considered to be significantly or highly 
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1. Nogo-A –Caspr interaction is involved in the paranodal axon-glial junction 
1.1 NgR is uniformly distributed along the myelinated axons  
NgR, the Nogo-66 receptor which is expressed by neurons in vivo, has been 
well-known as the sole receptor signaling Nogo’s inhibitory activity (Fournier et al., 
2001; Fig. 2C and 3). It is established that MAG, OMgp, and Nogo-A all converge at 
this molecule to impart effects on responsive neurons (Hunt et al., 2002; Fig. 3). 
However, the question remains as to whether this receptor behaves similarly in intact 
and developing axon-glial interface.  
First, the temporal-spatial patterns of the expression and distribution of NgR 
were investigated using immunohistochemical and western blotting analyses. The 
results demonstrated that NgR expression was much higher in the adult brainstem, 
hippocampus, and cerebral cortex, but was significantly lower in the spinal cord (Fig. 
7A). NgR was detectable as early as postnatal day 1 (P1), its high expression level 
maintained until P14; and the level gradually decreased after P21 (Fig. 7B). In 
contrast, Nogo-A expression was elevated at P5 and remained strongly expressed 
throughout adult life. For validation of the specificity of the NgR antibody we stained 
rat hippocampal sections. NgR co-localized with the neuron-specific 
microtubule-associated protein 2 (MAP2) in cell bodies and processes (Fig. 8A-C). 
Double labeling for NgR and Nogo-A was difficult for us due to the same polyclonal 
rabbit origin of both antibodies. Instead, double labeling of NgR and Kv1.2 were 
performed. In longitudinal brainstem sections, NgR did not co-localize with the 
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P5, P14, and P30 sections. 
Strikingly, the developmental expression patterns of Nogo-A and NgR did not 
have a similar pattern, especially at P21 and P30 (Fig. 7B). This is supported by data 
of Hasegawa et al. (2005) who showed that Nogo-A and NgR were differentially 
expressed. These results suggest that NgR might not be the only Nogo-A receptor 
during development. 
Figure 7. Nogo-A and NgR expression in the CNS.  
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blot analysis. NgR is identified with a higher level of expression in the brainstem and 
cerebral cortex. Expression level is lower in spinal cord. (B) Rat brain lysates 
prepared at various developmental stages were subjected to Western blotting 
analysis for Nogo-A and NgR detection. γ-Tubulin was used as the loading control. 
 
 
Figure 8. NgR is uniformly distributed in the neurons and white matter.  
(A-C) Sections from adult rat hippocampus were stained for NgR and neuronal marker 
MAP2. The composite picture (C) illustrates their overlapping distributions. (D-F) 
Sections from adult rat brainstem were subjected to double-staining of NgR with 
Kv1.2, a marker for identification of the juxtaparanodes. Bars: 50 µm. 
 
1.2 Nogo-A has a confined distribution in the CNS paranodes 
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Nogo-A was then examined along the white matter tracts of adult rat brainstem. Dr. 
Strittmatter’s group (Wang et al., 2002) has reported that neither Nogo-A nor NgR 
appears to be confined selectively to internodal or paranodal regions although Nogo-A 
is situated at sites of axon-myelin contact. Thus, in this study, it was decided to use 
two different antibodies against Nogo-A, respectively raised by our collaborator Dr. 
B.L. Tang (National University of Singapore; Liu et al., 2002) and the other by Dr. 
Strittmatter (Wang et al., 2002), to compare the staining patterns. In longitudinal 
sections, a similar pattern of Nogo-A staining was observed with these two Nogo-A 
antibodies (Fig. 9). In double immunofluorescent labelings with Kv1.1 (red; Fig. 9a-c, 
g-i), the pan-Nav channel (red; Fig. 9d-f), or Caspr (red; Fig. 9k-m), the Nogo-A 
labeling (green) flanked nodal Nav channel, and was flanked by juxtaparanodal Kv1.1 
and overlapped with paranodal Caspr labeling, thus reflecting the paranodal location 
of Nogo-A (Fig. 9). Similar results were obtained in other nerve fiber-rich CNS 
regions such as the corpus callosum and the spinal cord. As the control, the specific 
labeling of Nogo-A in axonal domains was undectable after the Nogo-A antisera 








Figure 9. Nogo-A clusters at the CNS paranodes.  
Adult rat brainstem sections were double immunolabeled for Nogo-A (green; a, c, d, f, 
g, i, k and m) and the Kv1.1 α-subunit (red; b, c, h and i), or pan-Nav channel (red; e 
and f) or Caspr/paranodin (red; l and m). For negative control, Nogo-A antiserum 
(1:200) was premixed with antigen before staining of an adult brainstem section (j). 
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Strittmatter (g-i). c, f, i and m are merged images of a-b, d-e, g-h, and k-l, respectively. 
Bars: 5 µm for a-i, 10 µm for j, 20 µm for k-m.  
 
The specific paranodal location of Nogo-A was further confirmed using 
immuno-EM. In line with a previous report (Huber et al., 2002), Nogo-A 
immuno-reactivity was high in the inner and outer loops of the paranodal myelin 
sheath (Fig. 10a) but low in compact myelin of rat spinal cord (Fig. 10b). Nogo-A 
immunoreactivity was high in the expanded terminal glial loops (Fig. 10b-c) and the 
axoglial junction between the loops and the apposing axolemma (Fig. 10d-e) at 
paranodes and was present only occasionally in the paranodal axon (Fig. 10d). These 
observations thus demonstrate that Nogo-A is enriched at CNS paranodes and may be 
a component of the paranodal protein complex. 
 
 
Figure 10. Ultrastructural localization of Nogo-A at paranodes in the spinal cord.  
(a) Immunogold labeling of cross-sections of myelinated axons reveals that Nogo-A is 
detected at the inner and outer myelin sheaths. (b and c) Immunogold particles of 
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longitudinal sections of paranodes, immunogold particles for Nogo-A are located at 
the tips of glial loops in the axoglial junction and some within the axon in d. A higher 
magnification of the boxed areas of d and e are shown in d’ and e’. ax: axon; OL: 
oligodendrocyte. Gold particles are indicated with arrows. Bars: 200 nm for a, d and e, 
100 nm for b, c, d’ and e’. 
 
1.3 Paranodal Nogo-A is predominantly derived from oligodendroglia 
Nogo-A was first identified in myelin preparations (Schwab and Caroni, 1988). To 
characterize the cellular origin of the paranodal Nogo-A, its distribution was 
examined in two animal models with loss of oligodendrocytes and/or defects in 
myelination: one is experimental autoimmune encephalomyelitis (EAE), a condition 
exhibiting progressive CNS demyelination (Swanborg 2001). The other is ceramide 
galactosyltransferase (CGT) deficient mice (Coetzee et al., 1996) that display the 
presence of reversed lateral loops but the absence of transverse bands as well as 
abnormal localization of Kv1 channels along their axons (Dupree et al., 1999). At the 
peak of demyelination in EAE rats (13-14 days post-injection of the spinal cord 
homogenate), longitudinal spinal cord sections were prepared for double 
immunofluorescent staining for Nogo-A or Caspr, and Kv1.1. Caspr distribution in 
paranodes was scarcely impaired in EAE samples (Fig. 11Ab). By comparison, the 
density of Nogo-A positive paranodal congregates was significantly decreased (by 
around 90%) in sections from EAE rats (Fig. 11Aa and B) compared to those from 
control animals. Only occasionally foci of Nogo-A positive paranodal clusters 
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11Aa). In concert with the loss of paranodal staining, Nogo-A expression levels in the 
whole spinal cord was down-regulated in EAE rats. However, Caspr expression was 
affected to a much lesser extent by this manipulation in the same tissue (Fig. 12). 
 
Figure 11.  Nogo-A distribution at paranodes is impaired in the EAE rat spinal 
cords.  
(A) Double IF labelings in EAE spinal cord sections of Nogo-A (a, green) and Caspr (b, 
green), each in combination with Kv1.1 (red). The star marks a Nogo-A positive cell 
body whereas the arrowhead indicates a spare paranodal Nogo-A labeling. Scale bar: 
10 µm. (B) Comparative quantitation of Nogo-A and Caspr clusters in EAE and control 
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Figure 12.  Nogo-A is down-regulated in the EAE rat spinal cords.  
(A) Western blotting analysis of spinal cord extracts from EAE and normal rats using 
antibodies to Nogo-A and Caspr (γ-Tubulin is for loading control). (B) Quantitation 
shows that Nogo-A expression is significantly down-regulated in the spinal cord 
extracts from EAE rats, as compared to normal rats. Caspr expression is only slightly 
affected (* P < 0.05). Nor. SC: spinal cords of normal rats; EAE SC: spinal cords of 
EAE rats.  
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channels (red) at paranodes (Fig. 13a). In P16 CGT-/- mice, however, the correlation 
between the congregations of both Nogo-A (green) and Nav channels (red) was 
indistinguishable along the axons (Fig. 13b). A double labeling of the 200 kDa 
neurofilament with Nogo-A revealed loose spiral-like labeling of Nogo-A along all of 
the neurofilament labeled axon in P21 CGT-/- mice (Fig. 13d). This rather deranged 
labeling pattern was clearly different from the compact clustering of Nogo-A labeled 
in wild type animals (Fig. 13c). This result suggests that the Nogo-A clustering along 
the axon is severely disrupted in the mutants. Together, these results demonstrate loss 
of paranodal clustering of Nogo-A in both the EAE rat model and in CGT mutant 
mice, supporting the notion that paranodal Nogo-A is derived from oligodendrocytes 




Figure 13. Nogo-A distribution in spinal cord sections from the wild-type and 
CGT deficient mice.  
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CGT -/- spinal cords at the postnatal day 16 (P16). (c and d) Spinal cord sections from 
wt and CGT -/- mice at P21 were double labeled for Nogo-A (Green) and NF-200 
(Red). Arrows in (d) indicate the Nogo-A labeled spirals. Scale bars: 10 µm. 
 
1.4 Nogo-A interacts with the paranodal Caspr/F3 complex 
Thus far, these observations raised the possibility that Nogo-A might interact with an 
axonal receptor other than NgR, particularly in the specific axon-glial compartments. 
Given the specific paranodal location of Nogo-A, it was further investigated 
whether paranodal axonal components, such as Caspr, contactin/F3, and NB-3 (an 
F3-related molecule) (Lee et al., 2000), are Nogo-A binding partners. To test this 
hypothesis, Nogo-A, Caspr, contactin/F3, and NB-3 were immunoprecipitated from 
membrane extracts of adult rat brain. Western blot analyses of the immunoprecipitates 
revealed that Nogo-A, Caspr, and F3, but not NB-3, were present in the 
immunocomplexes pulled down by either Nogo-A or Caspr antibodies (Fig. 14). 
Immunoprecipitation (IP) studies were further performed on Caspr/F3-, F3-, and wild 
type CHO cells transiently transfected with a Nogo-A expression construct, as well as 
Caspr/F3-CHO cells. Transfections were performed using Caspr/F3 double-expressing 
cells because F3 is required for coordinated cell surface expression of transfected 
Caspr (Faivre-Sarrailh et al., 2000). Western blotting demonstrated that Nogo-A and 
Caspr indeed associated with each other in Nogo-A/Caspr/F3-, but not Nogo-A/F3-, 
Nogo-A- or Caspr/F3 expressing CHO cells (Fig. 15). IP studies performed with 
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complex with Nogo-A (Fig. 16A). These results indicated that Nogo-A interacts 
specifically with Caspr rather than F3.  
 
 
Figure 14.  Nogo-A associates in vivo with Caspr-F3.  
Lysates of brain membrane fractions were immunoprecipitated with Caspr, Nogo-A, 
and NB-3 antibodies as well as non-immune IgG. The immunoprecipitates and 
detergent extracts from brain (Brain) together with the protein-A beads (Beads) were 
subjected to Western blotting analysis using antibodies against Caspr, Nogo-A, F3, 
and NB-3, respectively.  
 
1.5 The extracellular Nogo-66 trans-interacts directly with Caspr 
The extracellular domain of Nogo-A consists of a 66 amino acid loop bordering the 
two transmembrane domains, known as Nogo-66 domain (Fournier et al., 2001). Any 
interaction in trans between Nogo-A and Caspr should involve the Nogo-66 domain. 
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protein containing Nogo-66 (GST-Nogo-66) as well as GST as a control was 
performed to confirm their interaction. Caspr was detected in the precipitates 
recovered from GST-Nogo-66 but not GST (Fig. 16B), suggesting that the Nogo-66 is 
able to associate directly with Caspr in a trans-manner that is independent of F3. In a 
cell adhesion assay, different CHO cell lines (expressing Caspr or otherwise) were 
plated onto substrates coated with the Nogo-66 peptide or GST-Nogo-66 or the 
recominant GST fusion protein containing cytoplasmic N-terminal domain of Nogo-A 
(GST-Nogo-N) as well as GST. Only Caspr/F3-expressing cells, neither F3-expressing 
nor wild-type CHO cells, adhered readily to Nogo-66 or GST-Nogo-66. None of these 
CHO cell types adhered well to GST or GST-Nogo-N. 
  
 
Figure 15. Nogo-A interacts with Caspr but not F3.  
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Caspr/F3-transfected CHO cells were separately immunoprecipitated with antibodies 
to Caspr and Nogo-A as well as non-immune IgG. The immunoprecipitates and brain 
extracts (Brain) were subjected to western blot analysis using antibodies against 




Figure 16. Nogo-A interacts directly with Caspr via its extracellular domain.  
(A) Immunoprecipitation from Nogo-A, Caspr and F3 triple-transfected CHO cell 
lysates using Nogo-A antibodies as well as pre-immune IgG. Resulting precipitates 
were identified for Caspr presence. (B) Brain membrane fractions were passed 
through GST-Nogo-66 as well as GST. The eluted precipitates and brain membrane 
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To investigate if Nogo-66 interacts with Caspr or whether a binding pocket for 
Nogo-66 is generated by Caspr-F3 complex on the cell surface, removal of the 
GPI-linked F3 was achieved by using phosphatidylinositol-specific phospholipase C 
(PI-PLC) and Nogo-66 binding property of these cells were examined. After a PI-PLC 
treatment, Caspr/F3-CHO cells still adhered to both Nogo-66 and GST-Nogo-66, but 
not to GST coated substrates. To ensure that F3 was completely removed by the 
treatment, increasing concentrations of PI-PLC (0.02, 0.04 and 0.06 units/ml) were 
used. The level of cell binding remained constant in all three different concentrations 
of PI-PLC. In agreement with previous work (Faivre-Sarrailh et al., 2000), western 
blotting and immunostaining (figure not shown) using F3 antibodies demonstrated 
that the majority of F3 was indeed removed from Caspr/F3-CHO cells upon treatment 
with PI-PLC. This lack of effect of PI-PLC on the cell adherence to Nogo-66 
substrates suggests that F3 is not directly involved in the trans-interaction between 
Nogo-66 and Caspr.  
 
1.6 Nogo-A and Caspr share a similar temporo-spatial relation with Kv1.1 along 
myelinated axons during development 
In view of the potential interaction between the paranodal Nogo-A/Caspr identified 
above, the dynamic relationship between Nogo-A and Caspr during development was 
investigated next. To mark the boundary between paranodal and juxtaparanodal 
regions along myelinated axons, Kv1.1 distribution was closely inspected. Double 
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performed on brainstem sections of rats at various postnatal ages. Aggregation of both 
Caspr and Kv1.1 labeling were observed from approximately P5 onwards (Fig. 17). 
From P5 to P14 (Fig. 17A-I), Caspr staining at paranodes overlapped with that of 
Kv1.1, suggesting co-localization of both molecules at this critical early period of 
myelination. At P30 (Fig. 17k), Kv1.1 labeling became more distinctly 
juxtaparanodal, with only minimal bands of overlap with Caspr at 
paranodal-juxtaparanodal borders. In the adult (Fig. 17M-O), Caspr and Kv1.1 were 
segregated exclusively into their different prescribed microdomains along the 
myelinated axons.  
 
 
Figure 17. Caspr and Kv1.1 are transiently co-localized during development.  
Double immunofluorescent labeling for Caspr (Green) and Kv1.1 (Red) in rat 
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Double immunofluorescent staining for Nogo-A and Kv1.1 at P1 (Fig. 18a-c) 
revealed that Nogo-A was diffusely labeled along the nerve fibers. At P5 (Fig. 18d-f), 
clustering and aggregation of Nogo-A labeling became more evident. However, the 
staining pattern still did not bear well-defined domains or borders. Nodal gaps were 
apparent and hemi-nodes were seen as well. From P7 onward (Fig. 18g-i), Nogo-A 
distribution exhibited an obvious clustering towards the paranodes. Between P5-P14 
(Fig. 18d-l), there were varying degrees of overlap between congregates of Nogo-A 
and Kv1.1 immunostaining at both paranodal and juxtaparanodal regions. At P30 
(Fig. 18m-o), Kv1.1 clusters were exclusively localized to juxtaparanodes, similar to 
the situation in adult animals. Co-localization of the Nogo-A/Kv1.1 was then 
quantified by measuring the lengths of Nogo-A and Kv1.1 labeled regions on captured 
images (Fig. 19A). The average length of a Nogo-A labeled region was about 9 µm at 
P5, 5 µm at P7, shortening to about 2 µm from P14 to adult, suggesting that Nogo-A 
is progressively accumulated into narrower bands during the early stages of 
myelination. The average length of a Kv1.1 labeled region did not demonstrate such a 
marked change over time: 6 µm at P5 to 8 µm in the adult. Of note was the change in 
terms of the length of overlaps between Nogo-A and Kv1.1 labeling: it reduced from 
4 µm at P5, 2 µm at P14, and 1 µm at P30 to approximately 0 µm in the adult. These 
changes denote a transient co-localization of Nogo-A and Kv1.1 in paranodal regions 








Figure 18.  Nogo-A and Kv1.1 co-accumulate at paranodes in early stages. 
Brainstem sections from P1 to P30 rats were double-labeled for Nogo-A (Green) and 
Kv1.1 (Red). At P1, Nogo-A (a) is evenly distributed in nerve fibers; From P5 to P14, 
Nogo-A are co-congregating with Kv1.1 at paranodes. Scale bar: 5 µm.  
 
Also, the degree of co-localization between Nogo-A/Kv1.1 and Caspr/Kv1.1 
was compared (Fig. 19B). From P5-P14, paranodes double labeled for either 
Nogo-A/Kv1.1 or Caspr/Kv1.1 were >60%. In adult animals, Nogo-A and Caspr were 
separated from Kv1.1 and a complete segregation was ultimately achieved. Taken 
together, these observations demonstrate that Nogo-A and Caspr co-aggregate at CNS 
paranodes early in development and their interaction may involve the re-distribution 
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Figure 19.  Nogo-A and Caspr share a similar temporo-spatial relation to Kv1.1 
during development.  
(A) The lengths of Nogo-A, Kv1.1 labeling and their overlaps were measured from 
micrographs (µm, mean ± SEM). Nogo-A is clustering with time and gradually 
separated from Kv1.1. (B) Number of overlapping Nogo-A/Kv1.1 or Caspr/Kv1.1 
clusters at paranodes was counted. Nogo-A is in parallel with Caspr in 
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1.7 Nogo-A/Caspr complex interacts with Kv1 channels  
The observation that Kv1 channels transiently co-localizes with Nogo-A/Caspr 
complex at paranodes from P5-P14 implicates that the Nogo-A/Caspr complex may 
interact with Kv channels, and as such may cooperatively regulate the paranodal 
localization of Kv1.1 during the early stages of myelination. In GST pull-down assays 
using membrane extracts of adult rat brain both Caspr and Kv1.1 could be pulled 
down by GST-Nogo-66, but neither GST-Nogo-N nor GST (Fig. 20). This result 
further supports the notion that Nogo-66 is a trans-interacting partner of Caspr, and 
that Kv channels may interact with the complex. 
 
 
Figure 20.  GST pull-down analysis showing Nogo-66 association with Caspr 
and Kv1.1.  
Brain membrane fractions were incubated with GST-Nogo-66, GST-Nogo-N as well as 
GST. The eluted precipitates and brain membrane fractions (Brain) were subjected to 
Western blotting analysis for identification of Caspr and Kv1.1. Caspr and Kv1.1 are 
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1.8 Nogo-66 interacts indirectly with Kv1 channels via Caspr 
Next, it was asked whether Nogo-66 directly interacts with Kv1 channels. Kv1.1 
cDNA (Nakahira et al., 1996) was transiently transfected into Caspr/F3-, F3- and wild 
type CHO cells and the membrane extracts were subjected to a GST pull-down assay 
using GST and GST-Nogo-66 fusion proteins, respectively. Wild type and 
F3-expressing CHO cells did not express endogenous Caspr (Fig. 21A). Western blot 
analysis showed that Kv1.1 as well as Caspr could only be detected in GST-Nogo-66 
precipitate resulting from the Caspr/F3-expressing, but not F3 solely expressing and 
wild type CHO cells (Fig. 21B). These results demonstrate that Nogo-66 interacts 
indirectly, at least in vitro, with Kv1 channels via Caspr.  
 
1.9 Nogo-A/Caspr may assist in regulating Kv1.1 location 
The mechanism guiding Kv1 channel localization is not completely clear. To explore 
the spatial relationship between glia-related molecules and Kv1 channels in 
myelinated axons, the distribution of Nogo-A, Caspr, and Kv1.1 was examined in 
animal models that display deficits in myelination and channel distribution. The 
Shiverer mouse is a hypomyelinating mutant that lacks MBP and has axons with 
normal oligodendroglial ensheathment, but displays aberrant axoglial junctions and 
abnormal localization of Kv1 channels along its axons (Rasband and Trimmer, 2001). 
Double immunofluorescent staining demonstrated that both Caspr (green) and Kv1.1 
(red) clusters were sustained in the paranodal regions of the EAE rat (Fig. 22A), 
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Nogo-A (green) and juxtaparanodal Kv1.1 (red) in the spinal cord sections of normal 
mice (Fig. 22C), Nogo-A clustering was hardly detectable in the paranodal region of 
Shiverer mice (Fig. 22D-G). Nogo-A immunoreactivity in cell bodies, however, 
remained intact and distinct (arrows; Fig. 22C, F and G). In accordance with 
previous observations (Poliak et al., 2001), disorganized Caspr and Kv1.1 labeling 
co-localized at paranodes in Shiverer mice (Fig. 22I) but were absolutely separated in 
wild-type mice (Fig. 22H). 
Quantitative analysis of the distance between paired Kv1.1 immuno-labeling 
revealed that the distances between the Kv1.1 pairs were significantly reduced in both 
EAE and Shiverer mice compared with their respective control animals (P < 0.01; Fig. 
22J). These findings suggest that in both pathological conditions of EAE rats and 
Shiverer mice that display paranodal junction defects, K+ channels are relocated to the 
paranodes. Concomitantly, the accumulation of Nogo-A at the paranode was markedly 
reduced. Thus, certain glia-derived molecules involved in formation of axoglial 
junctions may also be essential for proper Kv1 channel localization at the 
juxtaparanodes in normal adult animals. The molecular structural basis for these 








Figure 21. GST pull-down analysis with cell lysates demonstrates that Nogo-66 
indirectly interacts with Kv1.1 via the associated Caspr.  
(A) Lysates from CHO, F3-CHO and Caspr/F3-CHO, together with brain extracts were 
subjected to Western blotting assay for verification of Caspr expression. (B) The 
aforementioned cells were further transiently transfected with RBG4/Kv1.1. Lysates 
were subsequently collected and separately incubated with GST-Nogo-66 or GST. 








Figure 22. Distribution of Nogo-A, Caspr and Kv1.1 in the EAE rats and shiverer 
mice. 
(A and B) Double IF labelings for Caspr (green) and Kv1.1 (red) in brainstem sections 
of EAE (A) and control (B) rats. The insets represent magnified views of the Kv1.1 
labeling. Scale bars: 10 µm for A-B and 5 µm for insets of A-B. (C-G) Double labeling 
of Nogo-A (green) and Kv1.1 (red) in spinal cord sections from wild type (WT) (C) and 
Shiverer (D-G) mice. F is a merged picture of D and E. Arrows in C, F and G indicate 
Nogo-A positive cell bodies. Bars: 10 µm. (H and I) Double IF stainings of Caspr 
(green) and Kv1.1 (red) in brainstem sections from wt (H) and Shiverer (I) mice. Bar: 
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and Shiverer (Shi) versus wt mice were measured from micrographs (µm, mean ± 
SEM), respectively. The values in EAE rats or Shiverer mice are significantly reduced 
when compared to their controls, respectively (** P < 0.01). 
 
 
2. Oligodendrocytes, via OMgp rather than TN-R, regulate the formation of 
NORs  
2.1 OMgp deposits in the NORs of both the CNS and PNS 
Among the NOIs, TN-R (Ffrench-Constant et al., 1986), several members of CSPGs, 
MAG (Bartsch et al., 1989), and Nogo-A all have respective accumulations in either 
nodes or paranodes. However, OMgp’s distribution pattern and physiological 
functions are not well-established. It has been previously reported that OMgp may be 
enriched in the paranodes of peripheral nerves (Apostolski et al., 1994; Sheikh et al., 
1999). However, this result was obtained by using an antibody targeting the common 
Gal (beta 1-3) GalNAc antigen. Mikol and Stefansson (1988), by contrast, noted the 
expression of OMgp near the nodes using antiserum against OMgp itself (Vourc’h and 
Andres, 2004). These previous observations have implicated a possible location of 
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Figure 23. OMgp deposits in the node of Ranvier. 
(A) Triple immunofluoresecent labeling of rat spinal cord section for OMgp (blue), 
Caspr (green) and Kv1.1 (red). Paranodal Caspr labeling confines that of OMgp, 
which is further flanked by juxtaparanodal Kv1.1 labeling. (B) Immunohistochemistry 
study was performed on longitudinal sections of adult rat spinal cord, using OMgp 
antibodies which were pre-incubated with quantitatively >500 fold GST-OMgp proteins 
for at least 4 hours. Scale bar: 20 µm.  
 
In the current study, the distribution of OMgp along white matter tracts in the 
CNS and sciatic nerves in the PNS was examined using the specific antibodies (Habib 
et al., 1998) against OMgp. To double confirm the specificity, control 
immunofluoresent labeling was conducted by pre-incubating the antibody with an 
excess of OMgp recombinant protein (> 500 folds in quantity). No detectable signal 
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performed on longitudinal sections of rat spinal cord using a combination of 
antibodies against OMgp, Caspr and Kv1.1 potassium channel demonstrated that 
OMgp (blue) was densely confined in NORs (Fig. 23B). To detail OMgp’s location in 
relation to the surrounding subcellular structures, IEM was further employed 
according to either pre-embedding ABC (Fig. 24a) or post-embedding immunogold 
(Fig. 24b-c) approaches. IEM results validated OMgp’s expression in compact myelin 
(Fig. 24d) and both protocols consistently manifested OMgp’s specific clustering in 
the NORs. Paranodes and internodes, as opposed to nodal gaps, were devoid of 
immunoreactivity for OMgp. Moreover, the distribution profiles shown by both 
protocols suggested an extra-axonal origin for nodal OMgp. It is likely that nodal 
OMgp could be derived from oligodendrocytes and/or NG2-positive perinodal 
astrocytes that come into contact with the NORs in the CNS (Ffrench-Constant and 










Figure 24. The nodal OMgp is of extra-axonal origin.  
(a) Adult rat spinal cord white matter was subjected to immuno-electron microscopy 
(IEM) according to the pre-embedding ABC method using antibody against OMgp. 
DAB immunoreactive particles are specifically enriched within perinodal space but 
scant in nodal axolemma. (b and c) Post-embedding immuno-gold labeling was 
performed in adult spinal cord ultra-thin sections. Gold particles for OMgp are 
detected within the extracellular matrix surrounding the node of Ranvier (N). Black 
arrows in b and c indicate the 10-nm gold particles. (d) In adult spinal cord sections, 
gold particles for OMgp are also present in compact myelin sheaths as indicated by 








Figure 25. OMgp distribution in both the CNS and PNS.  
(a-c) Double immunofluorescent (IF) labeling of adult spinal cord sections for OMgp 
(green) and Kv1.2 (red). c is the merged picture of a and b. (d-f) Double IF labeling of 
adult spinal cord sections for OMgp (green) and Caspr (red). f is the composition of d 
and e. (g-i) Double IF labeling of teased sciatic nerve for OMgp (green) and pan-Nav 
channel (red). i is the composite picture of g and h. All insets represent the magnified 
views of respective underlying pictures. Scale bars: 20 µm for a-i; 10 µm for insets of 
a-i. (j) Nodal OMgp labeling in adult spinal cords and teased sciatic nerves were 
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3% and 96.3 ± 4.3%, respectively. (k) Quantitation of double IFs of OMgp and Caspr 
performed in spinal cords. Nodal OMgp is detected as 8.9%, 34.0%, and 72.7% in 
axons < 0.3 µm, 0.3 to < 0.5 µm and 0.5 to < 1 µm, respectively, but 100% in axons ≥ 
1 µm.  
 
Unexpectedly, double immunolabeling of OMgp with pan-Nav channel 
revealed the same nodal location of OMgp in teased sciatic nerves (Fig. 25g-i). 
OMgp’s labeling was also significantly wider than Nav channel’s labeling (red, Fig. 
25g-i). Similarly, the labeling of nodal OMgp in the spinal cord was irregular so as to 
overlap that of Caspr (yellow, Fig. 25d-f). These observations were consistent with 
IEM results, collectively indicating the enrichement of OMgp in both the node and the 
juxtanode which decribes the border between nodes and paranodes. 
 
2.2 Nodal OMgp is derived from oligodendrocytic lineages in the CNS 
To identify OMgp’s cellular source, different cell lineages were isolated and cultured 
in vitro, followed by immnocytochemistry studies. As shown in Fig. 26, 
β-III-Tubulin-positive neurons and GFAP-labeled astrocytes were not stained by the 
antibodies against OMgp. Clearly, both O1-expressing mature oligodendrocytes with 
multi-branches and NG2-positive bipolar oligodendrocyte precursor cells (OPCs) 
(figure not shown) were strongly labeled by OMgp antibodies in both their soma and 
processes. This result is consistent with the previous in vivo finding that in the CNS 
OMgp is predominantly expressed by oligodendrocytes (Mikol and Stefansson, 1988). 
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subgroup of projection neurons (Habib et al., 1998). Here, the isolated neurons were 
OMgp negative, probably owing to their identities other than projection neurons.  
In preceding EM studies immno-particles for OMgp were not detected in 
axons, further supporting the oligodendrocytic rather than neuronal origin of nodal 
OMgp in the CNS. Besides the CNS, Apostolski et.al (1994) also reported the 
presence of OMgp in peripheral nerves. In support of this, OMgp was indeed 
identified in teased sciatic nerves (Fig. 25). Therefore, it is proposed that OMgp might 
be expressed additionally by myelinating Schwann cells.      
 
 
Figure 26. OMgp is expressed by oliogodendrocytes in culture.  
Isolated oligodendrocytes, neurons, and astrocytes were immuno-labeled by 
antibodies against their respective markers O1, β-III-Tubulin, and GFAP (all green), 
each in combination with OMgp staining (red). As indicated, O1 labeled 
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2.3 OMgp could exist in secreted or soluble form 
OMgp, resembling the CAMs of IgSF such as contactin/F3 and TAG-1, possesses a 
glycosylphosphatidylinositol (GPI) tail by which it is anchored in the cell membrane 
(Mikol and Stefansson, 1988). The GPI linkage, however, is susceptible to 
phopholipase cleavage; therefore GPI-linked molecules, such as contactin/F3, could 
exist in a released form even in natural conditions (Durbec et al., 1992). To verify this 
likelihood, lysates of OMgp-transfected CHO cells, OLN-93 cells and concentrated 
medium of primary cultured rat oligodendrocytes were collected and subjected to 
immunoblot assay. As demonstrated (Fig. 27), a lower size (~100 kd) of OMgp was 
present in oligodendrocyte medium, compared to those in both cell lysates and the 
brain membrane fraction (~120 kd), in agreement with the previous study (Mikol and 
Stefansson, 1988), suggesting that OMgp could be released by endogenous cleavage 
or naturally exist as a secreted form.  
 
Figure 27. OMgp could exist in both the membrane-bound and secreted forms.  
Lysates from OMgp transfected CHO, OLN cells (OM/CHO-Ly and OLN-Ly, 
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fraction (WBM) were subjected to SDS-PAGE and immuno-blotting assay. Arrow 
heads indicate protein bands corresponding to OMgp.  
 
2.4 Nodal OMgp is preferably related to large axons in the CNS 
Also of note is that in some nodes of small axons, OMgp’s labeling can not be 
detected. Thus, it was quantified in relation to the three markers. The ratios of 
OMgp’s labeling to that of Kv1.2 in the spinal cord and pan-Nav in the sciatic nerve 
were 83.4 ± 10.3 % and 96.3 ± 4.3 %, respectively. Likewise, OMgp’s labeling in the 
CNS represented 74.7 ± 3 % of Caspr’s (Fig. 25j). The numeric disparity implicates 
that in the PNS, OMgp is almost 100% localized to NORs; whereas in the CNS, it is 
not clustered in every NOR. Further, the relation of OMgp clustering to axonal size in 
the CNS was elaborated by quantitative analysis. Double immunolabelings of OMgp 
and Caspr in the spinal cords were separately quantified according to axon sizes. 
Nodal OMgp was always detected in axons with diameter ≥ 1 µm, whereas the 
detection level were 8.9%, 34.0%, and 72.7% for the smaller axons whose diameters 
were <0.3 µm, from 0.3 to <0.5 µm and from 0.5 to <1 µm, respectively (Fig. 25k). 
This distribution pattern indicates that OMgp clustering at NORs is proportionately 
related to axon caliber in CNS. The relationship is acceptable because production and 
aggregation of myelin proteins are in proportion to myelin thickness which is in 
proportion to axon size (Salzer, 2003). This distributional priority thus implies that 
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2.5 OMgp clustering at NORs correlates with nodal maturation 
Next, the expression and distribution profiles of OMgp during development were 
investigated, especially with a focus on the relevance to myelin process and nodal 
formation. Western blotting analysis with brain extracts from various postnatal days 
(Fig. 28) demonstrated that OMgp protein was expressed in the brain early at birth; 
however, expression was up-regulated at postnatal day 5 (P5) and remains at high 
level till P30, over which myelination actively proceeds. This result was consistent 
with an earlier report that OMgp transcript peaks at the late phase of myelination 
(Vourc'h et al., 2003), implicating a potential role for OMgp in terminating and/or 
maintaining myelination. To correlate OMgp’s aggregation with Nav and Kv1 channel 
clustering during nodal maturation, IF studies were performed. As shown, OMgp 
clustering in the NORs commenced around P6 and became prevalent by P15 when the 
nodal structure was matured (Fig. 29). These observations implicate that OMgp 




Figure 28. OMgp developmental expression correlates with myelination.  
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analyzed for OMgp expression, using Western blotting assay. γ-tubulin was probed as 
the loading control.  
 
2.6 OMgp co-accumulates with TN-R and NG2 in NORs of the CNS 
An increasing number of glia-derived molecules such as TN-R and NG2 have been 
found in NORs (Girault and Peles, 2002). Among them, TN-R is expressed and 
secreted predominantly by oligodendrocytes (Bartsch et al., 1993; Pesheva et al., 1997; 
Xiao et al., 1996; 1998), whereas NG2 could be synthesized by the perinodal 
astrocytes in the CNS (Butt et al., 1999). To analyze their relationship in NORs, 
double IF labelings were firstly performed between OMgp and NG2 as well as OMgp 
and TN-R. The results demonstrated the exact co-localizations of these three 
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Longitudinal sections of rat spinal cords at P6, P10, P15, and P21 were collected for   
labeling using antibodies against pan-Nav channel (red) and potassium channel β2 
subunits (Kvβ2, red) as well as that to OMgp (green). Scale bars: 20 µm in a-g. 
 
2.7 OMgp associates with extracellular matrix (ECM) and neuronal proteins 
Given that OMgp could be secreted from oligodendrocytes, it is thus interesting to 
address how the soluble protein gets concentrated in the NORs. The interactions of 
OMgp with the ECM and/or axonal proteins may underscore its tethering in this locus. 
To test this, in vivo IP studies with adult brain homogenates were conducted in search 
of binding candidates for nodal OMgp. Antibodies against a number of proteins 
enriched in the NORs were used in these experiments and NgR antibody was adopted 
as a positive control. OMgp was present in a large complex with abundant axonal 
molecules including NrCAM, N-CAM, contactin/F3 and perinodal ECM molecules 
such as TN-R and NG2 (Fig. 30B), further corroborating OMgp’s nodal location.  
Thus, OMgp, TN-R and NG2 associate with each other at NORs, suggesting 
the notion that these glial molecules might have effects on underlying axons. However, 
a previous study of TN-R knock-out (TN-R -/-) mice revealed no apparent 
abnormalities in myelination and nodal organization, although the conduction velocity 
in optic nerve is strikingly decreased (Weber et al., 1999). Akin to OMgp, TN-R is 
predominantly expressed by oligodendrocytes and enriched in NORs, thus serving as 








Figure 30. OMgp is in complex with a variety of nodal molecules.  
(A) Double IF stainings of spinal cord sections illustrate co-localization (Yellow) 
between NG2, TN-R (Red) and OMgp (Green) in the NORs. Scale bars: 20 µm. (B) 
Adult brain membrane fractions were separately immunopreciptated with polyclonal 
antibodies against NrCAM, NCAM, NG2, NgR, F3, TN-R/EGFL, monoclonal 
antibodies to NG2, TN-R (two clones: 619 and 596), and pre-immune rabbit IgG. The 
resulting precipitates together with 30 µg of the whole brain membrane (WBM) were 
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2.8 OMgp expression is down-regulated in spinal cord of the antisense transgenic 
(tg) mice  
Given that OMgp is a protein derived from oligodendrocyte/Schwann cells, it is 
intriguing to address the question how this molecule might contribute to the myelin 
development. To do this, the OMgp transgenic (tg) mouse strain was generated to 
specifically down-regulate OMgp expression in these myelin producing glial cells. 
Thus, the transgenic construct derived from murine cDNA encoding OMgp was 
cloned in an anti-sense direction downstream of the MBP promoter, namely 
pMBP-αOMgp (Fig. 5). Genotypes of mouse pups were determined by PCR with 
genomic DNA extracted from tail-cuts. 
In both the OMgp tg and wild type mice, the expression levels of OMgp and 
related myelin proteins were examined by western blotting analyses with spinal cord 
extracts. In tg mice in which OMgp expression was down-regulated, level of MBP but 
not CNPase appeared to decrease in comparison to wild type mice and the control 
protein (Fig. 31). Down-regulation of MBP in these tg mice is likely caused by the 
impaired myelination in these mice. However, the possibility still exists that the 








Figure 31. MBP, but not CNPase, is down-regulated in spinal cords of the OMgp 
transgenic mice.  
Western blot analyses of spinal cord extracts from both OMgp tg and wt mice, probed 
with antibodies to OMgp, MBP, CNPase and γ-tubulin. The latter is used for the 
loading normalization.  
 
2.9 Large spinal axons in the OMgp tg mice are hypo-myelinated  
To study the possible role of OMgp in CNS myelination, cross-sections of spinal 
cords of OMgp tg mice as well as wild type littermates were prepared for 
conventional EM. As seen in Fig. 32a-b, the myelin wrapping pattern was normal but 
the layers became thinner in OMgp tg spinal cords. To evaluate myelin thickness 
quantitatively, G ratio, i.e., the numeric ratio between the diameter of the axon proper 
and the outer diameter of the myelinated fiber (Michailov et al., 2004), as well as 
axon diameters were measured and subjected to statistical analyses. The axon 
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(2.115 ± 0.056 µm versus 2.175 ± 0.070 µm, respectively; Fig. 32c). In contrast, G 
ratios are 0.9026 ± 0.0013 for tg and 0.8913 ± 0.0012 for wild type mice, respectively. 
G ratios in OMgp tg mice are significantly higher than that in wt mice (P < 0.01; Fig. 
32d). These suggest that OMgp down-expression has no effects on the axon sizes but 




Figure 32. Myelin layer thickness, but not axon diameter, is decreased in spinal 
cords of the OMgp tg mice.  
Representative EM photos (a and b) showing the ultrastructures of myelin sheaths in 
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shows that there is no significant change regarding the distribution of axonal 
diameters (c); however, the myelin thickness, as reflected inversely by G ratios (d), is 
significantly reduced in spinal cords of the OMgp mutants compared to wt animals (** 
P < 0.01). Scale bars: 2 µm in a and b.  
 
Given that OMgp accumulation is mostly associated with larger axons (Fig. 
25k), the change of myelin thickness was further analyzed in relation to different 
axonal sizes. The scatter diagram (Fig. 33A) demonstrated that G ratio increment in 
OMgp tg mice was much more pronounced in larger axons. When grouped according 
to axon diameter, G ratio increment was significant only in axons ≥ 1 µm but not in 
the smaller axons (Fig. 33B). Thus, the findings strengthen the notion that OMgp is a 
regulator of myelin corresponding to axonal size.  
To fully understand the role of OMgp in initial axon-glial recognition, EM 
studies were also performed in longitudinal sections in 2-month old mice. The results 
demonstrate that paranodal transverse bands are normally developed and aligned in 
OMgp tg mice (Fig. 34b). However, the lateral glial loops are inverted with high 
probability in OMgp tg spinal cords (Fig. 34b), compared to the normal landing of 
loops in wt mice (Fig. 34a). EM photos illustrate that transverse bands are 
electron-dense, ladder like partitions or septa, serving as the hallmark of paranodal 
axoglial junctions (Salzer, 2003). These results thus far manifest that axon-glial 
recognition at early stage of myelination is not or just mildly affected by OMgp 
down-regulation. Indeed, OMgp high expression is related to late phase of 
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important for the onset of myelination.  
 
 
Figure 33. Hypo-myelination occurs in axons ≥ 1 µm in spinal cords of the 
OMgp tg mice. 
(A) G ratios were plotted against the axon diameters. In spinal cords, myelin sheaths 
thickness is reduced in OMgp tg mice compared to the wt littermates. The change is 
more obvious in larger axons (** P < 0.01). (B) G ratios were grouped according to 
axon diameters. It is statistically evident that axons ≥ 1 µm but not the smaller become 









Figure 34. OMgp down-expression has no influence on the paranodal axon-glial 
junction. 
EM studies in longitudinal sections reveal the normal appearance and array of 
paranodal transverse bands in OMgp tg (b) versus wt (a) mice (both 2-month old). 
Black arrows indicate transverse bands while white arrows mark the inverted glial 
loops in OMgp tg mice. Scale bars: 200 nm in a-b and the insets.  
 
2.10 Sciatic nerves are hyper-myelinated in response to OMgp down-expression 
Akin to myelin oligodendrocyte glycoprotein (MOG), OMgp was also identified in 
the PNS (Mikol and Stefansson, 1988; Apostolski et al., 1994; Pagany et al., 2003; 
and Fig. 25), although both are just quantitatively minor components of myelin 
sheaths and primarily thought of as CNS specific proteins. To elucidate function of 
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OMgp tg and wild type mice. In cross sections of sciatic nerves in OMgp tg mice, the 
overall myelin structures appear normal, however, the myelin thickness was 
unexpectedly increased, as revealed by G ratios in OMgp tg and wt mice (Fig. 35). 
This result indicates that OMgp presents opposite effects on myelination occurring in 
the CNS and PNS. It is also noteworthy that the G ratio reduction in sciatic nerves of 
OMgp tg mice seems independent of the axon diameters (Fig. 36), in accordance with 




Figure 35.  Myelin sheath thickness appears to be increased in sciatic nerves 
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(A) Toluidine blue staining of semi-thin sections of sciatic nerves from both OMgp tg 
versus wt mice (both 2-month old). Scale bar: 20 µm. (B) Representative EM photos 
showing the ultrastructures of myelin sheaths in sciatic nerves of both OMgp tg mice 
(b) and wt littermates (a) (all aged 2 months). No abnormalities regarding myelin 
wrapping is evident. Note that the myelin sheath is sligtly increased in OMgp tg sciatic 
nerve. Scale bars: 2 µm.  
 
Figure 36.  Sciatic nerves in the OMgp tg mice are hyper-myelinated. 
The myelin thickness, as meant by G ratios, is increased in sciatic nerves of OMgp 
mutants compared to wt animals (** P< 0.01). 
 
A number of molecules such as adenosine and NGF have been shown to 
have opposite effects on myelination of the CNS and PNS (Stevens et al., 2002; Chan 
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regulates axonal myelination via distinct receptors and/or signaling pathways in the 
CNS and PNS. 
 
2.11 Nodal gap is narrowed in large axons of the OMgp tg mice  
To reflect nodal and paranodal organization at the light microscopic level, spinal cords 
of both OMgp tg and wild type mice (2-month old) were prepared for IF analyses 
using antibodies against several markers. The presumed nodal gaps which are 
normally occupied by Nav channels and are bordered by Caspr labelings appeared 
narrower, particularly in large axons in OMgp tg mice (Fig. 37a-f).  
The distance between each pair of Caspr labelings was measured to reflect the 
nodal dimension, and axonal diameters were determined by the width of each Caspr 
labeling. Axons were therefore divided into 5 groups according to diameters (ø): ø 
<0.5 µm, 0.5 ≤ ø <1.0 µm, 1.0 ≤ ø <1.5 µm, 1.5 ≤ ø <2.5 µm and ø ≥ 2.5 µm. Raw 
data were collected from 3 different animal pairs and presented as mean ± SEM (µm) 
(Table 3). Statistical analyses further enunciated the significant shortening of nodal 
distances in axons with diameter ≥ 1 µm, but not in the smaller axons (Fig. 37k). This 
change is in harmony with OMgp’s preferable distribution in axons ≥ 1 µm, pointing 
to a predominant role of OMgp in larger axons.   
Nav channel distribution, which bears extremely high density in nodes, 
however, showed an indistinguishable alteration although the fluorescent density 
seems lower in the tg mice compared to wild type littermates (Fig. 37g-j). This 
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clustering Nav channels into NORs.  
 
 
Figure 37. The nodal gaps are shortened in large axons of the OMgp tg mice.  
(a-f) Double IF labeling using antibodies against pan-Nav (Red) and Caspr (Green) in 
spinal cord sections from OMgp tg mice and wt littermates. Arrows indicate nodal 
gaps. (g-j) Higher-magnification micrographs of the labeling. (k) Quantitation of IFs 
was performed in reference to different axonal diameters (* P < 0.05). Scale bars: 10 
µm in a-f and 5 µm in g-j. 
 
Table 3. Nodal lengths (mean ± SEM, µm) in spinal cords of 2-month old OMgp tg 
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  ø < 0.5 0.5 ≤ ø <1.0 1.0 ≤ ø <1.5 1.5 ≤ ø <2.5 ø ≥ 2.5 
wt 0.543 ± 0.044 0.563 ± 0.016 0.609 ± 0.031 0.706 ± 0.039 0.662 ± 0.040
tg 0.501 ± 0.020 0.604 ± 0.029 0.504 ± 0.054 0.566 ± 0.043 0.518 ± 0.078
 
2.12 Both nodal distance and OMgp expression are normal in the TN-R -/- mice 
In vitro studies have demonstrated that TN-R binds to Nav channels, thereby 
potentiating Na+ currents (Srinivasan et al., 1998; Xiao et al., 1999). In TN-R knock 
out mice (TN-R -/-), though the structure of NORs appear normal, the conduction of 
action potentials in optic nerve is decelerated remarkably (Weber et al., 1999). Given 
the altered nodal architecture identified in OMgp tg mice, it is reasonable to test 
whether a similar abnormality occurs in TN-R -/- mice, particularly within the spinal 
cord. Studies using antibodies against Caspr and OMgp were done in spinal cord 
sections of 2-month old TN-R -/- as well as age-matched wild type mice. OMgp 
distribution as well as the nodal distance are similar in TN-R -/- and wild type mice 
(Fig. 38). These results pointed to disparate roles for OMgp and TN-R, in reference to 
the nodal micro-environment.  
 
2.13 Lateral glial loops are disorganized in NORs of the OMgp tg mice 
To address in detail how the nodal architecture was altered in OMgp tg mice, EM 
analyses was performed. In longitudinal sections of spinal cord from OMgp tg mice 
the lateral glial loops from oligodendrocytes were less compacted and instead showed 
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littermates (Fig. 39). In addition, the nodal gap was shorter in OMgp tg mice when 
comparing myelinated fibers of similar diameter from both OMgp tg and wt mice. 
Notably, all these aberrant features seem to be much more severe in larger axons (Fig. 




Figure 38. The nodal gaps and OMgp expression at NORs appear normal in the 
TN-R -/- mice.  
Double immunofluorescent labeling of Caspr (Red) and OMgp (Green) in spinal cord 
sections from both TN-R -/- and wt mice. Normal distribution of OMgp and nodal 
distance are observed in TN-R -/- mice as compared to wt mice. Scale bars: 5 µm.  
  
Myelin thickness is developed and proportionately related to axon diameter 
(Smith et al., 1982; Salzer, 2003). To measure nodal lengths relative to the axon 
diameters, the nodal index (NI) is defined as (N1+N2)/D where N1 and N2 represent 
the nodal distance along the upper and lower borders in EM photos and D for the axon 
diameter (Fig. 39c). Data were respectively collected from at least 3 animals of both 
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gradually as the axon diameters increase (Fig. 40a). This tendency confirms the 
proposal that in larger fibers the narrower nodal distance is likely attributed to 
increasing lateral compression from the paranodal loops (Pedraza et al., 2001). For 
axons ≥ 1.0 µm, but not the smaller, NIs are significantly reduced in OMgp tg mice as 
compared with those in wild type littermates (Fig. 40a). The paranodal lengths were 
determined by the nearest and farthest glial loops landing on the axon. The values are 
presented as mean ± SEM (µm, Table 4). Significantly, paranodal lengths are 
increased in axons ≥ 1 µm (Fig. 40b). Taken together, these findings mean that in 
OMgp tg mice, less compaction of glial loops occurs, particularly in larger axons (Fig. 
32).  
To obtain an accurate knowledge of nodal disorganization in OMgp tg mice, 
the non-landing loops were counted. The average numbers of detached loops are 
presented as mean ± SEM (Table 4). Non-landing loops are significantly increased in 
axons ≥ 0.5 µm in tg compared to wt mice (Fig. 40c), suggesting that loop 
disorganization may precede the nodal shortening in OMgp tg mice. Moreover, the 
more severe impairment identified in larger axons further corroborated that OMgp 
regulates nodal architecture in a manner which is proportional to its density at this site, 








Figure 39. Nodal architecture is disorganized, particularly in large axons of the 
OMgp tg mice. 
EM analyses of longitudinal spinal cord sections from OMgp tg versus wt mice (all 
aged 2 months). Arrows indicate the inverted or detached oligodendrocytic loops. The 
parentheses mark the spans of nodal gap and linear segments indicate axon diameter. 
Axons of three different diameters are shown: a and b, ~1.4 µm; c and d, ~1.02 µm; e 
and f, ~0.78 µm. Nodal disorganization in OMgp tg mice is much pronounced in larger 
axons (b and d). Scale bars: 500 nm in a-d and 1 µm in e-f. 
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OMgp tg and wild type mice of 2 months age (ø: axonal diameter, µm). 
  ø<0.5 0.5≤ ø <1.0 ø ≥ 1.0 
wt 2.73 ± 0.21 1.86 ± 0.15 1.45 ± 0.08 Nodal index 
tg 2.71 ± 0.35 1.7 ± 0.12 0.98 ± 0.10 
wt 2.02 ± 0.12 2.26 ± 0.07 2.40 ± 0.28 Paranodal length 
tg 2.46 ± 0.18 2.21 ± 0.08 3.09 ± 0.13 
wt 0 1.71 ± 0.455 1.0 ± 0.632 No. of detached loops 










Figure 40. Nodal shortening and disorganization of lateral loops in the OMgp tg 
mice occur predominantly in axons ≥ 1 µm.  
(a) To evaluate the nodal span in relation to axon diameter, nodal index is defined by 
(N1+N2)/D. The nodal gap is significantly shortened in OMgp tg mice. (b) Paranodal 
lengths in OMgp tg versus wt mice were compared. In axons ≥ 1µm, paranodal length 
is slightly increased. (c) Detached loops in OMgp tg versus wt mice were counted and 
compared. Significantly, axons ≥ 1µm and even those between 0.5 ~ 1µm are 
associated with the detached loops (* P< 0.05 and ** P< 0.01).  
 
2.14 Normal organization of NORs in sciatic nerves of the OMgp tg mice 
Considering the similar distribution of OMgp in the NORs of sciatic nerves, it is 
questioned whether in the OMgp mutants, NORs in the PNS are also aberrantly 
organized or not. Sciatic nerves of OMgp tg versus wild type littermates were studied. 
Double IF labeling with Nav channel and Caspr demonstrated normal distribution 
patterns of both molecules in PNS NORs and paranodes of OMgp tg mice (Fig. 41). 
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normal organization compared to wild type mice (Fig. 42). The landing of lateral 
loops is not specifically altered in sciatic nerves of OMgp tg mice. Given that 
hyper-myelination occurred in sciatic nerves in these mutant mice, however, it is 
essential to compare the lengths of NORs and paranodes in the future. 
 
Figure 41.  Nav channel and Caspr are normally distributed in the NORs and 
paranodes, respectively, in sciatic nerves of the OMgp tg mice.  
Longitudinal cryo-sections of sciatic nerves from both OMgp tg (b) and wt (a) mice 
(2-month old) were subjected to immunofluorescent double stainings using antibodies 
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Figure 42.  Nodal organization is not altered in sciatic nerves of the OMgp tg 
mice.  
In longitudinal view of sciatic nerve sections, organization of the NORs and perinodal 
milieu is normal in OMgp tg mice (b, 2-month old), as compared with age-matched wt 
mice (a). Scale bars: 500 nm. 
 
2.15 Nodal disorganization is not observed in the TN-R -/- mice 
Both cross and longitudinal sections of spinal cord from TN-R -/- as well as wild type 
mice (aged 2-month) were prepared for EM analyses. In cross sections the myelin 
layers enwrapped axons in a normal thickness in TN-R -/- compared to wt mice (Fig. 
43a-b). In longitudinal sections the lateral glial loops abutting nodal gap were 
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adjacent perinodal astrocyte processes (Fig. 43c-d). No obvious inversion of 
oligodendrocytic loops was detected in TN-R -/- spinal cords. Quantitation of 
paranodal length and nodal index revealed no difference between TN-R -/- and wild 
type mice (not shown). These observations suggest that OMgp, but not TN-R, is 
specifically required for the consolidation of glial loops and thus the proper formation 
of nodal span, probably by counteracting the lateral pressure from extending 
internodal myelin (Fig. 44).  
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TN-R -/- mice.  
EM analyses of cross and longitudinal spinal cord sections from TN-R -/- (b and d) 
versus wt (a and c) mice (all aged 2 months). The parentheses mark the spans of 
nodal gap. Scale bars: 1 µm in a and b; 500 nm in c and d. 
 
2.16 Conduction velocity in spinal cord of the OMgp tg mice is decreased 
To determine whether and how the hypo-myelination and disorganization of NORs in 
large axons of OMgp tg mice affect conduction of action potentials, compound action 
potential (CAP) was recorded over the same distance from the ventral funiculus of the 
spinal cord. As expected, the conduction velocity in OMgp tg mice (4.4 ± 0.3 m/sec; n 
=10) was significantly lower (p = 0.011) than that in wild type mice (5.5 ± 0.4 m/sec; 
n =8) (Fig. 44). Given the finding that Nav channel distribution in NORs is scarcely 
altered in OMgp tg mice, this result indicates that structural alterations in the OMgp 
mutant contribute to the change of nerve conduction. Nonetheless, it is necessary to 
test whether OMgp in NORs has direct role in regulating Nav channels expression 
and function. 
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significantly lower compared to wt littermates.  
(a) Representative recordings (averages of 20 traces) of compound action potential 
(CAP) from equal lengths of ventral funiculus (~ 1 cm). Stimulus artifact is removed for 
clarity. Arrow marks onset of a 100 µsec stimulus. (b) Conduction velocity of OMgp tg 
mice (n = 10) is 20% lower than in wt mice (n = 8) (* P < 0.05). 
 
2.17 Distinct roles of OMgp and TN-R in the NORs 
As a summary, a comparison was made between OMgp and TN-R regarding their 
functions in CNS nodes (Table 5). Both OMgp and TN-R are synthesized and 
secreted predominantly by oligodendrocytes in vivo (Bartsch et al., 1993; Pesheva et 
al., 1997) and are co-localized specifically at NORs (Ffrench-Constant et al., 1986). 
In vitro studies have demonstrated that TN-R binds to Nav channels, thereby 
amplifing Na+ currents (Srinivasan et al., 1998; Xiao et al., 1999). In the present study, 
the myelin structure has been further investigated in the spinal cords of TN-R -/- mice. 
Consistently, no abnormalities of myelination and nodal organization occurred in this 
mutant (Fig. 38, 43). There was also no apparent change regarding Nav channel 
expression or distribution in TN-R deficient mice, although the conduction velocity 
along the afflicted optic nerves is dramatically decreased (Weber et al., 1999). Here, a 
new axon subdomain termed juxtanode (JN) is regulated with a possible involvement 
in the landing of lateral oligodendrocytic loops. In OMgp mutants, the lateral 
oligodendrocyte loops in juxtanodal region tend to be looser, inverted and detached. 
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and the nodal span was shortened (Fig. 37, 39, 40, 44). In the OMgp mutant strain, 
these structural abnormalities as well as the down-regulated expression of Nav 
channel α subunits (to be introduced below, Fig. 49) may have led to the reduction of 
conduction velocity in ventral funiculus of spinal cords (Fig. 45). Altogether, these 
comparative findings indicate that OMgp and TN-R undertake distinct parts in nodal 
organization and functional modulation of Nav channels (Table 5). OMgp therefore 
might represent a molecular mechanism by which oligodendrocytes assist in nodal 
formation during the late phase of myelination. 
 
Figure 45.  A schematic drawing shows nodal disorganization in the OMgp tg 
but not in wt and TN-R -/- mice.  
The ‘juxtanodal region’ is proposed that is critically required for proper landing of 
lateral glial loops to axolemma at the terminating stage of myelination. N: node of 
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* All identified abnormalities are pronounced in the myelinated axons ≥ 1 µm of spinal cords. OLs: 
Oligodendrocytes; ON: optic nerve; ND: no data. 
 
 
3. OMgp regulates Nav channel expression but not the clustering at NORs 
3.1 OMgp associates with Nav channel subunits in vivo 
Voltage-gated Nav channels α subunit 1.2 (Nav1.2) at earlier stages of the 
development and Nav1.6 after myelin maturation are sequentially clustered in the 
NORs (Boiko et al., 2001; Kaplan et al., 2001). The constitutive β subunits, including 
β1 and β2, are also enriched in the nodal axolemma (Boiko et al., 2001; Kaplan et al., 
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subunit. To better understand the relation of OMgp with Nav channels, IPs were 
performed using antibodies against Nav channel α, β1, and β2 subunits with adult 
brain membrane extracts. OMgp was detectable in immunoprecipitates recovered 
from antibodies against pan-Nav, Nav1.6, Navβ1, Navβ2, but neither rabbit IgG nor 
Nav1.2 that was absent from matured nodes (Fig. 46A). In reverse, β1 and β2, but 
none of α subunits was detected in OMgp immunoprecipitates (figure not shown). 
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Figure 46. OMgp associates with Nav channel β subunits. 
(A) Membrane fractions from adult rat brains were immunopreciptated with polyclonal 
antibodies against OMgp, Nav1.2, Nav1.6, Navβ1, Navβ2, monoclonal anti-pan-Nav 
as well as pre-immune rabbit IgG. Precipitates and 30 µg of brain membrane (BrM) 
were subjected to SDS-PAGE and Western blotting analysis. OMgp is shown in 
association with Nav channel subunits β1, β2 and Nav1.6, but not Nav1.2. (B) Cell 
lysates of CHO-Navβ1 and CHO-Navβ2 were passed through the immobilized 
GST-OMgp as well as GST. Precipitates, cell lysats (ly) and brain membranes (BrM) 
were subjected to Western blot analysis.  
 
3.2 OMgp interacts directly with sodium channel β1 and β2, but not α subunit 
To further confirm the direct interactions between OMgp and Nav channel β1 and β2 
subunits, GST pull-down analyses and cell binding assays were carried out. 
Immobilized full-length OMgp fused to GST as well as the GST were incubated with 
either Navβ1-transfected CHO or Navβ2-transfected CHO cell lysates. Precipitates 
eluted from the glutathione-agarose beads were subjected to western blotting analyses, 
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GST-OMgp precipitates, but not GST precipitates (Fig. 46B). Surface expression of 
OMgp in the OMgp- but not the mock- transfected CHO cells was validated by 
immunocytochemistry (Fig. 47k). To perform cell-binding assay, cell culture dishes 
were dot-coated with GST-β1 or GST-β2 as well as GST. OMgp or mock-transfected 
CHO cells were plated onto the coated substrates. OMgp-CHO, but not mock CHO 
cells were repelled from the protein dots of either GST-β1 or GST-β2 (Fig. 47a-d). 
GST showed no effect on OMgp-CHO cells (not shown). The numbers of 
OMgp-CHO cells in every 6.25 mm2 field were averaged as 2 ± 1.2 on GST-β1, 3 ± 
1.5 on GST-β2 surface, and 9 ± 0.7 on the GST surface (Fig. 47l). To determine 
whether this cell repulsion involves OMgp itself, PI-PLC was used to cut the 
GPI-linkage and by doing so to remove OMgp from the cell surface before being 
plated. To ensure complete cleavage to occur, ascending concentrations of PI-PLC 
(0.02, 0.04 and 0.06 U/ml) were imposed on cells. Average cell numbers are listed in 
Table 6. Repulsion was completely abolished by pre-incubation with 0.04 U/ml 
PI-PLC, as evidenced by uniform distribution of cells across the protein boundaries 
(Fig. 47e, f, m). In independent experiments, GST-Navβ1 and Navβ2 were separately 
pre-mixed with 2 fold GST-OMgp before being dot-coated, the repulsive effects were 
also attenuated, but to a lesser extent (Fig. 47g-h). OMgp-CHO cells were 
pre-incubated with polyclonal antibodies against OMgp prior to plating. When the 
antibody was used at 1:500 dilution, the cellular repulsion against both GST-β1 and 
GST-β2 substrates was efficiently abrogated (Fig. 47i-j). Taken together, these results 
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CNS. In general, clustering of Nav channel subunits at the NORs depends upon 
oligodendrocytes/myelin maturation (Kaplan et al., 1997; 2001). Hence, it is 
particularly intriguing to address how OMgp affects Nav channels’ distribution and/or 
their functions. 
  
Table 6. Numbers of OMgp-CHO cells (average in mean ± SEM) attached to different 
GST protein surfaces after treatment with PI-PLC at different concentrations (U/ml). 
 0.02 U/ml 0.04 U/ml 0.06 U/ml 
GST-β1 2 ± 0.03 5.3 ± 1.2 7 ± 1.8 
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the OMgp transfected CHO cells.  
(a-d) OMgp expressing CHO and mock transfected CHO cells were plated in culture 
wells which were pre-coated in the left upper corner with GST-Navβ1 or Navβ2. 
OMgp-CHO cells, but not wt CHO cells, are repulsed from both recombinant proteins. 
(e-f) Prior to the aforementioned experiments, OMgp-CHO cells were incubated with 
PI-PLC (0.04 U/ml). (g-h) Before being dot-coated, GST-Navβ1 and Navβ2 were 
separately pre-mixed with 2 fold GST-OMgp and then exposed to the cells. (i-j) Before 
plating, the cells were pre-treated with polyclonal antibodies against OMgp (1:500). To 
differing extents, the repulsive effects are diminished by the above pre-treatments. (k) 
Immunocytochemistry using polyclonal anti-OMgp confirms the surface expression of 
OMgp on transfected CHO cells. Scale bar: 50 µm. (l) Quantitation of the cell 
repulsion (* p < 0.05). (m) Quantitation of repulsive effects after treatment with three 
different concentrations of PI-PLC.  
 
3.3 Recombinant OMgp protein fails to induce Nav channel clustering  
Previously, a protein originating from oligodendrocytes with an unknown biochemical 
identity was suggested to play a role in regulating Nav channel clustering in the initial 
stage of myelination (Kaplan et al., 1997; 2002). Given the putative interactions 
among OMgp and Nav channel subunits, it is interesting to determine whether OMgp 
acts as a candidate for such a role. It has always been believed that optic nerve shares 
the same mechanisms as the rest of the CNS regarding Nav channel clustering. Thus, 
the 2-step immuno-panning retinal ganglion cells (RGCs) culture was adopted for this 
study. After 10-day culture of purified RGCs in the presence of neurotrophic factors 
BDNF and CNTF, recombinant OMgp proteins as well as GST were added into the 




CHAPTER 3 RESULTS 
140 
for both proteins were added. Nav channel staining was conducted using either 
monoclonal antibody against pan-Nav or a polyclonal anti-Nav1.2. There was no 
obvious difference between the two groups regarding Nav channel distribution (Fig. 
48). This observation suggests that OMgp, at least in vitro, is not sufficient to trigger 
Nav channels clustering at least in RGC neurons. In parallel, distribution of Nav 
channels was still confined at NORs in OMgp tg mice, meaning little intervention of 
Nav channel clustering (Fig. 37). In the future, conditional knock-out mice, instead of 
the tg mice, may provide a better opportunity to resolve this issue.  
 
Figure 48. OMgp protein shows no activity of inducing Nav channel clustering. 
Purified RGCs from P8 rats were cultured in the presence of BDNF and CNTF for 10 
days, followed by incubation with GST-OMgp (fl) (c) or GST (b) proteins for another 
2-3 days. Immunocytochemistry studies were conducted using antibodies against 
pan-Nav for visualizing Nav channel clustering. BF: bright field. Scale bars: 20 µm. 
 
3.4 Nav channel α, but not β subunits, is down-regulated in the OMgp tg mice 
To address OMgp’s role in Nav channels expression, western blotting analyses were 
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using antibodies against a pan-Nav channel, β1 and β2 subunits, and γ-tubulin (as the 
loading control). The expression of β1 and β2 was not changed, whereas pan-Nav α 
subunit was shown to be considerably down-regulated in OMgp tg mice compared to 
those in wild type mice (Fig. 49). β subunits are homologous to CAMs of IgSF (Isom 
et al., 2002). Increasing evidence lends supports to the notion that interactions of β 
subunits facilitate the expression of Nav channels (α subunits) on cell surfaces 
(Kazarinova-Noyes et al., 2001; Liu et al., 2001; Ratcliffe et al., 2001; McEwen and 
Isom, 2004; Shah et al., 2004). However, further studies are necessary to address 
whether OMgp uses this mechanism to regulate Nav channels expression at NORs.  
 
 
Figure 49.  Expression of Nav channel subunits in the OMgp tg mice. 
Western blotting analyses of spinal cord extracts of OMgp tg mice and wt littermates, 
using antibodies against OMgp, Nav channel α (Pan-Nav), β1, β2 subunits, and 
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4. Summary 
This study has established that in axon-glial interface of myelinated fibers, myelin 
components MAG, Nogo-A and OMgp as well as other members of neurite outgrowth 
inhibitors (NOIs) have distinct locations related to NORs (Table 7). Nogo-A is 
enriched at CNS paranodes where it interacts with Caspr (Fig. 50a-c). OMgp 
co-aggregates with TN-R at nodes, acting differently to TN-R and probably regulating 
the formation of the NORs and Nav channel expression (Fig. 50d-f). By contrast, 
NgR, the common receptor for MAG, Nogo-A and OMgp, is evenly distributed along 
myelinated axons (Fig. 50g-i). The spatial disparity has led to new suggestion for the 
physiological functions of these myelin proteins. 
 
Figure 50. Disparate distribution patterns of NgR, Nogo-A, OMgp, MAG and 
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(a-c) Double immunolabeling of Nogo-A (green) and Caspr (red) performed in 
cerebellum sections of adult rat. Arrows denote the paranodal staining of Nogo-A. (d-f) 
Double immunolabeling of OMgp (green) and TN-R (red) in spinal cord sections of 
adult rats. (g-i) Double immunolabeling of NgR (green) and MAG (red) on brainstem 
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Regardless of their adverse roles in the neural degeneration, a lot of so-called 
neurite-outgrowth inhibitory molecules possess specific locations related to NORs 
(Girault and Peles, 2002). The present study identified OMgp and Nogo-A as 
components accumulating at the nodes and paranodes, respectively (Fig. 52). At these 
sites, they contribute to myelin maturation and axonal development, via mediating 
axon-glial interactions. Nav and Kv1 channels, which are accumulated respectively at 
the nodes and juxtaparanodes, could be targets regulated by glial signals. Disruption 
of Nogo-A-Caspr interaction at paranodes causes misplacement of Kv1 channels. In 
the nodes OMgp associates with a large number of other nodal molecules, by which it 
finely regulates the formation of NORs and expression of Nav channels. The results 
of this study have demonstrated that myelin components are molecular signals 
regulating subcellular domain specification along the myelinated axons.  
 
1. NgR ligands are confined into distinct domains of the myelinated fibers 
Axonal regeneration in mammalian CNS is prevented by the inhibitory signals from 
myelin components, e.g. OMgp, Nogo-A and MAG. Their effects may be mediated by 
a common receptor complex that comprises NgR as the ligand binding component and 
p75NTR being the signal transducing element (Fournier et al., 2001; Domeniconi et al., 
2002; Liu et al., 2002; Wang et al., 2002a, 2002b;). Recently, the LRR and Ig 
domain-containing, Nogo receptor-interacting protein (LINGO-1) was identified as a 
third necessary component in this receptor complex (Mi et al., 2004). When they are 
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(Wang et al., 2002a). It is broadly accepted that recruitment of p75 and LINGO-1 
makes this receptor complex capable for signal transduction across the cytoplasmic 
membrane.  
P75 is a member of the tumor necrosis factor (TNF) receptor family and 
represents a non-specific low-affinity receptor for neurotrophins (NTs) including 
nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5) (Barker, 2004). Furthermore, 
p75 regulates a rich variety of intracellular signaling pathways related to apoptosis, 
differentiation or nerve survival/growth (Bronfman and Fainzilber, 2004; Nykjaer et 
al., 2004). It is somewhat unexpected that NgR and p75 knock-out mice showed no 
enhanced regeneration (Song et al., 2004; Zheng et al., 2005). In addition, the 
inhibitory activity of Nogo-N is thought to be independent of NgR (Woolf, 2003). 
These findings led to the speculation that many of these inhibitory proteins may 
function through additional receptors and intracellular pathway(s), other than NgR.  
Thus far, further identification of receptors and the downstream signaling 
pathways utilized by these myelin proteins emerges as a new research interest. It has 
been observed that MAG bound to the nerve cell surface gangliosides GD1a and 
GT1b, thereby regulating MAG’s inhibitory activity (Vinson et al., 2001; Vyas et al., 
2002). Also, Nogo-A was identified in association with NIMP (Hu et al., 2002), 
α-tubulin and MBP (Taketomi et al., 2002).  
For these molecules, novel biological roles beyond the inhibitory actions 
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2003; Meier et al., 2003; Vourc'h et al., 2003). These include regulation of the neural 
plasticity, myelination and cell differentiation. MAG, Nogo-A and OMgp are 
myelin/oligodendrocyte components, however, their precise locations in axon-glial 
junctions of myelinated axons are poorly illustrated. This study has shown that 
Nogo-A bears a high density distribution at the CNS paranodes while OMgp and 
TN-R are accumulated at the nodes, in contrast to even distribution of NgR. As 
described previously, MAG was also enriched at the CNS paranodes and other 
non-compact myelin regions (Quarles and Trapp, 1984; Bartsch et al., 1989). The 
specific distribution of these proteins in the axonal domains, therefore, has prompted 
us to investigate their roles in axon-glial interactions and myelin development. 
 
2. Oligodendrocyte regulates the formation of NORs 
At and near NORs axon-glia interactions are categorized into at least two types: 
between axon and the myelinating glia, and between axon and the perinodal glia 
(Rosenbluth, 1988). Early in development, molecules from both axons and glia, could 
interact with each other in regulating the nodal formation. One existing concept 
suggests that cell adhesion molecules are essential components of intercellular 
junctions. In the heterologous axon-glial junctions, however, glial components are 
also suited for such a role. Repellent molecules at NORs include TNs of 
oligodendrocytes, CSPGs from astrocytes, the others derived from myelin. How do 
the glial and myelin proteins guide axon myelination? This study suggests that the 
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development or during remyelination.  
TN-R is predominantly expressed and secreted by oligodendrocytes (Bartsch 
et al., 1993; Pesheva et al., 1997). During active myelinogenesis, TN-R is present at 
contacts between axons and myelinating oligodendrocytic processes (Bartsch et al., 
1993). In addition to interactions with axonal contactin/F3 and Nav channel β2 
subunit (Ffrench-Constant et al., 1986; Bartsch et al., 1993; Pesheva et al., 1993; Isom 
et al., 1995; Xiao et al., 1996; 1998), TN-R also interacts with members of the CSPGs 
family such as versican and phosphocan (Aspberg et al., 1995; Xiao et al., 1997; 
Milev et al., 1998). These interactions may occur within perinodal ECM so that 
molecules from either adjacent oligodendrocytes or the interposed glial processes may 
form a macromolecular complex at the NORs. This meshwork of protein-protein 
interaction may provide a platform to regulate NOR with respect to its differentiation, 
maturation, and function. The present study has added OMgp to this complex of 
interaction.  
Due to the presence of a GPI-tail, membrane-bound OMgp is susceptible so as 
to be cleaved by endogenous phospholipases. Biochemical evidence confirmed that 
OMgp, like contactin/F3, existed in a secreted or soluble form. It is hypothesized that 
the secreted OMgp could aggregate at NORs, owing to bindings with other ECM 
proteins or axonal and perinodal glial molecules. The present study further identified 
a broad association of OMgp with TN-R, NrCAM, N-CAM, NG2, contactin/F3, as 
well as with Nav channel β1 and β2 subunits. It is worth noting that the binding 
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Nevertheless, molecules in this complex, even if they co-localize, may have distinct 
roles at this site. OMgp clustering during development is well-matched to the 
timecourse of nodal maturation, implying an involvement of OMgp in this event.    
Compared to the TN-R knock-out mice and wild-type littermates, the OMgp 
transgenic mice, where OMgp expression has been down-regulated in 
myelin-producing cells, exhibited a specific disorganization at the NORs. The 
abnormalities are characterized by displacement of lateral glial loops and shortening 
of nodal spans. Contactin/F3, Caspr and other axonal adhesion molecules are key 
elements of the axon-glial interactions which contribute to axonal differentiation. 
However, parameters such as the nodal distance and Nav channel clustering appear 
normal in either Caspr or contactin/F3 deficient mice (Bhat et al., 2001; Boyle et al., 
2001), suggesting that additional molecules contribute to nodal maintenance. The 
results obtained from the OMgp tg mice strengthened that oligodendrocytes provide 
signals for elaborating and maintaining nodal architecture. During myelinogenesis, 
particularly at late stage, internodal extensions generate an increasing compression 
against the existing nodes (Pedraza et al., 2001). It is therefore hypothesized that 
OMgp may act as a counterbalance to keep nodal width in a proper range. Of 
particular note is that OMgp distribution at nodes shows a proportionate relationship 
to axon diameters. Supporting this notion is the observation that abnormalities in the 
OMgp tg mice are more pronounced in axons ≥ 1µm. It is well-known that myelin 
sheath thickness or the number of lamellae is in proportion to axon diameter (Smith et 
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physical pressure against the nodes. This means that larger axons may require higher 
amounts of OMgp than smaller ones. As a result, loss of OMgp would have a 
preferential and dominant influence on the larger fibers.   
OMgp was also identified at all nodes within sciatic nerves of the PNS. 
However, sciatic nerves of the OMgp tg mice did not display similar phenotypes as 
the spinal cords. This type of discrepancy has also been observed in Caspr and 
contactin/F3 mutant mice where the paranodal junctions of the PNS are totally 
preserved, but severely defective in the CNS (Bhat et al., 2001; Rios et al., 2003). The 
explanation could be that additional stability of the PNS nodes is provided by 
Schwann cell microvilli and basal lamina and also the adherens junctions at paranodes 
(Fannon et al., 1995). Alternatively, it is likely that other molecules in the PNS 
compensate for OMgp’s role in nodal organization.  
It is noteworthy that OMgp carries the Thomsen-Friedenreich glycan that has 
been specifically localized to the NORs (Apostolski et al., 1994; Kleene and 
Schachner, 2004). Autoantibodies against this glycan have been associated with motor 
neuron disease and sensorimotor pathology (Thomas et al., 1996). Moreover, Gal 
(beta 1-3) GalNAc-bearing moieties in OMgp may be targets of immune-mediated 
neuropathies (Sheikh et al., 1999). These observations have lent support to functional 
importance of OMgp at the nodes.  
 
3. Glial regulation of Nav channel expression and clustering at NORs 
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myelinated axon is an evolutionary advance, which fundamentally depends on the 
formation of NORs and concentration of Nav channels in these sites. The mechanisms 
underlying these two events, however, are not yet well-established.   
Nav channels are also concentrated at the axonal initial segment (AIS) and 
neuromuscular junction (NMJ). While AIS is the site where action potentials are 
elicited, NORs are essential for their speedy travel along the axon. Because of the 
spatial continuity and structural similarity to NORs, AIS is sometimes deemed as “the 
first node”. However, it is not sure whether they are formed in a similar way or not. 
The answer is prone to “No” because of the fact that different from AIS, NORs are 
committed solely to the myelinated axons. In this view, comparative studies are 
necessary in order to understand different mechanisms of Nav channel clustering at 
both sites.  
NMJ is structurally homologous to synapses, where muscular molecules such 
as acetylcholine receptors (AChRs) and Nav channels are aggregated upon 
innervation. The extracellular matrix protein agrin has been identified as an inducer of 
these two clusters (Froehner, 1991; Sharp et al., 1996). As such, it might be feasible to 
identify which external molecules, comparable to agrin at NMJ, drive Nav channel 
clustering at the nodes.  
The intrinsic mechanisms governing Nav channel concentration at nodes 
probably include its selective transportation to the nodes, the rapid clearance from the 
internodes, the diffusion barrier at paranodes and the local bindings to axonal 
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well-documented (Salzer, 2003). My hypothesis is that Nav channels clustering at 
nodes may require coordination of the intrinsic and extrinsic signals. Interactions with 
extra-axonal molecules may constitute extrinsic modulation of the Nav channel 
expression, accumulation and function. 
A contribution to the extrinsic theory is the finding that a soluble 
oligodendrocytic protein alone is sufficient to guide Nav channel clustering in the 
presumptive NORs along naked axons (Kaplan et al., 1997; 2001). The biochemical 
identity of this protein, however, remains a mystery. In the PNS, Nav channel and 
ankyrin G cluster at NORs, relying upon direct contact between axon and myelinating 
Schwann cells (Ching et al., 1999). This may not involve any soluble factors. In 
general, expression or re-distribution of the Nav channels and remodeling of the 
axonal domains are paritially determined by certain glial factors. 
This notion has been further substantiated by the findings that 
oligodendrocytic TN-R accumulates at nodes where it interacts with axonal 
contactin/F3 and Nav channel β2 subunit (Ffrench-Constant et al., 1986; Bartsch et al., 
1993; Pesheva et al., 1993; Isom et al., 1995; Xiao et al., 1996; 1998), by which it 
amplifies Na+ currents (Xiao et al., 1999). Consistent with this, conduction velocity 
along optic nerves in the TN-R deficient mice is reduced. Nevertheless, Nav channel 
expression and distribution in these mice remain normal (Weber et al., 1999). These 
observations underscore the role of TN-R in regulating Nav channel activation rather 
than its expression and clustering. Indeed, TN-R protein displayed no capacity of 
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2001). Beside TN-R, Rptpβ/phosphocan, which is probably derived from the 
perinodal glia in the CNS, regulates firing dynamics of the Nav channels (Ratcliffe et 
al., 2000). 
An alternate example in the PNS is indicated by dystroglycan, a core 
component of the dystrophin-glycoprotein complex. Nodal axolemmas in the PNS are 
closely associated with the Schwann cell microvilli (Fig. 1; Robertson, 1957; 
Hildebrand et al., 1993). What specific roles do the microvilli play? Analyses of 
dystroglycan deficient mice revealed a role of this molecule in axon-glial coordination 
at the PNS nodes. Loss of dystroglycan in Schwann cell microvilli results in a 
decreased density of Nav channels and slowed nerve conduction (Saito et al., 2003). 
This involves dystroglycan in a trans-interaction between nodal axolemma and 
microvilli. Indeed, dystrophin via its PDZ domain interacts with Nav channels 
(Schultz et al., 1998).  
In the current study, one discovery is that nodal OMgp interacts with Nav 
channel β subunits. During development, OMgp clustering lagged behind that of Nav 
channel and was related to the nodal establishment. In vitro, OMgp protein failed to 
induce Nav channel clustering along neurites of the purified RGCs. In the OMgp 
transgenic mice, Nav channel distribution at the nodes remained unchanged. These 
evidences collectively suggested no or little contribution of OMgp in Nav channel 
clustering. Based on these findings, it has been proposed that OMgp may not be a 
clustering signal but rather a functional regulator of Nav channels. To test this, 
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lung (CHL) cells and primary hippocampal neurons. The results, however, have 
demonstrated that OMgp does not play a direct role in modulating Na+ currents.   
Significantly, the protein expression of Nav channel α subunit is modestly 
down-regulated in the OMgp tg mice, suggesting that OMgp, via the interactions with 
β subunits, regulates the expression of functional Nav channels. In this regard, OMgp 
resembles contactin/F3 and neurofascin, both of which are able to enhance Nav 
channels expression at nodes (Kazarinova-Noyes et al., 2001; Liu et al., 2001; 
Ratcliffe et al., 2001; McEwen and Isom, 2004; Shah et al., 2004). Contactin/F3 and 
neurofascin are two axonal molecules at nodes and cis-interact with Nav channels. It 
is likely that the cis-interactions may occur early in the cytoplasm, like the one 
between Nav1.3 and contactin/F3 (Shah et al., 2004). However, this seems not ture for 
OMgp because of it being a glial molecule. Given that OMgp may exist as a soluble 
form, it could interact with Nav channel subunits in either a trans-or a cis- fashion. I 
am hypothesizing that soluble OMgp at nodes may trigger a different pathway which 
critically requires β subunits. The similar roles of axonal and glial molecules in 
regulation of the Nav channel density have thus emphasized the central role of β 
subunits. However, expression of Nav channel α subunit is quite a complicated 
process considering that it bears multiple transmembrane domains. Therefore, 
identification of how β subunits regulate the membrane insertion of α molecule will 
be worthwhile for future study.    
An additional interest is the isoform transformation of Nav channels at the 
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during development (Boiko et al., 2001; Kaplan et al., 2001; Salzer, 2002). What is 
the mechanism of this switch and how it is significant in function remain to be 
answered. Of note is the fact that this switch relies heavily on myelin compaction 
(Boiko et al., 2001). In the shiver mice where myelin sheaths are not consolidated due 
to the loss of MBP expression, Nav1.2 is sustained at high level and most are not 
replaced by Nav1.6. This observation has raised a possibility that myelin or 
oligodendrocytes may regulate the gene expression in axons. But, what is the causal 
factor: MBP itself or the disrupted myelin organization following MBP loss? It will be 
interesting and informative if the switch is similarly stalled in other animal models 
including the OMgp tg mice.    
As alluded to above, Nav channels are moved toward the future nodes and 
Nav1.2 is clustered by re-location. This appears unlikely for Nav1.6; but rather, 
enrichment of Nav1.6 at the mature nodes is achieved only by its active insertion to 
nodal membranes and selective internalization of Nav1.2 at the same time. 
Transported vesicles accumulate in the nodal cytoplasm and Nav1.6 is seen in these 
vesicles (Caldwell, 2000), supporting the existence of above mechanisms. Myelin 
signals are implicated in regulation of the axonal cytoskeleton and axon caliber (de 
Waegh et al., 1992). However, the mechanisms are still unclear. Some future studies 
are dedicated to identify cytoplasmic elements downstream of these axon-glial 
interactions. These include kinases and phosphatases, the pathways responsible for 
protein delivery and internalization, and transcription factors regulating 
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4. Nogo-A-Caspr interaction in the paranodal compartment 
Nogo has been named after its inhibitory nature being identified. The receptor NgR 
signals the inhibition produced by Nogo-66, the extracellular segment of Nogo 
(Fournier et al., 2001). However, it has been noted that expressions of Nogo and its 
receptor NgR are not well matched, either in the development or after CNS lesions 
(Huber et al., 2002; Josephson et al., 2002; Josephson et al., 2003). Furthermore, 
Nogo-66 is not the sole ligand of NgR because MAG and OMgp are also binding 
partners of NgR (Wang et al., 2002). It is therefore envisioned that NgR rather than 
the ligands is a key determinant of the inhibitory effect. However, it was quite 
disappointing that NgR deficiency neither reduced in vitro the neurite inhibition nor 
improved the in vivo regeneration of lesioned corticospinal tract (CST) (Kim et al., 
2004; Zheng et al., 2005). This indicates that additional receptor(s) for Nogo might 
mediate functions beyond the neuronal inhibition.  
Nogo-A, one of the three Nogo splice variants, is produced by 
oligodendrocyte/myelin at early postnatal stage (Wang et al., 2002). Nogo-A’s 
expression coincides well with the time course of myelination (Fig. 7), suggesting its 
involvement in the developmental event. In the current study, it has been identified 
that Nogo-A has a confined distribution at the CNS paranodes where it interacts with 
the junction associated protein Caspr/paranodin. This interaction is understandable 
because Nogo-66 on oligodendrocytic processes exposes itself to the opposite axonal 
molecular repertoire throughout the myelination. Nogo-66 could be recognized by 
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developmental studies (Fig. 17, 18, 19). According to a recent report, recruitment of 
Caspr inhibits the direct interaction between contactin/F3 and Nf155 (Gollan et al., 
2003), implicating that Nf155 is not a preferable partner of this axonal complex. In 
this respect, Nogo-A-Caspr interaction is at least comparable to F3-Nf155 interaction 
in the paranodal axon-glial coordination. PTPalpha is also expressed by glial cells 
(den Hertog, 1999; Ledig et al., 1999) and readily interacts with contactin/F3 (Zeng et 
al., 1999), raising a possibility that PTPalpha could be an additional receptor for 
contactin/F3. However, my own result revealed that PTPalpha was diffusely 
distributed in CNS myelinated fibers. Nevertheless, other glial components may 
contribute too. Further studies of Nogo-A-Caspr interaction in conditional knock-out 
mice with a particular focus on their inter-dependence are essentially required to 
address their roles in paranodal building.   
The NOR and abutting domains are characteristics of the myelinated axons. 
Processes emanating from myelinating glia clutch at paranodes to build the molecular 
fence that serves to separate Nav and Kv1 channels from each other (Salzer, 2003). In 
comparison to Nav channels at NORs, axonal sorting and distribution of shaker-type 
Kv1 channels appear to be determined intrinsically. For instance, the proper axonal 
targeting of Kv1.2 depends on its N-terminal T1 tetramerization domain (Gu et al., 
2003). Misonou et al. (2004) also found that Ca2+-dependent dephosphorylation of 
Kv2.1 impaired its clustering in the pyramidal neurons. 
The majority of mechanisms underlying Kv1 channel clusters at 
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retaining Kv1 channels at this site (Bhat et al., 2001; Boyle et al., 2001; Poliak et al., 
2001; Arroyo et al., 2002; Ishibashi et al., 2002). How does the Nogo-A-Caspr 
interaction contribute to Kv1 channel distribution? CGT (ceramide 
galactosyltransferase) deficient mice are featured by the disrupted paranodal junctions 
and disappearance of Caspr/paranodin in the paranodes (Poliak et al., 2001). My 
research describes in these mice Nogo-A being dispersed rather than clustered at the 
paranodes (Fig. 13). This indicates the possibility that myelin disruption may result in 
loss of ligands/receptors such as Nogo-A, consequently causing defects in axon-glial 
junctions. Nogo-A was missing from paranodes in another model, the shiverer mice, 
which was accompanied by displacement of Caspr/paranodin and Kv1 channels (Fig. 
22). Together, the results suggest that not only axonal molecules but also some glial 
counterparts such as Nogo-A are paramount for the proper location of Kv1 channels. 
Accumulating evidence from this study suggests that Kv1 channel 
accumulation and maintenance at the juxtaparanode involves the Nogo-A-Caspr 
complex. In the myelinated axons of the CNS, Kv1 channel labeling becomes more 
prominent over the postnatal development, initially localizing to juxtaparanodes and 
also to paranodal bands that alternate with Caspr immunoreactivity (Rasband et al., 
1999). At later postnatal stages, Kv channels are excluded from the paranodes and 
become exclusively juxtaparanodal. It has been shown here that Nogo-A, via Caspr, 
associates indirectly with Kv1.1. In addition, the temporo-spatial transition of Nogo-A 
and Kv1.1, as well as that of Caspr and Kv1.1 are similar, implying that an interaction 
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Nogo-A/Caspr colocalizes with Kv1.1 at paranodes at the early stages of myelination. 
Nogo-A may therefore complement or regulate the action of Caspr in establishing the 
mature axonal domains and in doing so aid in Kv1
 
channels distribution to 
juxtaparanodes (Fig. 51). Investigation of Nogo-A (or Nogo-A/Caspr) constitutive or 
conditional deficient animals in vivo, possibly using oligodendrocyte specific 
promoters, may help reveal the role of Nogo-A during myelination. According to the 
quantitative analyses in both EAE rats and Shiverer mice, the lengths of the gaps 
between paired Kv1 channel clusters were reduced significantly. This occurred in 
conjunction with a significant reduction in Nogo-A clusters. Kv1 channels may 
therefore co-localize with Caspr again in these pathological conditions. A collection of 
these results implicated paranodal Nogo-A participating in the exclusion of Kv1 
channels. Thus it will be interesting to explore whether this transient interaction also 
occurs during remyelination. 
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interaction at the paranodes during myelination.  
Paranodal Nogo-A trans-interacts with axonal Caspr, possibly regulating Kv1 channel 
localization during the early stages of myelination (from P5). With the firm 
establishment of axoglial junctions in the adults, Kv1 channels were excluded from 
paranodes where Nogo-A/Caspr interaction is maintained. N: node of Ranvier, PN: 
paranode, JPN: juxtaparanode. 
 
Of additional interest was that Kv1 channels interact with Caspr as early as P5 
when they co-localized at immature paranodes. After maturation, however, Kv1 
channels were excluded from the paranodes and concentrated in the juxtaparanodes. 
This relocation of Kv1 channels may be an indicator of the maturation of the 
paranodal junction/sieve. Recruitment of Nogo-A and other glial components into the 
paranodal complex may serve as the driving force to relocate Kv1 channels. Therefore, 
disruption of myelin and loss of Nogo-A from paranodes will release Caspr. The 
disengaged Caspr then binds back to and attracts Kv1 channels so as to display the 
dispersed and overlapped distributions of Caspr and Kv1 channels at both paranodes 
and juxtaparanodes (Fig. 22). To directly support this explanation, the analysis of 
Nogo-A deficient mice is of extreme importance.   
What will be the functional consequences in the neuronal/axonal interior 
following the Nogo-A-Caspr interaction? Caspr possesses a putative SH3 binding 
domain and a FERM (protein 4.1-Ezrin-Radixin-Moesin) binding sequence in its 
cytoplasmic region (Menegoz et al., 1997; Peles et al., 1997), enabling itself as a 
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member of the 4.1 family of cytoskeletal proteins (Ohara et al., 2000; Parra et al., 
2000), which is enriched at paranodes and juxtaparanodes (Denisenko-Nehrbass et al., 
2003b). Akin to other 4.1 family members (Sun et al., 2002), 4.1B functions as a 
tumor suppressor (Tran et al., 1999; Yu et al., 2002). 4.1B interacts with the 14-3-3 
protein that is further able to bind a multitude of functionally diverse signaling 
proteins, including kinases and phosphatases (Fu et al., 2000; Robb et al., 2004). All 
these raise the possibility that Nogo-A may exert growth suppressing effects or other 
activities on neuron/axon by recruiting 4.1B via Caspr (Fig. 52).  
 
5. Possible roles of MAG in axon-glia interactions  
Since MAG has been identified at junctional sites of myelinated fibers, it is implicated 
in axon-glial communication due to its adhesive properties (Bartsch et al., 1989; 
Arroyo and Scherer, 2000). NgR/p75 and the gangliosides GD1a and GT1b are 
receptors for MAG, mediating its inhibitory effect on axonal growth (Domeniconi et 
al., 2002; Liu et al., 2002; Vyas et al., 2002). Subtle abnormalities in myelin wrapping 
and nerve conduction were detected in MAG deficient mice, assigning a role for 
MAG in myelin integrity (Montag et al., 1994; Weiss et al., 2001). Axonopathy is also 
evident in these mice, including the reduced axon caliber and more tightly packed, 
hypophosphorylated neurofilaments in the internode (Yin et al., 1998; Kumar et al., 
2002). MAG is connected with a role in regulating axonal development, although no 
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6. OMgp exhibits opposing effects on myelination in the CNS and PNS  
It was identified in this study that OMgp was enriched at NORs not only in the spinal 
cord but also in the sciatic nerves. In the OMgp transgenic mice, large axons in spinal 
cord were hypo-myelinated whereas fibers of sciatic nerve underwent 
hyper-myelination, propably indicating that OMgp may play oppositing roles in 
myelination of the CNS and PNS. This opposition has also been repeatedly noted for 
several other molecules. For example, adenosine serves as an active axon-glial signal 
in the CNS to promote differentiation and myelination, but ATP is the signaling 
molecule in the PNS where it arrests differentiation and inhibits myelination (Fields 
and Stevens, 2000; Stevens et al., 2002). In contrast, NGF promotes myelination by 
Schwann cells but reduces myelination by oligodendrocytes (Chan et al., 2004). These 
observations make it likely that different receptors and/or signaling pathways in 
oligodendrocytes and Schwann cells are used by the same molecule. OMgp exists in 
the CNS as a soluble factor and its expression and clustering are matched to the late 
phase of myelination. Based on these findings, OMgp is suspected of an autocrine 
signal regulating myelination in the CNS. Whether OMgp might have a similar or 
distinct role in the PNS is an interesting question. It would be anticipated that OMgp 
might have a different function for myelin development in the PNS. In this view, 
receptors of OMgp in myelinating glia need to be explored, through which insights 
into the mechanisms of how autocrine signals regulate the differentiation of 
oligodendrocytes and Schwann cells could be gained.  
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processes (Butt et al., 1999). Do these processes, which resemble Schwann cell 
microvilli, express OMgp? If so, then how do they contribute to the formation of 




Figure 52. A schematic summary describes axon-glial interactions involving the 
neurite outgrowth inhibitors (TN-R, MAG, OMgp and Nogo-A). 
 
7. What roles does NgR play in the intact CNS? 
All available data characterized NgR as a major component in failure of CNS 
regeneration. However, NgR is expressed in a way not restricted to injury sites (Huber 
et al., 2002; Hunt et al., 2002; Josephson et al., 2002, 2003). My study also confirmed 
that NgR expression commences as early as P1 with a slight down-regulation by P14 
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arises as of what roles NgR might play in the intact CNS?  
In recent years, several studies have suggested that NgR plays a role in neural 
plasticity, owing to its presence within synaptic profiles in hippocampus, cerebellum 
and other regions of the brain (Josephson et al., 2002; Wang et al., 2002). NgR 
expression was reduced in animal models of learning and memory which are 
subjected to kainic acid treatment or running tasks, pointing to a role in neuronal 
plasticity (Josephson et al., 2003). So far, it is not known whether potential ligands of 
NgR have a matched distribution at these sites, particularly considering that both 
OMgp and Nogo-A are expressed in a subset of neurons. Studies with NgR transgenic 
or conditional knock-out mice may decode its physiological role in synapses 
formation and/or plasticity.   
In myelinated or non-myelinated axons, NgR is uniformly distributed (Wang 
et al., 2002; Figs. 8, 50), indicating that NgR is not closely related to myelin wrapping. 
On the other hand, the even distribution along axons exposes NgR with the equal 
opportunity to all ligands from myelin. Given the fact that both MAG and Nogo-A are 
normally present in the perinodal myelin membrane (Buss and Schwab, 2003), it is 
plausible that NgR via interactions with both protein should have resulted in failure of 
myelination, in a way similar to axonal repulsion.  
The present results demonstrated that Nogo-A and OMgp each have distinct 
interactions unrelated to NgR, which are involved in myelin development and 
maintenance. How these newly identified interactions are related to the binding with 
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and/or down-regulation of physiological receptors may represent a possible 
relationship. During development, Nogo-A was increasingly up-regulated whereas the 
NgR level was gradually declined (Fig. 7), implicating that Nogo-A may be able to 
interact with additional receptors, for example, Caspr. After injury, however, Caspr 
expression is down-regulated in axons afflicted with multiple sclerosis (Wolswijk and 
Balesar, 2003), highlighting the requirement of Caspr expression in myelin 
maintenance.  
It is of major interest to understand physiological roles of these myelin 
associated “inhibitory” molecules. This attempt would lead to the identification of 
specific targets for promoting neuronal regeneration and axon myelination.  
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A growing body of evidence from studies of CNS regeneration supports the 
hypothesis that NOIs, which are known for their involvement in limiting CNS 
regeneration, have yet undiscovered physiological functions. The current study has 
demonstrated some evidence in support of their roles in axon-glial communication 
during axonal myelination.  
Among the NOIs, MAG, Nogo-A and OMgp are ligands binding the common 
receptor, NgR. NgR is evenly expressed and distributed along axons. The present 
study has identified that both NgR ligands, OMgp and Nogo-A, are glial molecules 
which cluster along the myelianted axons.   
OMgp accumulates at the NORs in the CNS as well as PNS. The backbone of 
OMgp contains leucine-rich repeats (LR) and HNK-1 carbohydrates which allow 
interactions with other molecules. Nodal OMgp associates with a number of ECM 
axonal molecules in vivo. Among these, OMgp interacts with Nav channel β subunits. 
However, in vitro studies have excluded a function in Nav channel clustering. In a 
transgenic mouse strain where OMgp expression is down-regulated, Nav channel α 
subunits are down-regulated too, thus suggesting a role for OMgp in regulating Nav 
channels at the gene expression level.  
In addition, nodal architecture and nerve conduction are impaired particularly 
in large axons of OMgp transgenic mice. These phenotypes have demonstrated that 
OMgp clustered at the later phase of myelination is functionally required for final 
assembly of NORs. In contrast, TN-R knock-out mice do not exhibit the same 
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formation of NORs.  
In the OMgp tg mice, it has been unexpectedly observed that 
hypo-myelination occurrs in the CNS but hyper-myelination in the PNS. OMgp is 
therefore a possible regulator of myelination with oppositing effects in both locations. 
Moveover, OMgp is unlikely required for the initiation of myelination because 
transverse bands mature and organize properly at paranodes. Taken together, present 
results provide evidence supporting OMgp’s involvement in late stage of myelination 
and the elaboration of NORs.   
Nogo-A is enriched at the CNS paranodes where it trans-interacts with 
Caspr/paranodin. In several demyelination animal models, loss of Nogo-A clusters is 
accompanied by mis-location of Shaker-type Kv1 channels. It is speculated that 
Nogo-A via binding to Caspr/paranodin might play a role in shaping the molecular 
barrier at paranodes. During myelination, oligodendrocytes stretch the processes 
along the axons. Nogo-66, the extracellular loop of Nogo-A, facilitates the contact 
with axonal counterparts. Nogo-A expressed on tips of the migrating oligodendrocytic 
loops may move into paranodes as myelin compacts. It is worth noting that Nogo-A’s 
consolidation parallels that of Caspr, implicating that Nogo-Caspr interaction occurs 
as early as the onset of myelination. 
The current study has provided mechanisms of how myelin-related molecules 
communicate with axons in the normal context. In summary, the myelin components 
may act not only as the structural components, but as basic mediators of axon-glial 




CHAPTER 5 CONCLUSION & PERSPECTIVE 
171 
However, the signaling events downstream of these interactions await further 
investigation. In principle, studies of conditional Nogo-A and OMgp knock-out mice 
will help to unlock some functional aspects of these interactions. Clustering of Nav 
and Kv1 channels are hallmarks of a polarized axon upon myelination; knowledge of 
mechanisms governing their expression and distribution is instructive to understand 
how nerve conduction and even neural circuits run in glial settings. On the other hand, 
electrophysiological investigations may help to elucidate the direct impacts of these 
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Appendix 1: Solutions and Buffers 
 
Regeneration Buffer: 
1 M NaCl;  
0.1 M borate acid  pH8.5. 
 
Elution buffer:  
7.5mM glutathione (MW: 307.3);  
50mM Tris/HCl  pH8.0. 
 
Denaturation buffer: 
100 mM Tris/HCl pH8.0;  
8 M Urea;  
2 mM EDTA;  
300 mM DTE (Dithioerythritol). 
 
Renaturation Buffer: 
0.1 M Tris/HCl pH8.0;  
200 mM L-arginine;  
10 mM Cystamine;  
2 mM EDTA (ethylenediaminetetraacetic acid). 
 
Cell lysis buffer: 
20 mM Tris-HCl pH7.5;  
5 mM EGTA;  
25 mM β-glycerophosphate;  
2 mM dithiothreitol (DTT);  
1 mM sodium orthovanadate;  






1% protease inhibitors and 0.1% NP-40. 
 
Tissue lysis buffer-1  
50 mM Tris-HCl pH7.5;  
5 mM EDTA;  
1% Triton X-100;  
proteases inhibitors. 
Tissue homogenizing buffer  
320 mM sucrose;  
10 mM Tris-HCl pH 7.4;  
1 mM NaHCO3 pH 7.4;  
1 mM MgCl2. 
 
Tissue lysis buffer-2 
10 mM Tris-HCl pH9;  
150 mM NaCl;  
0.5% Triton X-100;  
1% sodium deoxycholate (DOC);  
0.5% SDS;  
2 mM EDTA;  
1% protease inhibitor cocktail. 
 
Solutions used for western blotting: 
1x TBS: (1 Liter)                  
Tris base 2.42 g;  
NaCl 0.8 g;  
add ddH20 up to 1 liter; adjusted to pH7.6 with HCl.               
1x TBST: (1 Liter)    






0.1% Tween 20. 
 
Ringer’s Solution 
ddH2O 10 liter;   
NaCl  85 g;   
KCl  2.5 g;   
CaCl2  3g;   
NaHCO3  2g. 
             
Binding Buffer (for GST pull-down assay) 
NaCl  250 mM;   
HEPES pH7.9 50 mM;   
EDTA  0.5 mM;   
NP-40  0.1%;   
DTE  1 mM.  
 
0.1 M phosphate buffer (PB) 
NaH2PO4. H2O  2.76 g;  
Na2HPO4. 2H2O 14.24 g (or Na2HPO4 11.38 g);  
Add ddH2O up to 1 liter. 
Or prepare stock solution:                         
A  NaH2PO4.2H2O  78 g/L;   
B  Na2HPO4. 2H2O  89 g/L. 
To make 0.1 M PB, pH7.4 (100ml): A 3.8 ml;  B 16.2 ml;  ddH2O 80 ml.                 
 
0.5 M cacodylate buffer 
Sodium Cacodylate (CH3)2AsOONa.H2O 107.015 g  
dissolved in ddH2O (up to 1 liter), filtered. 
